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Abstract
Therapeutic dose application by highly tumor-conformal scanned ion beam radiation therapy is
currently in most cases not possible for indications which exhibit tumor motion. Due to interfer-
ence effects, the dose application is likely to be distorted so that treatment is not safely possible.
Distorted dose profiles can be improved by means of statistical averaging - the corresponding
technique is known as re-scanning and was investigated in this work.
Carbon ion treatment planning studies for five lung cancer cases and six different re-scanning
flavors were performed. The data show that at least the techniques breath-sampled and random-
time-delay re-scanning should be able to compensate dose inhomogeneities sufficiently as to
enable patient treatment.
Re-scanning was technically implemented in a research version. Experiments were performed
to test the implementation, to verify the dose application and to investigate the motion mit-
igation efficiency. The corresponding dose levels showed only small deviations compared to
the therapy delivery mode for stationary targets. The experimental data for motion mitigation
strengthened the findings of the simulations. Over- and underdosage can be efficiently reduced
using re-scanning.
Zusammenfassung
Tumorkonforme Bestrahlung mit einem gescannten Ionenstrahl ist meistens nicht möglich,
wenn sich der Tumor während der Bestrahlung bewegt. Die Interferenz von Bewegung und
Bestrahlung verfälscht die Dosisapplikation oft in einem klinisch nicht vertretbaren Maß. Eine
Methode, die alsMehrfachbestrahlung (MB) bekannt ist und im Rahmen dieser Arbeit untersucht
wurde, kann diese Interferenzeffekte durch statistische Mittelung reduzieren.
Mittels Bestrahlungsplanungsstudien auf Basis von fünf Lungentumordatensätzen wurden
sechs verschiedene MB-Varianten bewertet. Mindestens zwei Varianten, die Atemperiode-
angepasste und die Zufalls-Pausen MB, konnten die Dosisinhomogenitäten so weit reduzieren,
dass eine klinische Anwendung möglich sein sollte.
Die MB wurde als Forschungsmodalität auch technisch implementiert. Durch Experimente
konnten die Implementierung, die Dosisapplikation und die Effizienz der Bewegungskompensa-
tion validiert werden. Im statischen Fall zeigen die Ergebnisse zeigen nur geringe Abweichungen
im Vergleich zum Therapiemodus. Die Experimente zur Reduzierung der Interferenzeffekte stüt-
zen die Ergebnisse der Simulationen. Über- und Unterdosierungen können effizient durch die
MB reduziert werden.
1

Contents
List of Abbreviations 7
1. Motivation 9
2. Introduction - research background and fundamentals 11
2.1. Development of heavy ion therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1.1. Physical properties of heavy ion interaction with matter . . . . . . . . . . . . 12
Interactions of photons and matter . . . . . . . . . . . . . . . . . . . . . . . . . 14
Interactions of ions and matter . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.2. Radiobiology of heavy ion irradiation . . . . . . . . . . . . . . . . . . . . . . . 17
DNA - the primary target of radiation . . . . . . . . . . . . . . . . . . . . . . . 17
The relative biological effectiveness (RBE) . . . . . . . . . . . . . . . . . . . . 20
Linear-quadratic and local effect model (LEM) . . . . . . . . . . . . . . . . . 21
Fractionation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.1.3. Generation and application of ion beams . . . . . . . . . . . . . . . . . . . . . 22
Passive beam delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Active beam delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2. Treatment of static tumors with heavy ions . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.1. Tumor imaging and delineation . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.2. Treatment planning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.3. Treatment of moving tumors with heavy ions . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.1. Tumor motion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.2. A moving tumor - challenges in dose application, imaging, motion moni-
toring and delineation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Interplay effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Tumor imaging and delineation . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Motion monitoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.3.3. Treatment planning and dose calculation . . . . . . . . . . . . . . . . . . . . . 34
2.3.4. Motion mitigation by gating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.3.5. Motion mitigation by beam tracking . . . . . . . . . . . . . . . . . . . . . . . . 36
2.3.6. Motion mitigation by re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Slice-by-slice re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3
Volumetric re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Random-time-delay re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Breath-sampled re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Iso-layered re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
2.4. Aim of this work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3. Treatment planning studies 47
3.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2. Material & methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.2.1. 4D treatment planning framework . . . . . . . . . . . . . . . . . . . . . . . . . 48
Time resolved computed tomography (4DCT) patient data . . . . . . . . . . 50
Treatment plan parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Fractionation scheme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Re-scanning modes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
The physical-beam-record simulation environment . . . . . . . . . . . . . . . 53
Simulated physical beam record files - PBRsim . . . . . . . . . . . . . . . . . . 59
3.2.2. Patient simulation studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Standard cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Special case I - breath-sampled re-scanning uncertainty . . . . . . . . . . . . . 62
Special case II - variation of the number and the maximum length of the
random-pauses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.2.3. Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.3.1. The physical-beam-record simulation environment . . . . . . . . . . . . . . . 65
3.3.2. Patient simulation studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Standard cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Special case I - breath-sampled re-scanning uncertainty . . . . . . . . . . . . . 73
Special case II - variation of the number and the maximum length of the
random-pauses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.4.1. The physical-beam-record simulation environment . . . . . . . . . . . . . . . 77
3.4.2. Patient simulation studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Standard cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Special case I - breath-sampled re-scanning uncertainty . . . . . . . . . . . . . 84
Special case II - variation of the number and the maximum length of the
random-pauses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
3.5. Conclusion and outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4
4. Dosimetry and feasibility aspects of re-scanning irradiation 89
4.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.2. Material & methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
4.2.1. Re-scan implementation - general aspects . . . . . . . . . . . . . . . . . . . . 90
4.2.2. Dosimetry - detectors & methods . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.2.3. Implementation & dosimetry at GSI . . . . . . . . . . . . . . . . . . . . . . . . 94
4.2.4. Testing the implementation & dosimetry at GSI . . . . . . . . . . . . . . . . . 95
4.2.5. Implementation & dosimetry at HIT . . . . . . . . . . . . . . . . . . . . . . . . 97
4.2.6. Testing the implementation & dosimetry at HIT . . . . . . . . . . . . . . . . . 100
4.2.7. Motion effects mitigation by re-scanning . . . . . . . . . . . . . . . . . . . . . 103
2D irradiation: Experiments - Amplitude, period, phase and scanpath de-
pendence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
2D irradiation: Simulations - Amplitude, period, phase, intensity, scan-
path and spill profile dependence . . . . . . . . . . . . . . . . . . . . 105
3D irradiation: Experiments with phantoms . . . . . . . . . . . . . . . . . . . 106
3D irradiation: Simulations with phantoms . . . . . . . . . . . . . . . . . . . 107
4.3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
4.3.1. Implementation & dosimetry at GSI . . . . . . . . . . . . . . . . . . . . . . . . 108
4.3.2. Implementation & dosimetry HIT . . . . . . . . . . . . . . . . . . . . . . . . . . 113
4.3.3. Motion effects mitigation by re-scanning . . . . . . . . . . . . . . . . . . . . . 120
2D irradiation: Amplitude, period, intensity and scanpath dependence . . 120
2D irradiation: Size of the field penumbra . . . . . . . . . . . . . . . . . . . . 129
2D irradiation: Starting phase dependence . . . . . . . . . . . . . . . . . . . . 130
2D irradiation: Spill profile dependence . . . . . . . . . . . . . . . . . . . . . . 133
3D irradiation: Density variation phantom . . . . . . . . . . . . . . . . . . . . 135
3D irradiation: Breathing thorax phantom with 6D target-motion . . . . . . 136
4.4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
4.4.1. Implementation & dosimetry - a general view . . . . . . . . . . . . . . . . . . 137
4.4.2. Implementation & dosimetry at GSI . . . . . . . . . . . . . . . . . . . . . . . . 138
4.4.3. Implementation & dosimetry at HIT . . . . . . . . . . . . . . . . . . . . . . . . 141
4.4.4. Motion mitigation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
2D irradiation: Amplitude and scanpath dependence . . . . . . . . . . . . . . 144
2D irradiation: Reducing the size of the field penumbra . . . . . . . . . . . . 146
2D irradiation: Correlation effects, phase dependence and the statistical
nature of re-scanning . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
2D irradiation: Intensity and spill profile dependence . . . . . . . . . . . . . 149
3D irradiation of phantoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
4.5. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
5
5. Discussion and summary 153
6. Conclusion 161
A. Appendix of chapter 3 163
A.1. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
A.1.1. Caption: Mean and standard deviations of the Vx or D5   D95 measures
along with the corresponding significance tests . . . . . . . . . . . . . . . . . 163
A.1.2. Caption: Breath-sampled re-scanning uncertainty: Mean and standard de-
viations of the Vx or D5   D95 measures along with the corresponding
significance tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
A.1.3. Caption: random-time-delay re-scanning uncertainty: Mean and standard
deviations of the Vx or D5   D95 measures along with the corresponding
significance tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
A.1.4. Standard cases: Figures, mean V95, V107 D5 D95 values along with corre-
sponding significance testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Patient 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Patient 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
Patient 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
Patient 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Patient 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
A.1.5. Special case I - breath-sampled re-scanning uncertainty: Mean V95, V107
D5  D95 values along with corresponding significance testing . . . . . . . . 175
Patient 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
Patient 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
Patient 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Patient 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
A.1.6. Special case II - variation of the number and the maximum length of the
random-pauses: Mean V95, V107 D5  D95 values along with corresponding
significance testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
Variation of the number of the random-pauses . . . . . . . . . . . . . . . . . . 181
Variation of the maximum length of the random-pauses . . . . . . . . . . . . 182
B. Appendix of chapter 4 185
B.1. Material & methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
B.1.1. Dosimetry at Heidelberg Ion-Beam Therapy Centre (HIT) . . . . . . . . . . . 185
B.2. Motion effects mitigation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
B.2.1. Motion effects mitigation by re-scanning at HIT . . . . . . . . . . . . . . . . . 188
6
List of Abbreviations
4DCT time resolved computed tomography
ADC analog-to-digital converter
ACCvirtual virtual-accelerator
AP anterior-posterior
BT beam tracking
BEV beam’s eye view
BED biological effective dose
BreThoPho breathing-thorax-phantom-with-
6D-target-motion
BS breath-sampled (re-scanning)
CT computed tomography
CTV clinical target volume
DNA deoxyribonucleic acid
DVH dose volume histogram
DAH dose area histogram
DeVarPho density-variation-phantom
FWHM full width at half maximum
GSI GSI Helmholtzzentrum für
Schwerionenforschung GmbH
GTV gross tumor volume
HIMAC Heavy-Ion Medical Accelerator in
Chiba
HIT Heidelberg Ion-Beam Therapy Centre
HU Hounsfield unit
IC ionisation chamber
IES iso-energy slice
IMPT intensity modulated particle therapy
IMRT intensity modulated radiotherapy
ITV internal target volume
LR left-right
LEM local effect model
LET linear energy transfer
MBP machine beam plan
MBR machine beam record
MDACC MD Anderson Cancer Center
MGH Massachusetts General Hospital
MRI magnetic resonance imaging
MWPC multiwire proportional chamber
MU monitor units
NIRS National Institute of Radiological
Sciences
NSCLC non-small cell lung cancer
OD optical density
PET positron emission tomography
PBP physical-beam-plan
PBR physical-beam-record
PBRSimEnv physical-beam-record simulation
environment
PCR phase-controlled re-scanning
PDF probability density function
PMMA polymethyl methacrylate
PPIC1 parallel-plate ionization chamber 1
PPIC3 parallel-plate ionization chamber 3
PSI Paul Scherer Institut
PTV planning target volume
RBE relative biological effectiveness
RDBT real-time dose compensation combined
with beam tracking
RKI Robert Koch Institute
ROI region of interest
RPTC Rinecker Proton Therapy Centre
SI superior-inferior
Slice slice-by-slice re-scanning
SOBP spread out Bragg peak
TCU therapy control unit
OAR organ at risk
7
TRiP TReatment planning for Particles
TKR therapy control room
VOI volume of interest
WEPL water-equivalent path length
8
1 Motivation
Cancer is one of the most leading causes of pain and death to patients worldwide. The Robert
Koch-Institut (RKI, 2012) lists about 470.000 new cases and 216.000 deaths per year in Ger-
many. Up to 40% of all cancer deaths could be avoided by reducing tobacco use, improving
diets and physical activity, lowering alcohol consumption, eliminating workplace carcinogens
and immunizing against hepatitis B virus and the human papillomavirus (WHO, 2007). The
most effective treatment options include surgery, chemotherapy, radiotherapy and combina-
tions of these. In about 50% of the incidences radiation is used in the treatment course (Schardt
et al., 2010). In principle, every tumor can be controlled if a sufficient level of radiation can be
applied to it (Durante and Loeffler, 2010, 2013). However, this is not always possible because
it cannot be avoided in radiotherapy that healthy tissue receives a certain level of dose, too. If
an organ at risk (OAR) (e.g kidneys, liver, heart, spinal cord or brain stem) is too close to the
tumor it might not be possible to irradiate the tumor with a high dose level without causing
severe side effects. Therefore the development of radiotherapy techniques is driven by the aim
to deliver a dose distribution as conformal as possible to the tumor.
A method called active beam scanning with heavy ions, which is used at GSI Helmholtzzen-
trum für Schwerionenforschung GmbH (GSI) and Heidelberg Ion-Beam Therapy Centre (HIT),
is the latest development in that direction and clinical studies have shown the physical and
biological advantages of ion beams in dose conformity and tumor control rates (Schulz-Ertner
and Tsujii, 2007). Up to date, heavy ion beams are mainly used for stationary tumor types be-
cause the conformal irradiation of moving tumors is a big challenge. Especially lung tumors are
subjected to a rather large motion trajectory and, unfortunately, this type is the most frequent
cause of cancer death worldwide (and in Germany) with approximately 20% of the total can-
cer mortalities with an absolute number of 1.4 million humans (IARC, 2013). A moving tumor
causes several problems for radiotherapy: When determining the position of the tumor with a
computed tomography (CT) its movement leads to a blurred image, the same movement then
disturbs the dose application because the medical physicist is only able to apply a certain dose
to a specific position inside the tumor when its position is known.
The main effect of organ motion on conformal radiotherapy can easily be understood through
an analogy with photography. When a photo is taken of an object that moves significantly during
the exposure, the image will be blurred like displayed in figure 1.1. It can further be seen that
the area of the moving picture has been enlarged. The same is true if one tries to paint a picture
with a pencil on a moving canvas. The analogies represent e.g. making a 3D CT or irradiating a
dose distribution to the tumor, respectively. Some strategies have been proposed to treat moving
9
Figure 1.1.: Left picture: Brilliant Einstein. Right picture: Motion e ects can ruin taking or paint-
ing a clear picture as well as therapy success in heavy ion irradiation.
tumors using ions (Bert and Durante, 2011). One of these strategies, namely re-scanning, will
be addressed in this thesis. The beneficial outcome of a treatment course is very likely to fail if
dose inhomgeneities, which are due to the motion, cannot be efficiently reduced. In contrast to
standard heavy ion irradiation, the beam crosses the tumor volume in re-scanning mode many
times to reduce those dose inhomgeneities. It shall be shown in this work if re-scanning could be
a sensible option to treat patients with moving tumor in the near future at clinics like the HIT.
The scope of this thesis can be grouped as follows:
• Chapter 2 gives an overview of the physical and biological fundamentals of ion beam
therapy and introduces the re-scanning technique.
• Chapter 3 presents treatment planning studies of five patients with lung tumors on a basis
of simulated beam applications in the re-scan mode. The effectiveness of re-scanning with
respect to reducing dose inhomogeneities will be addressed and discussed.
• Chapter 4 address the technical feasibility of re-scanning and presents experimental results
performed at GSI and HIT. Simulations which complement and confirm the experimental
results are presented and discussed.
• Chapter 5 contains a discussion and a summary.
• Chapter 6 will conclude the thesis.
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2 Introduction - research background and
fundamentals
2.1 Development of heavy ion therapy
The discovery of the X-rays as a "new kind of radiation" in 1895 by W. C. Röntgen marked a
quantum jump in the field of physics. In the following years radiation became an important tool
in various academic fields like nuclear physics or medicine. The first medical use of the X-rays
was reported in the Lancet in 1896 - only one month after Röntgen’s discovery (Hall and Giaccia,
2006). In the historical development of radiotherapy two general tendencies are visible: The
clinical results of therapies are improved by a greater conformity of the applied radiation to
the target volume and by an increased biological effectiveness of the radiation (Kraft, 2000).
In 1946 R. Wilson (Wilson, 1946) first wrote that ions will meet these requirements much
better than photons. The first patient was treated with protons in 1954 at Lawrence Berkeley
Laboratory (Tobias et al., 1958). Due to the technically very challenging tasks involved it took
many years until the full physical and biological benefit of the heavy ions could be exploited
in a therapy pilot project at GSI Helmholtzzentrum für Schwerionenforschung GmbH (GSI)
which started patient treatment in the year 1998 (Kraft, 2000). Until today, both photon and
ion therapy are constantly improved in terms of dose application by the development of new
techniques and advantages in the understanding of the interaction of radiation with human
cells.
Figure 2.1 compares an optimized dose distribution for two state of the art techniques, namely
intensity modulated radiotherapy (IMRT) and intensity modulated particle therapy (IMPT).
While both methods show a homogeneous target coverage, the integral dose delivered to the pa-
tient is much smaller when using IMPT and, especially, the dosage to an organ at risk (OAR) can
be greatly reduced. Furthermore, the reduced dose low dose region in case of IMPT (Kaderka,
2011) is believed to reduce the risk of secondary cancer or side effects after modern radiotherapy
(Newhauser and Durante, 2011), so that even a pregnant 27-year-old woman (diagnosed for a
skull-base chordoma) was irradiated and no abnormalities have been observed in a follow-up
study of the child (Münter et al., 2010).
Since this work is focused on heavy ion therapy, information about new developments in
photon therapy can be found elsewhere (Kilby et al., 2010). In the following physical, technical,
medical and biological details will be introduced concerning heavy ion therapy.
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Figure 2.1.: Comparison of treatment plans with 9 fields of X-rays (IMRT – left picture) and with
2 fields of carbon ion (IMPT – right picture). In both cases the dose coverage of
the target volume is good but for carbon ions the dose to the normal tissue is much
smaller. Figure from (Amaldi and Kraft, 2008).
2.1.1 Physical properties of heavy ion interaction with matter
Figure 2.1 already showed that a tumor can be irradiated more conformal and with less integral
dose to the whole body by using carbon ions instead of photons. Both types of radiation mainly
interact with the tissue by the means of so called secondary electrons which have been produced
by the elementary interaction processes. However, these elementary interaction processes are
diverse for both heavy ion and photon irradiation which results in a different distribution of
the secondary electrons which then leads to different biological damage (Alpen, 1998; Hall and
Giaccia, 2006). After a small maximum in the entrance region, the dose of the photons drops
exponentially with the penetration depth. The depth dose curve of heavy ions on the other side
features a distinct narrow peak with a sharp dose fall off. This maximum is commonly known as
the Bragg-Peak. The basic physic interactions of these different properties are briefly introduced
in the following sections. An overview of the different depth dose distribution for various kinds
of radiation is illustrated in figure 2.2.
The dose, D, deposited in the tissue as a physical quantity is defined by the ratio of the
absorbed energy dE per mass element dm (Alpen, 1998)
D =
dE
dm
[1 Gy= 1 J/kg]. (2.1)
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Figure 2.2.: Depth dose profiles with di erent energies compared to carbon ions at two di erent
energies. The photon curves drop exponentially after reaching a maximum (build-
up e ect) shortly after entering the medium. The maximum of the dose deposition
of the carbon ions is a well defined function of the initial energy of the particles.
This maximum of the dose deposition is the so called Bragg-Peak which is located
around the end of the particle track. The distinct Bragg-Peak can be used to deposit
the dose in case of heavy ion irradiation more conformal to the target than by using
photons. Figure from (Lüchtenborg, 2012).
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Interactions of photons and matter
An overview of the interaction process of photons with matter are given e.g. in (Alpen, 1998).
To summarize the most important facts:
While passing through matter, photons in the energy regime (approximately 18 MeV) of ra-
diotherapy are mainly scattered by the photoelectric effect (cross section ⌧photo), by Compton
scattering (cross section  Compton) and pair production (cross section pair). The cross sections
depend on photon energy and material. Due to the nature of these interactions it follows that
the intensity I of a monoenergetic beam of photons with initial energy of I0 passing through an
absorber material of the thickness x is described by an exponential function:
I(x) = I0 · e (⌧photo+ Compton+pair )x . (2.2)
This function determines the depth dose distribution of photon in tissue (see figure 2.2).
Interactions of ions and matter
The absorbed dose of a parallel ion beam with the fluence F transversing a thin layer of material
with the mass density ⇢ can be calculated as (Schardt et al., 2010):
D [Gy]= 1.6 · 10 9 · dE
dx

keV
µm
 
· F îcm 2ó · 1
⇢
ñ
cm3
g
ô
, (2.3)
with dE/dx being the specific energy loss per unit length. Within the therapeutic energy range
of carbon ions,   = v/c ⇡ 0.7 (c = speed of light,v = particle’s velocity), dE/dx is dominated
by inelastic collisions of the incident particles with the target electrons and can be well described
with the Bethe-Bloch (Bethe, 1930; Bloch, 1933a,b) formula (Schardt et al., 2010; Nakamaru,
2010) including the shell correction C/Zt (which takes orbital velocities of the target molecules
into account) and a density correction term  /2 (Fano, 1963):
dE
dx
=
4⇡e4Zt Z2p
mev 2
ñ
ln
2mev 2
hIi   ln(1   
2)   2  C
Zt
   
2
ô
. (2.4)
Zp and Zt tag the nuclear charges of the projectile and target, me and e are the mass ind the
charge of an electron and hIi denotes the mean ionization energy of the target medium. At high
velocities the electrons of the projectile carbon ion are complete stripped off. At lower velocities
the mean charge decreases due to recombination processes and Zp needs to be replaced by the
empirical effective charge formula (Barkas, 1963):
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Ze f f = Zp
h
1  exp( 125  Z 2/3p )
i
. (2.5)
Stopping power curves can be seen in figure 2.3.
Figure 2.3.: Specific energy loss of carbon ions and protons in water. Equation 2.4 describes the
electronic energy loss. Figure from (Schardt et al., 2010)
Equations 2.4 illustrates that the distinct Bragg-Peak at low projectile energies of the heavy
ions is mainly caused by the 1/v 2 dependence. This increase of the specific energy loss at low
velocities is caused by the fact that the projectile ion spends more time in the Coulomb field of
the interacting atom. When the velocity gets gradually lower, the effective charge of the projectile
(see equation 2.5) is reduced so that the energy loss decreases again until the particle finally
stops.
The presented concepts illustrate the most important physical properties of heavy ion irradia-
tion concerning this thesis. Further information like range straggling, lateral scattering, nuclear
fragmentation or online in-vivo PET imaging can be found elsewhere (Kraft, 2000; Schardt et al.,
2010).
It was already mentioned that the main biological effect is caused by the secondary electrons,
which primarily transfer their energy via bremsstrahlung. Their distribution and energy spectra
is therefore crucial to understand the difference between different types of radiation. Figure 2.4
shows as an example the microscopic track structure of protons and carbon ions. Why different
physical properties result in diverse implications for therapeutic beam application can only be
understood by including related concepts and ideas of radiobiology, which will be introduced in
the next section.
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Figure 2.4.: Simulated paths of and energy distribution of secondary electrons produced by pro-
tons and carbon ions at di erent energies. Figure courtesy of M. Krämer.
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To summarize:
• X-rays and ions interact fundamentally different with matter. Nevertheless, both types of
radiation generate secondary electrons which then transmit the energy to the tissue.
• X-rays have an exponentially decreasing depth-dose profile wheres heavy ions show a sharp
peak (Bragg-peak) shortly before they stop. The depth of this peak is a function of the
particle’s energy.
• Carbon ions are especially well suited to apply a very conformal dose distribution to the
target.
2.1.2 Radiobiology of heavy ion irradiation
The effects of radiation on humans do not only depend on the total amount of energy which is
absorbed by the body but also to a great amount on how the energy is deposited. A total body
dose of 4 Gy of X-rays given to a human is lethal in about half of the individuals exposed (Hall
and Giaccia, 2006). In case of a body mass of 70 kg this corresponds to 67 calories which is the
energy necessary to heat 3 ml of coffee from a temperature of 37 C to 60 C. Drinking a sip of
the 60 C does not cause damage to humans. It follows that the evenly absorbed energy of heat
is obviously less harmful than the energy of X-rays which is delivered in small individual energy
packets - the photons.
DNA - the primary target of radiation
The biological effect caused by photons and heavy ions is due to the potential of both irradiation
types to ionize the molecules of a cell. These ionizations damage parts of the cell which can re-
sult in cell death, malfunctioning or genetic mutations. Since the deoxyribonucleic acid (DNA)
is the carrier of the genetic information and associated with the just mentioned process, it is be-
lieved that the DNA is the main critical target in radiotherapy. Many experiments demonstrating
that the chromosomal asymmetric exchange aberrations (dicentric, ring) are proportional to cell
killing (Hall and Giaccia, 2006), support this thesis.
As schematically illustrated in figure 2.5, the DNA consist of a backbone made of sugar-
phosphate groups. Attached to this backbone are four different bases adenine (A), cytosine
(C), guanine (G) and thymine (T) which code the genetic information via their sequence. Fig-
ure 2.5 a) shows that damage to the DNA can be caused by direct and indirect action which may
result in b) either single-strand or double-strand breaks. Double-strand breaks can be very com-
plex so that the different repair mechanism of a cell can fail when trying to restore the original
DNA coding sequence. The goal of radiotherapy is to induce severe damage to the tumor cells
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so that these repair mechanisms fail and the cell takes the controlled pathways of apoptosis or
mitotic cell death1.
Figure 2.5.: (a) Direct and indirect radiation damage to the DNA. Direct damage is caused by
energy deposition in direct hits from electrons liberated in ionization processes. Free
hydroxyl radicals (OH), formed by ionization in the hydrolysis of water, can cause
indirect damage to the DNA in chemical reactions. (b) Schematic illustration of se-
lected types of radiation damage to the DNA. The e ectiveness of the repair mech-
anisms of cells depends on the complexity of the damage (Richter, 2012).
The probability to induce complex lesions to the DNA increases with increasing local energy
deposition. The associated measured quantity is the so called linear energy transfer (LET). It
is defined as the energy locally deposited per length and typically given in keV/µm. Figure 2.6
shows the LET values for X-ray and carbon ion radiation. The LET of carbon ions is amongst
others a function of the energy of the carbon ions. The greatest value is reached in the region
around the Bragg-peak. It follows that carbon ions are much more efficient in causing complex
lesions to the cell. The rational behind this is that a uniform dose distribution, as caused by
the X-rays, can cause many simple lesions, as single-strand breaks, at different sites of the
DNA (or the cell) but these are repaired very efficiently. For example, if the DNA is in a non
replicative state, the repair of single-strand breaks lesions is in the order of one error per 107 
1011 depending on the source of data (Alpen, 1998).
1 Necrosis is another pathway of cell death. It is marked by an uncontrolled destruction of the cell which can
cause unwanted reaction of the immune system like inflammation.
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Figure 2.6.:Microscopic dose distribution for photons and carbon ions with di erent specific
energies (Scholz, 2003). The local dose deposition of the X-rays is rather uniform.
When the energy of a carbon ion decreases the local dose position is increased until
the energy which corresponds to the Bragg-peak is reached.
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The relative biological e ectiveness (RBE)
The repair of complex double-strand lesions on the other hand is very error-prone. Therefore
heavy ions are more efficient in causing cell death. This is accounted by the relative biological
effectiveness (RBE):
RBE=
Dref 
Dion
     
iso-effect
. (2.6)
The RBE is defined as the ratio of a reference dose of X-rays Dref  divided by the dose Dion of ion
irradiation that results in the same biological effect. It depends on many different parameters
such as the biological end point, dose, particle type, and energy as well as the tissue under con-
sideration. As a result, the RBE is different for every location in the treatment field. For particle
therapy the RBE-weighted2 dose is defined as the product of the RBE and the absorbed physical
dose. It takes the higher efficacy of ions into account and is reported in units of Gy(RBE). It
follows, that if a tissue is irradiated with a certain level of RBE-weighted dose than the same
biological effect can be expected - independent of the used radiation type.
Figure 2.7.: Exemplary survival curve that compares heavy ion and photon radiation as a function
of dose. Depending on the endpoint the RBE value changes. Figure from (Schardt
et al., 2010).
2 sometimes also called photon-equivalent or biological dose
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Linear-quadratic and local e ect model (LEM)
The cell survival curves S as a function of the dose D like shown in figure 2.7 are usually
described by a linear quadratic model:
S(D) = exp( ↵D   D2). (2.7)
↵ and   are the linear-quadratic parameters which describe the model (Alpen, 1998). The
ratio ↵/  is characteristic of the tissue type and the kind of radiation and is related to the re-
pair capacities of the cells. A large ↵/  indicates a high radiation sensitivity. The linear part
(↵D) corresponds to cell damage caused by the traverse of a single event (e.g. one ion) and the
quadric term ( D2) caused by two independent events (e.g. two ions). For ion radiation the
linear term is more dominant than in the case of photon irradiation. It follows that single events
are the main cause of radiation damage when using heavy ions. The large variations of the RBE
with respect to many parameters like the mixed radiation field, the energy, the kind of radia-
tion or the tissue type facilitate the need for a biological model which predicts the RBE values
across the treatment field in the dose optimization process (see section 2.2.2). The local effect
model (LEM) was developed at GSI by Scholz et al. (Scholz and Kraft, 1994) to meet these
demands. The basic assumptions are: 1) On the local level the radiation damage by sparsely
ionizing photon radiation is the same as for ion radiation because both damages are transmitted
via secondary electrons. 2) The cell nucleus is the sensitive target. 3) The effect of the heavy
ion irradiation for a specific tissue can be predicted by knowing the X-ray cell inactivation dose-
response curve along with the radial dose distribution of the heavy ions. It follows that the
different biological response originates from the characteristic dose deposition pattern like dis-
played in figure 2.6. The quality of the LEM has increased over the years (Elsässer and Scholz,
2007) and validated in cell experiments (Elsässer et al., 2010; Gemmel et al., 2011) and is still
extensively investigated at GSI (Friedrich et al., 2012). The LEM was used in clinical routine
in the GSI pilot project (Krämer and Scholz, 2000) as well as it used currently at Heidelberg
Ion-Beam Therapy Centre (HIT) since 2009.
Fractionation
Fractionation basically means splitting the planned dose of the tumor in n-parts and to irradiate
the patient in each fraction with a dose of d = D/n (Hall and Giaccia, 2006). Fractionation
schemes can take as long as several weeks and its effects are commonly known as the four Rs of
radiobiology: 1) Repair of sublethal damage. 2) Reassortment of cells within the cell cycle. 3)
Repopulation. 4) Reoxygenation. The rational of fractionation is that e.g. tumors and healthy
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tissue have a different ↵/  ratio. Applying the dose in many fractions harms the tumor more
severely than the healthy tissue. The biological effective dose (BED)
E
↵
= (n d)
✓
1+
d
↵/ 
◆
, (2.8)
with E = exp( ↵D    D2) being the biologic effect, is the quantity by which different frac-
tionation regimes are intercompared. It follows that tissues with a different ↵/  ratio exhibit
different sensitivity to various fractionation schemes. These can therefore be chosen as to stress
the healthy volume less while almost having the same damage to the tumor. Since the ↵/ 
ratio of the affected healthy tissue and tumor can be different it follows that there is no ideal
fractionation procedure that fits for all patients. In general the effect is much smaller in case of
heavy ions compared to X-ray irradiation because the ↵/  ratio does not show the characteristic
shoulder in the linear-quadric model - as can be seen in figure 2.7. But the additional sparing of
the normal tissue is not so important in heavy ion therapy since the integral dose to the healthy
tissue is anyway much smaller as by using X-rays like displayed in figure 2.1.
To summarize:
• The DNA is the primary target for radiation damage.
• The local dose deposition determines how efficiently the DNA is damaged. High local doses
lead to more complex lesions which may not be repaired readily and can lead to cell death.
• Carbon ion irradiation causes more complex lesions to the DNA then X-rays.
• The effectiveness of the carbon ion radiation compared to X-rays can be described by the
RBE which is complex function of tissue, projectile particle, biological endpoint, energy
and the particle field.
2.1.3 Generation and application of ion beams
The required maximum penetration depth of about 30 cm in the human body corresponds to
kinetic energies of protons and carbon ions of 200 and 430 MeV/u, respectively. Therefore, a
broad range of energy has to be accessible3. Particle acceleration is typically realized using either
cyclotron (Pedroni et al., 1995) or synchrotron (Haberer et al., 1993) (figure 2.8) accelerators.
Cyclotrons are smaller, less expensive and technically not so challenging as synchrotrons but
the beam leaves the cyclotron with only one well defined energy so that passive beam shaping
elements (see below) are necessary to receive the required energy range to irradiate the whole
3 At GSI the energy spectrum is from 88.83 to 430.10 MeV/u for carbon ions.
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Figure 2.8.: Heavy ion acceleration at GSI. Starting from the ion sources, the beam is accelerated
in the UNILAC and than injected into the ring accelerator SIS 18. If the beam has
reached the desired energy it is extracted be electromagnetic impulses and enters
the beam line which leads to Cave M, where the patient treatment was realized
(figure from (GSI, 2013)).
tumor volume. Synchrotrons provide a very flexible pulse-to-pulse energy variation which al-
lows using active beam shaping delivery (see below) allowing a better dose conformity to the
target volume. The dynamics of the pulse delivery is in general different for each synchrotron.
This includes the spill profile, the particle extraction time, the intensity levels and the time to
accelerate the particles. The sophisticated synchrotron system is very expensive so that strong
efforts are done to reduce the costs. New and promising accelerator techniques especially in the
field of the particle acceleration via interaction of thin foils with high power lasers (Kraft et al.,
2010; Weichsel et al., 2008) are currently investigated but it will certainly take some years until
they can be implemented in a therapy system.
Passive beam delivery
In the early years of patient treatment with ions passive beam delivery was used (Koehler et al.,
1975, 1977) because its technical demands are much less than using active beam scanning (see
2.1.3). Figure 2.9 gives an overview of this technique. A thin beam leaves the accelerator.
Several beam shaping steps have to be done in order that the dose deposition of the beam
matches the tumor. How the beam profile is influenced by these steps (in the middle row of
the corresponding figure) can be seen in the upper and lower rows. 1) The beam is broadened
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using a scattering system. 2) Then the energy spectrum of the beam is broadened with a range
modulator. 3) The maximum energy is adjusted using a range shifter. 4) Lateral and distal
conformity are achieved by a collimator and a compensator. New compensator have to be
designed and build in case of every patient treatment field.
Figure 2.9.: Schematic overview of the passive beam delivery system. The beam size and the
penetration depth is shaped by the devices in the middle row as to irradiate the
target volume. The hatched area indicates the resulting inevitable irradiation of
normal tissue. The degree of irradiation of normal tissue depends on the tumor
shape. A target with a rectangle shape could be irradiated more conformal. Figure
from (Richter, 2012).
It can be seen that the system has several drawbacks. Healthy tissue close to the proximal
tumor regions inevitable receive the full treatment dose. The volume of healthy tissue that is
irradiated largely depends on the tumor size. The interaction of the initial beam with the system
leads to fragmentation and a greatly enhanced neutron dose, which leads to an irradiation of
large parts of the patient’s body, so that passive delivery beam systems are not the perfect
solution when treating pediatric patients (Newhauser and Durante, 2011; Hall and Giaccia,
2006) whose sensitivity with respect to additional dose stress is higher than for adults. No
active energy variation is needed for this technique so that cost-effective cyclotrons can be used.
Active beam delivery
The best conformity can be reached by using active beam scanning. The following introduction
of active beam scanning describes the principle mechanisms used at GSI and HIT. The tumor
is separated into iso-energy slices (IES) which essentially represent the water-equivalent path
length (WEPL) of the particles having the same energy. The actual geometrical path length
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might be different in regions with different density (e.g. bone or normal tissue). Many slices
are needed to cover the longitudinal dimension of the tumor. To reduce the number of these
slices a 3 mm ripple filter is used at HIT and GSI (Weber and Kraft, 1999) which broadens the
Bragg-peak. However, to obtain a homogenous dose distribution in the direction of the particles,
the IESs need to be superimposed. This leads to the so called spread out Bragg peak (SOBP),
which is depicted in figure 2.10.
Figure 2.10.: shows the superposition of nine Bragg-Peaks which results in the SOBP. The most
distal IES receives its dose essentially only from one IES whereas the most prox-
imal IES is eight-times pre-irradiated until beam’s particles have the energy that
coresponds to its WEPL. Although the RBE weighted dose is very flat around the
target, the corresponding absorbed (physical) dose is not flat. That is because the
RBE is not constant throughout the SOBP but depends e.g. on the LET. Figure
courtesy of Michael Scholz.
Each slice then contains of many so-called rasterpoints which represent the tumor’s lateral
dimension. The grid spacing of the rasterpoints is typically 2 mm and 3 mm, respectively. To
ensure homogenous dose distribution the full width at half maximum (FWHM) of the beam is
set to be at least three times larger than the grid spacing. The rasterpoints are being scanned
according to a pre-optimized scan path (see figure 2.11). The beam’s direction, intensity and en-
ergy are adjusted to irradiated each of these rasterpoints. The figure 2.12 provides an overview
of the active beam scanning process. While the particle beam irradiates a certain rasterpoint,
the beam monitor checks whether the actual measured values (e.g. position, intensity) corre-
spond to the planned values. If the prescribed dose is reached a signal is sent which changes
the current of the deflecting magnets so that the beam is directed to the next point. If on the
other hand the therapy control unit (TCU) detects an deviation between the actual position of
the pencil beam and the prescribed on then a signal is sent to the magnets in order to shift the
beam the the prescribed position. In case of a failure or an error the extraction of the beam
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must be stopped by sending interlock signals within 1 ms at GSI. This is done by deactivating a
fast quadrupol and a bending magnet in the beam line.
Figure 2.11.: IES from a real patient irradiated at GSI. The size of the black squares is equivalent
to the prescribed number of particles to the rasterpoint. The typical grid spacing
between the points is 2 mm and 3 mm, respectively. The purple line shows the scan
path. If the irradiation of an IES is finished, the energy of the beam is changed and
the same procedure starts again for the next IES.
The active scanning beam system at GSI and HIT is a little bit different from the technique
used at Paul Scherer Institut (PSI). At PSI the spot scanning method is used (Pedroni et al.,
1995). In this procedure the beam is switched of between two positions whereas the raster
scanning at GSI and HIT works in continuous mode (Haberer et al., 1993), i.e., the beam is
not switched off while the beam travels to the next position. Both approaches offer excellent
sparing of healthy tissue when irradiating static tumors.
To summarize:
• Heavy ions are accelerated by linear accelerators, cyclotrons or synchrotrons.
• Active beam scanning systems provide the best tumor conformity.
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Figure 2.12.: Active beam delivery system. The therapy control system requests beams which cor-
respond the IES of the tumor. Those energy levels generally di er for each patient.
The treatment is performed slice-be-slice by moving the beam on a meander path.
The heavy ion pencil beam is steered to each individual rasterpoint by changing the
magnet field of the scanning magnets. The beam position and particle number is
measured by a beammonitor system and fed back to the therapy control. Adapted
from (Schardt et al., 2010).
2.2 Treatment of static tumors with heavy ions
Each patient needs a specific treatment. Treatment planning systems calculate these individual
irradiation plans mainly according to the size and the location of the tumor. Other aspects which
influence the calculation of these specific plans are e.g. the number of fractions or the position
of OARs. All treatment planning systems, independent of irradiation with photons or heavy
ions, aim to deliver an adequate dose to the tumor while sparing healthy tissue and especially
OARs. According to recommendations of the ICRU, 100% of the target volume should receive
between 95% and 107% of the prescribed dose (ICRU, 1993). Several steps are necessary to
facilitate the optimization process which will be presented below.
2.2.1 Tumor imaging and delineation
"If you can’t see it, you can miss it" (Schlegel, 2010) underlines the importance of precise imaging
devices to delineate the tumor from its surroundings. In case of static tumors X-ray computed
tomography (CT)s provide quantitative information about anatomical structures by recording
photon attenuation images. This data is in the further planning process also used to determine
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the particle range and the deposited dose in the tissue. Typical pixel resolution is in the order of
1 mm. Magnetic resonance imaging (MRI) is often applied in combination with the CT to get a
higher resolution of the anatomy (Schardt et al., 2010). This enhances the accuracy with which
the physician is able to distinguish the subvolumes shown in figure 2.13 defined by the ICRU
(ICRU, 1993) as
GTV "The Gross Tumor Volume (GTV) is the gross palpable or visible/demonstrable extent and
location of the malignant growth."
CTV "The Clinical Target Volume (CTV) is a tissue volume that contains a GTV and/or subclinical
microscopic malignant disease, which has to be eliminated. This volume thus has to be
treated adequately in order to achieve the aim of therapy: cure or palliation." Concepts
that deal with the size of the clinical target volume (CTV) can be found elsewhere (van
Herk et al., 2000).
PTV "The Planning Target Volume (PTV) is a geometrical concept, and it is defined to select ap-
propriate beam sizes and beam arrangements, taking into consideration the net effect of all
the possible geometrical variations and inaccuracies in order to ensure that the prescribed
dose is actually absorbed in the CTV."
OAR "Organs at risk (OAR) are normal tissue whose radiation sensitivity may significantly in-
fluence treatment planning and/or prescribed dose." (e.g. heart, brain stem, diaphragm)
Figure 2.13.: Sub-volumes of a static tumor (e.g. in the head) described in 2.2.2 which are neces-
sary to perform the treatment planning.
2.2.2 Treatment planning
After delineation, the dose treatment planning optimization calculation starts. Each of these
processes must take the properties of the individual therapy system into account. At GSI the
dedicated software tool TReatment planning for Particles (TRiP) was developed (Krämer and
Scholz, 2000). First a grid is set up which covers the lateral (by creating planes with raster-
points) and depth dimensions of the tumor (by selecting the energy range). The number of
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degrees of freedom in heavy ion therapy is much greater than in photon therapy, since each
rasterpoint can be irradiated with a different particle number. A typical single treatment field
may comprise as many as 50 000 individual beam spots. Then the optimization can be formu-
lated as a least-squares minimization problem (in simplified form)
 2 =
X
xtar get
(DP(x)  DA(x))2
+
X
xOAR
(DP(x)  DA(x))2⇥ ✓ (DA(x)  DOAR(x))
= min
with DP(x) as the planned dose at the point x, DA(x) is the actual calculated dose distribution
and DOAR(x) is the maximum allowed RBE-weighted dose in the OAR. ✓ denotes the Heaviside
function. Its purpose is to impose a penalty if DOAR(x) is exceeded, but to do nothing if the
actual dose is below that limit (Krämer and Durante, 2010). Biological effects due to the LEM
are also incorporated in the optimization process according to
Dbio(x) = DA(x)⇥ RBE(x),
with Dbio(x) being the RBE-weighted (or biological) dose. The RBE is a complex function of
the LET and the mixed radiation field (Krämer et al., 2000). An example of the optimized dose
distribution with TRiP was already shown in figure 2.1.
2.3 Treatment of moving tumors with heavy ions
2.3.1 Tumor motion
Tumors can change their position relative to the coordinate system of the treatment room in
general due to the following reasons:
Patient motion: Motion of the patient itself by e.g. unintended movement of the head or other
parts of the body or stress versus relaxation of muscles during the treatment4. These
motions can usually be suppressed (e.g. by mechanical fixation of the patient’s head like
done in the pilot project at GSI).
Inter-fractional motion: Motion in-between two fractions. These kind of motion effect is negli-
gible within one fraction. The time-scale of inter-fractional motion ranges between hours
4 Sometimes patient are afraid when irradiations starts but relax after some time because they cannot feel any
pain from the interaction of the ions.
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and days. Internal anatomical position can change due to different filling of the bladder or
rectum or because of regression of the tumor volume during the radiation course (Britton
et al., 2007).
Intra-fractional motion: Motion within one fraction. The movement is mainly caused by respi-
ration which affects tumors located in the thorax and the abdomen. The time-scale of the
motion is therefore linked to the breathing period of the patient. Lung tumors and tumors
close to the diaphragm are effected by this kind of motion. The motion traces of lung tu-
mors have been observed by many researches. Liu et al. (Liu et al., 2007) report that lung
tumor motion is most prominent in the superior-inferior (SI) direction. The proportions of
tumors that moved more than 0.5 cm along the SI, lateral, and anterior-posterior (AP) axes
during normal breathing were 39%, 2%, and 5%, respectively. Only 11% of the tumors
moved more than 1 cm. Sonke et al. (Sonke and Belderbos, 2010) report that respiratory
motion greater than 2 cm has been observed for tumors located close to the diaphragm and
occasionally in other positions, but are generally smaller than 1 cm. Shirato et al. (Shirato
et al., 2004) observed a hysteresis in the relationship between pressure and lung volume;
the lung volume is different between inspiration and expiration at the same pressure. In
the same individual, the tidal volume and frequency can change with the biochemical con-
dition, body position, abdominal contents and emotional condition (anxiety). The medians
of the mean amplitude in tidal respiration were 1.0 (range, 0.2 - 2.8) mm, 2.8 (0.2 - 24.6)
mm, and 1.5 (0.2 - 8.2) mm for left-right (LR), cranial-caudal (CC), and anterior-posterior
(AP) directions, respectively. No correlation has been reported between the amplitude of
tumor respiratory movements and patient characteristics such as weight, height, age and
pulmonary function in a small series of data acquisition from patients. At rest, a healthy
person breathes 12 to 15 times per minute. Shirato et al. (Shirato et al., 2004) report that
the average length of 1 breathing cycle was 3.6±0.8 seconds. The breathing cycle fits well
with equation
z(t) = z0  b cos2n(⇡t⌧   ), (2.9)
where z0 is the position at exhale, b the extent of motion, ⌧ the breathing period,   the
starting phase and n a general parameter which describes the shape of the model. 43 %
of their patients yielded the best results of the fitting curve with n = 1 and for 38% with
n = 2 of these lung tumors, respectively. Lujan et al. (Lujan et al., 1999) showed that
equation 2.9 describes tumor motion much better than pure sinusoidal motion because it
takes into account that the tumor generally stays longer in the exhale than in the inhale
phase.
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In the following, this work deals only with effects and challenges of intra-fractional motion
since this type currently inhibits the treatment of e.g. lung tumors with heavy ions when using
active scanning systems as will be described in more detail below.
2.3.2 A moving tumor - challenges in dose application, imaging, motion monitoring and
delineation
The motion of the tumor introduces several difficulties as well in the planning and the beam
application process which will be introduced in the following. The severity of these effects is so
large that no satisfying homogenous dose distribution can be delivered to moving lung tumors
so far.
Interplay e ect
Figure 2.14.: Interference of dose application and tumor motion can cause severe dose distor-
tion. This schematic shows a target which moves crosses in a vertical motion three
di erent motion phases. The points symbolize the rasterpoints and the scanpath
is indicated by the arrows. The middle phase is the planning and treatment phase.
If the tumor rests in this phase the final dose distribution would agree with the
planned one. Due to the tumor motion, the actual irradiated points do often not
agree with the planned ones. Therefore, the interplay e ect can cause inhomo-
geneities in the final dose distributions (cold and hot spots). In addition, it might
happen that the normal tissue also receives radiation exposure.
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Figure 2.14 shows the so called interplay effect which is especially severe when using active
scanning systems. Due to the interaction of the tumor motion and the beam application inter-
ference patterns are likely to arise in the dose distribution which are so large that successful
treatment of e.g. lung tumors is not possible by using the planning target volume (PTV) concept
above which is clinically used, e.g. for treatments with photons or passive particle beam systems
(Phillips et al., 1992; Jiang et al., 2003; Bert et al., 2008b). Intra-fractional motion is especially
challenging when the dynamics of the beam delivery system is on the same time scale as the
tumor motion.
Figure 2.14 displays that simply increasing the area of irradiation, so that it encompasses the
whole motion contour, would not reduce the interplay effect, because the interference effects
will still be present. Methods to eliminate these obstacles will be presented in the sections 2.3.5,
2.3.4 and 2.3.6.
Tumor imaging and delineation
In addition to the subvolumes gross tumor volume (GTV), CTV and PTV, which have been
already introduced in section 2.2.1, the motion requires the definition of another sub volume
which takes the motion into account. The so-called internal margin (IM) and internal target
volume (ITV) are illustrated in figure 2.15 and defined as follows (ICRU, 1999):
IM "The Internal Margin, commonly asymmetric around the CTV, is intended to compensate for
all movements and all variations in site, size and shape of the organs and tissues contained
or adjacent to the CTV. They may result, e.g., from respiration, different fillings of the
bladder, different fillings of the rectum, swallowing, heart beat, movements of the bowel."
ITV The term ITV is commonly used to describe the volume encompassing CTV and IM.
Figure 2.15.: Sub-volumes which are necessary to perform the treatment planning in case of a
moving tumor. This example shows a snapshot of the position of the tumor. It is
either in ex- or inhale position and will move to the left within the contour of the
ITV.
The imaging process usually covers at least a whole motion period as to see the total size of the
tumor movement. Dedicated time resolved computed tomography (4DCT) methods had to be
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developed (Ford et al., 2002; Rietzel et al., 2005). The CT is then subdivided into several phases
and a CTV is contoured in each of these phases. The geometrical union of these individual
CTVs compromises the ITV. Like shown in figure 2.15, the ITV is subsequently extended to the
PTV which accounts for additional uncertainties. This geometrical union is sufficient in photon
therapy to account for the motion extent when calculating the PTV. To clarify, this geometrical
union does not reduce interplay effects either in IMRT (Bortfeld et al., 2002) and IMPT. In
contrast to photons, heavy ions exhibit large variations in the particle range when transversing
materials of different densities like shown in figure 2.16.
Figure 2.16.: Changes in the radiological path length induced by lung tumor motion are indi-
cated by iso-range lines for posterior-anterior incidence of the ion beam. The
motion changes the relative positions of the body’s anatomy. The green arrow
shows e.g. the change of the 10 cm iso-range line when the tumor moves from
the exhale to the inhale position. The location of the tumor is indicated by the red
arrows. The induced range changes can lead to underdosage of the tumor if e.g.
a rib moves in and out the radiologic path or to additional dosage to the normal
tissue. Adapted from Bert et al. (Bert and Durante, 2011).
A new way of creating an ITV which covers all the motion induced radiological path changes
had to be found in order that the target always receives its prescribed dose independent of its
motion phase. Graeff et al. (Graeff et al., 2012) implemented such a method at GSI which fulfills
this criteria. The ITV is created as a union of all CT motion phases which take the changes of
the WEPL into account (ICRU, 2007). Therefore it accounts for lateral and longitudinal motion
related expansion of the radiated volume. If beam delivery is performed in the passive mode,
the interplay effect does not occur and homogeneous dose delivery to the tumor volume is
achievable by the irradiation of an ITV according to (Graeff et al., 2012). The term ITV is in the
following always meant to be an ITV in the flavor of Graeff et al. (Graeff et al., 2012).
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Motion monitoring
Some techniques which (sections 2.3.5 and 2.3.4) shall enable irradiation in the face of tumor
motion require the information about its spatiotemporal position during treatment delivery. An
overview of those imaging techniques is given by Evans et al. (Evans, 2008). Direct tumor po-
sitions can be obtained by e.g. fluoroscopy (Kilby et al., 2010) or electromagnetic transponders
or markers (Mendenhall et al., 2012) implanted in or nearby the tumor. The implantation of
markers and transponders is always a risk to the patient as well as the additional dose due to
the imaging by the fluoroscopy. The amount of the additional dose exposure depends and the
chosen sampling rate and on the system in use. The more images are taken during treatment
the better is the knowledge of the tumor’s spatiotemporal position and the higher is the un-
wanted radiation exposure to the patient. To reduce the additional dose, methods and models
have been developed which describe and predict the position of the tumor relative to so-called
surrogate signals. This includes camera systems (Riboldi et al., 2012) or pressure belts measur-
ing the deformation of the thorax due to breathing (Steidl et al., 2012a; Korreman, 2012). The
position of the tumor is then predicted by measuring the surrogate signals and inserting this
information into a model which describes the external and internal motion correlation. Ionascu
et al. (Ionascu et al., 2007) report good internal-external correlation along the superior-inferior
direction with small or no internal external time shifts and amplitude mismatches. Along the
anterior-posterior direction, they found relatively large time shifts and amplitude mismatches.
2.3.3 Treatment planning and dose calculation
The optimization of the beam plan parameters has already been described in case of a static
tumor in section 2.2.2. In the scope of this thesis the treatment planning in case of a moving
target basically includes the usage of the ITV according to Graeff et al. (Graeff et al., 2012)
which accounts for the motion related extension of the PTV.
D. Richter (Richter, 2012) reports in detail on the implementation of a 4D functionality into
TRiP in order to perform dose calculations. These methods have to temporally correlate the de-
livery of each single pencil beam position with the motion of the target as described by motion
trajectory and 4DCT as shown in figure 2.17. Input data are the motion trace of the target and
the so called physical-beam-record (PBR) file. A PBR5 file can in principle be generated by a
dedicated simulation tool (see chapter 3) or by measurement. The former case is used when
doing forward dose simulations and the latter when doing dose reconstruction. A PBR contains
the information which rasterpoint of the tumor was irradiated along with the measured particle
number and the time stamp when irradiation was finished. Validation of the used models and
5 The PBR files at HIT and GSI are slightly different. At HIT the time stamp can only be obtained by including
the information of a so called machine beam record (MBR) file.
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algorithms, with biological as well as physical measurements, have been performed in numerous
experiments (Bert et al., 2010; Gemmel et al., 2011; Richter, 2012). After the successful imple-
mentation of 4D dose calculation in TRiP it was possible to tackle motion mitigation techniques
as well in simulations and experiments.
Figure 2.17.: a) PBR files contains the information when a certain rasterpoint has been irradi-
ated. The mutual time stamp of the motion trace and the PBR file enables TRiP to
know in which motion phase the point was irradiated, as seen in b). Those di er-
ent sub-treatment plans are then merged into the reference phase as shown in c)
so that the 4D dose calculation can be performed.
2.3.4 Motion mitigation by gating
Figure 2.18 illustrates the concepts of the gating techniques. Motion monitoring is mandatory
to get spatiotemporal information of the tumor. The irradiation is only performed in a selected
part of the breathing cycle. Usually this part is the more stable exhale position or it can be
selected in order to irradiate the tumor at a great distance away from the OAR (see 2.15). If
the tumor is within that amplitude region, which is named the gating window (see figure 2.18
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a) and (Minohara et al., 2000)), a gate signal is sent which permits irradiation of the tumor
(see figure 2.18 b)). If the beam is available in this period, the particles are extracted and
the tumor is irradiated (see figure 2.18 b)-c)). The main reason for reducing the interplay
effect is the reduction of the motion amplitude (the gating window) while irradiating the tumor.
The drawback of this method is that the folding of the gate signal with the duty cycle of the
synchrotron which results on prolongation of the treatment time (see figure 2.18 d)). The
smaller the gating window the more homogeneous is the dose distribution but the longer the
treatment time. Therefore the selection of the size of the gating window is always a compromise
between clinical and economical factors. Nevertheless, some residual motion will still be present
within the gating window which will still cause minor interplay effects, that can be further
reduced by combining gating with the re-scanning (see (Furukawa et al., 2007) and section
2.3.6) technique. Gating can be used with active as well as with passive beam scanning systems
and is already implemented at a few therapy centers (Iwata et al., 2010; Minohara et al., 2000).
P. Steidl reports about the implementation of gating at HIT (Steidl, 2011).
Figure 2.18.: illustrates the principles of the gating method. The scanning beam is only extracted
if the tumor is within a well defined part of the breathing cycle. This reduces inter-
play e ects but prolongates treatment time. Figure from (Richter, 2012).
2.3.5 Motion mitigation by beam tracking
Beam tracking was first proposed for photon IMRT (Keall et al., 2001) and is e.g. currently
clinical used in X-ray surgery in the Cyberknife synchrony system (Kilby et al., 2010). The
clinical usage of beam tracking in heavy ion therapy is likely to take a few more years since it is
the technically most challenging motion mitigation technique.
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The ideal beam tracking system knows the exact position of the target during the whole treat-
ment course and adapts the beam application accordingly. Assuming the rasterpoint be irradi-
ated next is named ni. The system would adjust the energy and the magnets in a way that the
pencil beam can follow ni precisely as to irradiated it like the tumor was static. Healthy tissue
could be spared to the same level as in the static irradiation.
The real beam tracking system however never knows the position of ni exactly and cannot
adapt the beam plan parameters instantly. Continuous fluoroscopy, to get the tumor’s potion,
would lead to unacceptable dose exposure of the patient and substitute internal-external corre-
lation methods always introduce some uncertainties. By adapting the beam parameters to the
motion, the system needs to estimate where the target will be a few moments later. If e.g. the
patient starts coughing in between regular fluoroscopy checks (which are necessary to adapt
and confirm the model) the internal-external correlation will be lost and the pencil beam will
deposit its whole dose at the wrong place. The magnets cannot follow ni without a small time
shift and the adaption of energy also takes some time and includes the implementation of ad-
ditional range shifters into the beam line (Saito et al., 2009). Experiments demonstrating the
precision of an ion-beam tracking system have been performed at GSI (Bert et al., 2010) and
shows that regular motion with a homogeneous phantom can be compensated. Due to rotation
of the tumor or a beam which transfers the tumor with a different angle due to translational
motion, the pre-irradiated dose distribution changes which has to be adapted online which is a
very challenging task as described in (Luchtenborg et al., 2011).
Van de Water et a. (van de Water et al., 2009) simulated beam tracking with active proton
scanning. For their most realistic case of a heterogenous target and positional error they found
that beam tracking can even have negative influence on the dose homogeneity and that the
re-scanning (see section 2.3.6) technique performed best. To reduce the impact of positional
errors and uncertainties of other kinds beam tracking can be combined with re-scanning to the
so-called re-tracking technique.
2.3.6 Motion mitigation by re-scanning
Re-scanning was first proposed by Phillips et al. (Phillips et al., 1992) to reduce interplay effects
in active proton scanning in the presence of motion. The basic assumption is that interplay
patterns (see figure 2.14) of the same IES very likely differ from each other due to a different
starting phase, different intensity or different motion trace characteristics. If many of these
interplay patterns are merged, it is very likely that the overdose a rasterpoint has received in
one scan is compensated by underdosage of the very same rasterpoint in another scan so that
the resulting dose distribution gets more homogeneous. Therefore, if a slice shall be re-scanned
r-times, the dose per re-scan run is reduced to Dr = D0/r, with D0 being the original prescribed
dose and r the number of re-scans.
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Figure 2.19 displays how re-scanning can, in the ideal case, compensate motion effects.
Figure 2.19.: The irradiation is planned to be performed with a re-scan number e.g. of r = 3.
Therefore Dr = 1/3 · D0 which is symbolized by the orange circles. The 1st scan
starts at t1 and ends at t2 - the interplay pattern emerges like sheen in figure 2.14.
The 2nd scan starts at t2 - the target is therefore in another motion phase, so
that the interplay pattern looks di erent (the same is true for the 3rd scan). In
the ideal case the merging of these three di erent interplay patterns results in a
homogenous final dose distribution.
In reality it is a priori not known at which re-scan number the final dose distribution has
converged close enough to the homogeneity values of the static irradiation as to treat patients.
Dedicated measurements and simulations have to be performed with as realistic conditions as
possible. The effectiveness of re-scanning to reduce interplay patterns can depend i.a. on the
following multiple parameters (Zenklusen et al., 2010; Mori et al., 2013; Knopf et al., 2011;
Furukawa et al., 2007; Bortfeld et al., 2002; Bert and Durante, 2011):
Patient specific parameters: Breathing period, amplitude of motion, target volume and target
motion direction.
Beam application specific parameters: Re-scanning method and re-scan number, time to change
the particle’s energy, scanning speed and scanning direction, applied dosage, dose gradi-
ents in the treatment field, field direction and number of fields.
The averaging effect of re-scanning is addressed in Bortfeld et al. (Bortfeld et al., 2002).
Under the condition that the beam application and the motion are not correlated they tackled
the dose variance of a rasterpoint by statistical means. They report that the probability density
function (PDF) of the dose variation of a voxel turns into a Gaussian shape centered around
the expected value after approximately five fractions (see section 2.1.2) due to the central limit
theorem. In terms of physical dose the effect of f = n fractions is very similar to r = n re-scans.
The FWHM of the Gaussian shape PDF gets efficiently smaller due to the averaging effect by
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increasing the number of fractions, but the width depends strongly on the delivery technique
and has to be investigated individually with the properties of the individual system. They also
report, that additional re-scanning in each fraction which takes approximately as long as the
breathing cycle is especially well suited to reduce the dose variance which also reported by
Furukawa et al. (Furukawa et al., 2007).
The ITV generated for re-scanning irradiation is larger than the ITVs when using beam tracking
or gating because it has to cover all motion phases. On the other hand, re-scanning does not need
additional radiation exposure during the treatment to determine the trajectory of the tumor. It
follows that re-scanning is best suited for small motion amplitudes of tumors which are not
located too close to OAR. A great advantage of re-scanning is that it can also be combined with
gating and with beam tracking as improve their outcome.
Re-scanning exists in different flavors with different demands on hardware and and treatment
planning. The methods also differ with respect to their effectiveness to reduce interplay pattern.
Some of the most prominent variations will be presented in the following. In principle many
more types are imaginable and will be presented in chapter 3.
Slice-by-slice re-scanning
Figure 2.20.: Illustration of the slice-by-slice re-scanning mode. Figure adapted from (Seco et al.,
2009).
The schematic drawing of the slice-by-slice re-scanning mode can be seen in figure 2.20. In
the slice-by-slice re-scanning (in graphics often abbreviated as slice) mode, with r = n, the pencil
beam sweeps in the first re-scan run in normal sequence over the rasterpoints. The second
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re-scan run starts when the pencil beam arrives at the last point of the IES, then the scanning
direction is reversed and the beam travels back to the starting point. This procedure is repeated
n-times so that the actual IES nominally receives its total prescribes dose. Subsequently the
energy is decreased and the identical process starts with the next IES until the whole volume
is irradiated. This method generates the fewest energy changes and often uses the maximal
possible spill intensity. At GSI and at HIT treatment time in slice-by-slice re-scanning mode is in
general as short as in the standard delivery mode used for patients.
Volumetric re-scanning
Figure 2.21.: Illustration of the volumetric re-scanning mode. Figure adapted from (Seco et al.,
2009).
The schematic drawing of the volumetric re-scanning mode can be seen in figure 2.21. In the
volumetric re-scanning (in graphics often abbreviated as vol) mode, with r = n, the pencil beam
scans subsequently all IES with 1/n of their prescribed doses by decreasing the energy after each
run. If the whole volume is scanned the precess is repeated n  1 times until the the volume
is nominally irradiated with its prescribed dose. In general this mode prolongs the treatment
time compared to slice-by-slice re-scanning because the method creates the maximum number of
energy chances. At GSI it takes 3.3 s to change the energy of the pencil beam.
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Figure 2.22.: Illustration of the random-time-delay re-scanning mode. Figure adapted from (Seco
et al., 2009).
Random-time-delay re-scanning
The schematic drawing of the random-time-delay re-scanning (in graphics often abbreviated as
random) mode can be seen in figure 2.22. The sequence of the random-time-delay re-scanning
mode is identical to the one of the slice-by-slice re-scanning mode. The difference is that a
random pause is added if a re-scan run is finished. The motivation is the reduce synchronity
effects (Rietzel and Bert, 2010) between motion and beam application. Interplay patterns will
look very similar if the tumor is almost in the same motion phase each time a re-scan run
starts (which is called the synchronity effect). Therefore the averaging effect might be greatly
reduced when a IES is merged after the irradiation like shown in figure 2.19. The likelihood
that the irradiation always starts in the same phase decreases by adding the random pause after
each re-scan run. As a consequence the treatment time is prolonged compared to slice-by-slice
re-scanning.
Breath-sampled re-scanning
The schematic drawing of the breath-sampled re-scanning (in graphics often abbreviated as BS)
mode can be seen in figure 2.23. The sequence of the breath-sampled re-scanning mode with
r = n re-scans is identical to the one of the slice-by-slice re-scanningmode. Prior to the treatment
the breathing period of the patient is measured (e.g. with the help of VisionRT system (Vision
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Figure 2.23.: Illustration of the breath-sampled re-scanning mode. Figure adapted from (Seco
et al., 2009).
RT Ltd, London, UK) or the Anzai belt (Anzai Medical Co., Ltd, Tokyo, Japan)). For every IES,
the intensity of the spill is adjusted in order to match the n re-scans as good as possible with
the breathing period of the patient. Slice-by-slice re-scanning often finishes the beam application
of a IES, with the currently existing systems, in a fraction of the breathing period6. It follows
that very often not all motion states of the tumor receive dose application in the slice-by-slice
re-scanning mode. In breath-sampled re-scanning mode however all motion states receive dose.
Breath-sampled re-scanning is technically more challenging than the other methods presented
above, since a reliable and precise intensity control of the beam is mandatory in addition to
the dedicated treatment planning. The treatment time is generally a little bit longer than in the
slice-by-slice re-scanningmode, because the pencil beam speed is greatly reduced in the proximal
IESs. It will be shown in chapter 4 that this fact has positive influence with respect to dosimetry.
Furukawa et al. (Furukawa et al., 2007) also show that breath-sampled re-scanning strongly
reduces synchronity effects between motion and beam application so that the averaging effect
works more efficiently. Initial measurement and simulation show (Furukawa et al., 2007; Seco
et al., 2009) that breath-sampled re-scanning seems to be one of the most promising re-scanning
techniques.
6 This depends not only on the systems’s intensity, but also on the tumor volume and the location of the IES.
Distal IES generally take longer to irradiate.
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Iso-layered re-scanning
The schematic drawing of the iso-layered re-scanningmode can be seen in figure 2.24. Iso-layered
re-scanning limits the dose application per rasterpoint by a maximal value for each re-scan run
(Zenklusen et al., 2010). This means that points with higher prescribed dose is re-scanned more
often which is a sensible choice because its weight to the overall total dose delivery is large. The
pencil beam is forced to sweep much faster over the target area in slice-by-slice re-scanningmode
so that iso-layered re-scanning is technically less challenging for the system. However, the beam
path needs to be optimized many more times. Figure 2.24 b) illustrates that the rasterpoints in
the middle of the IES are only re-scanned two times and are singled out in the third re-scan run.
As a consequence, often scan paths will be created with too large distances from one rasterpoint
to the next in case of the raster scanning approach used at GSI and HIT. On the other hand, the
spot scanning system of PSI is well suited for this task.
Figure 2.24.: Left picture: illustration of the slice-by-slice re-scanning mode when irradiating an
inhomogeneous IES. Right picture: illustration of the iso-layered re-scanning mode
when irradiating an inhomogeneous IES. Figure from (Zenklusen et al., 2010).
To summarize:
• Moving (lung) tumors are very likely to ruin the outcome of a treatment for a active beam
scanning system because some parts of the tumor are likely to receive under- and over-
dosage. This is the so-called interplay effect.
• In general the motion is distinguished in 1) patient motion, 2) inter-fractional motion
and 3) intra-fractional motion. The intra-fractional motion, which is e.g. associated with
breathing happens on a time scale of seconds, is the kind of motion which is addressed in
this thesis.
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• At GSI 3D treatment planning and dose calculation were extended to include temporal
behavior of the target.
• Three techniques are proposed to mitigate motion effects in radiotherapy. Beam tracking,
gating and re-scanning. The re-scanning method relies on statistical averaging of the dose
distribution and exists in various flavors and its effects toward motion mitigation shall be
addressed in this thesis.
2.4 Aim of this work
This work investigates the motion mitigation technique called re-scanning. Its tumor conformity
is not as good as using the beam tracking or gating method but it is believed to compensate in-
terplay patterns inside the tumor more robustly than beam tracking (van de Water et al., 2009)
and in contrast to gating the treatment time is greatly reduced. Furthermore, re-scanning can
be combined with both techniques in order to make beam tracking more robust or to decrease
the treatment time in case of gating. In contrast to the other techniques, re-scanning is techni-
cally less challenging and therefore much easier to implement in a clinical environment. Beam
tracking and gating rely on very precise motion detection during therapy and the reliability of
patient data, e.g. 4DCT image registration which can introduce additional uncertainties. The
different re-scanning flavors do not need the knowledge about the position of the tumor during
treatment and are less sensitive to uncertainties in the patient data. Only one re-scanning tech-
niques relies on information about the breathing period of the patient which can be obtained
very easily. Re-scanning is based on statistical averaging of different interplay patterns in a way
that the resulting dose distribution is homogeneous and can be used in patient treatment.
Chapter 3 explains how re-scanning is implemented in the existing treatment planning and
dose calculation environment at GSI. Theses tools are then used to perform treatment planning
studies for five lung cancer patients. The outcome of the motion mitigation efficiency of re-
scanning depends on parameters like the motion amplitude, spill shape, spill intensity, motion
period, target trajectory, starting phase and the re-scanning flavor. The different re-scanning
methods are simulated over a broad range of these parameters as to cover almost all relevant
clinical cases. The resulting dose distribution are investigated whether treatment of patients
will be possible in the presence of motion.
Before a new technology is used to treat patient elaborate measurements have to be performed
as to check whether safe and precise dose irradiation is possible. Those measurements are pre-
sented in chapter 4 for re-scanning irradiation performed at GSI and at HIT. An overview about
the implementation at both facilities is given. Experiments are done slice-by-slice re-scanning and
breath-sampled re-scanning in re-scanning modes with and without motion of detectors (which
represent the tumor). Comparing the static measurements of standard and re-scanning irradi-
ation mode reveals if the new method is compatible with the existing systems. In addition,
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simulations are done which mimic the experimental setup as to broaden the range of investi-
gated parameters. It shall be shown if re-scanning irradiation is in principle possible to treat
patients at HIT and at GSI.
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3 Treatment planning studies
3.1 Introduction
Treatment planning studies are valuable for various reasons. It was shown in numerous studies
that experimental dose measurement and simulation results obtained by TReatment planning
for Particles (TRiP) in the presence of motion match very well and exhibit a good correlation
(Richter, 2012; Gemmel et al., 2011; Lüchtenborg, 2012) so that TRiP can be used to predict
the outcome of patient treatment if the used parameters are chosen appropriately. Due to lim-
ited experimental beam time new mitigation techniques are often tested in simulation studies
before the implementation in the therapy control system is performed. In addition, the acces-
sible parameter space is much greater when doing simulations compared to experiments. Both
approaches, experiments and simulations, are necessary and stimulate each other.
The studies in this chapter make use of time resolved computed tomography (4DCT) datasets
of five lung cancer patients treated at MD Anderson Cancer Center (MDACC) and investigate,
via simulations, how efficiently the various re-scanning modes can reduce interplay effects in
the presence of motion in case of parameter sets which should cover almost all clinical rele-
vant cases for active scanning carbon ion therapy. A great benefit arises from the fact that at
GSI Helmholtzzentrum für Schwerionenforschung GmbH (GSI) various motion mitigation tech-
niques are investigated so that the results can easily be compared if they are optimized in a
similar fashion. The present work and the treatment planning studies of J. Woelfelschneider
(Woelfelschneider, 2011) use exactly the same optimization methods and patient data set to
generate the internal target volume (ITV)-treatment fields so that re-scanning can be compared
to the use of fractionations as motion mitigation technique. R. Luechtenborg (Lüchtenborg,
2012) also used the same patients data sets along with the corresponding ↵/  ratios to study
the beam tracking motion mitigation approach. Trials at the National Institute of Radiological
Sciences (NIRS) with passive beam shaping methods examined clinically different fractionation
schemes and showed promising results even for one fraction (Tsujii and Kamada, 2012). With
respect to motion mitigation in beam scanning, hypo-fractionation is contra-productive so that
motion mitigation techniques like re-scanning become even more important. The more fractions
are used the higher is the probability that the random interplay patterns of each fraction ho-
mogenize the dose distribution. Therefore, the fractionation effect is similar to re-scanning but
happens on a different time scale.
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Due to the fact that passive carbon beam delivery is less sensitive to interplay effects most
patients with lung tumors have so far been irradiated at NIRS in Japan (Tsujii and Kamada,
2012). 5-year survival among those patients receiving a single fraction was 52.6% (Mori et al.,
2013). Active proton beam scanning was recently used to treat patients with small motion
amplitudes at MDACC patients have been treated under anesthesia at Rinecker Proton Therapy
Centre (RPTC) (Eckermann et al., 2011) so that the intrafractional motion could be considered
as being quasi-static.
3.2 Material & methods
3.2.1 4D treatment planning framework
Figure 3.1 gives an overview of the 4D treatment planning framework. The basic ideas shall
be summarized at this point in order to clarify the meaning and functionality of the individual
methods which will be described in more detail in the following sections.
1. The basic input is the 4DCT data set. Each data set contains specific information about the
patient which is used by TRiP to generate the optimized treatment plan for each patient.
2. The treatment plan is written to a so-called physical-beam-plan (PBP). In patient irradiation
mode this PBP can be uploaded to the therapy control system and then the treatment can
start.
3. In the 4D treatment planning framework the PBP and data about the accelerator performance
are basic input data for the physical-beam-record simulation environment (PBRSimEnv)
tool which was written in the scope of this thesis. This tool calculates the irradiation
sequence for different accelerator setting and irradiation modes (e.g., normal irradiation
or the different re-scanning modes).
4. The PBRSimEnv writes the irradiation course into a simulated PBP. The PBRsim is in general
different for each re-scanning method. In addition, the file PBPcorrected is produced which
accounts for the fact that the prescribed particle number deviates from the actual irradiated
particle number because of systematic errors of the ionization chambers.
5. The 4DCT information (which contains the patient specific information) and the PBRsim and
PBPcorrected files (that describe which rasterpoint has been irradiated in which motion phase
along with the actual dose level) are mandatory input data for TRiP.
6. TRiP calculates the 4D dose distribution which can then by analyzed by several means in
order to judge the quality of the irradiation process.
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Figure 3.1.: Overview of the 4D treatment planning framework. The numbers represent the
sequence in the 4D treatment planning framework. Details will be described in the
following sections.
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Time resolved computed tomography (4DCT) patient data
This section refers to figure 3.1 (1.):
Five lung tumor patients have been treated at the MDACC in Houston, Texas, USA. The asso-
ciated 4DCT data sets have kindly been provided so that they could be used as data input for the
patient treatment studies. The clinical target volume (CTV) range is from 45 cm3 to 236 cm3.
The motion amplitude along the direction of the largest motion were from 1mm to 25mm. An
overview about the data set is given in table 3.1. The patient numbering is sorted with respect
to the magnitude of the motion which shall make it easier for the reader to catch the correlation
between the severity of the interplay effect as function of the amplitude. The 4DCTs consist of
ten motion states. All computed tomography (CT) states represent an equally long time span,
this method is known as phase-based motion state definition. Contours of the gross tumor vol-
ume (GTV), the CTV and several organs at risk (OAR) were drawn on the reference motion state
(end-exhale) CT image. Non-rigid registration has been performed to propagate the contours
through the motion phases. Transformation fields, to establish the voxel correspondence be-
tween the respiratory phases, were determined by the open source software Plastimatch using
a B-spline algorithm (Shackleford et al., 2010). Based on this registration, the motion of the
tumor and the surrounding tissue are described by a set of 3D transformation fields. These fields
are used to propagate the CTV from the reference phase to each motion phase forming the ITV.
For each patient an individual ITV (Graeff et al., 2012) had to be generated as to compensate
for both target motion and range changes caused by motion. This method has already been
described in section 2.3.2.
patient pathology volume LR AP SI 3D motion
[cm3] [mm] [mm] [mm] [mm]
1 Adenocarinom 123 -1 < 0.3 -1 1.4
2 SCC 236 < 0.5 1 -5 5.1
3 NSCLC 45 -2 -3 -5 6.2
4 NSCLC 160 -5 2 -20 20.7
5 Adenocarinom 125 1 -3 -26 26.2
Table 3.1.: Patient data with tumor type (Non-small-cell lung carcinoma (NSCLC), Squamous
cell carcinoma (SCC) and Adenocarinom), CTV size and maximal tumor motion in
superior-inferior (SI), left-right (LR) and anterior-posterior (AP) direction. The 3D mo-
tion amplitude is calculated as being the Euclidean norm.
Treatment plan parameters
This section refers to figure 3.1 (1. and 2).:
50
The design of the treatment planning studies performed in this work are based on the method
used for treatments with scattered carbon beams at the NIRS, taking four fields in the transversal
plane with beam entrance angles of 20 ,  20 ,  70  and  110  with respect to the horizontal
beam (Miyamoto et al., 2003, 2007; Woelfelschneider, 2011).
For each field the particle number to be delivered per grid position of the ITV was optimized
individually using TRiP according to a single-field uniform dose approach. Iso-energy slices
were spaced at 3 mm water-equivalent distance using a 3 mm ripple filter (Weber and Kraft,
1999). The lateral spacing of beam positions within an iso-energy slice (IES) was 2 mm. The
carbon beam focus size, which is in general a function of the particles energy, was about 6 mm
full width at half maximum (FWHM). No planning target volume (PTV) margins were used
since only intra-fractional motion related uncertainties were studied.
The relative biological effectiveness (RBE) weighted dose has been calculated with TRiP using
the local effect model (LEM) model (see section 2.1.2). The ↵ and   values used in this thesis
and in the reports of J. Woelfelschneider (Woelfelschneider, 2011) and R. Luechtenborg (Lücht-
enborg, 2012) are identical as to facilitate the highest degree of comparability. As introduced in
section 2.1.2, normal tissue and tumor cells generally have a different ↵/  ratio. For the CTV
tissue, an ↵/ CTV = 6 Gy (↵ = 0.021 Gy 1,   = 0.0035 Gy 2) was chosen. This value is close
to the ↵/  ratio of 5.585Gy used by Kanai et al. for NSCLC (Kanai et al., 2006).
Normal tissue typically has a lower ↵/  ratio (see Section 1.2.2). In this work ↵/ norm = 2 Gy
(↵ = 0.3 Gy 1,   = 0.0015 Gy 2) has been assigned to all tissues but the CTV. This value has
been based on results from carbon irradiation of the spinal cord of rats (Karger et al., 2006).
Fractionation scheme
This section refers to figure 3.1 (1. and 2.):
The RBE weighted dose, which was used to optimize each field, depends on the fractionation
scheme. To separate the different influences on interplay reduction of many treatment fractions
(Woelfelschneider, 2011) and re-scanning the chosen fraction number in this work was set to
one. The treatment approach thus mimics the case that a patient is being irradiated with four
different fields on a single day. The RBE weighted dose for one fraction was calculated to
be 17.70 Gy(RBE). The dose per field is the fraction dose divided by the number of fields
(Woelfelschneider, 2011; Lüchtenborg, 2012).
Re-scanning modes
This section refers to figure 3.1 (3. and 4.):
Six different re-scanning methods have been investigated in this thesis. Breath-sampled re-
scanning, slice-by-slice re-scanning, volumetric re-scanning and random-time-delay re-scanning
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were already introduced in 2.3.6 as they have been already proposed elsewhere (Seco et al.,
2009). Local-parameter re-scanning and mixed-scanpath re-scanning have been created in the
scope of this work and will be introduced briefly in this section. The implementation of random-
time-delay re-scanning was different than proposed in the literature, details are listed below.
Figure 3.2.: Illustration of the mixed-scanpath re-scanning mode. The four squares represent a
single IES which is irradiated with a re-scan number of r = 4. The main direction of
the scan-path is changed for every new re-scan run from horizontal to vertical and
vice versa.
Mixed-scanpath re-scanning is carried out in the same order as slice-by-slice re-scanning with
the only difference that the scan-path is changed for each subsequent re-scan run like
illustrated in figure 3.2. This is motivated by results of initial re-scanning experiments (see
section 4.3.3) and simulations at GSI and other researchers (e.g., (Knopf et al., 2011))
which showed that the interplay effect is more severe (less severe) if the motion direction
and the main scanpath direction are perpendicular (parallel) to each other. The rational is,
thatmixed-scanpath re-scanningmakes the irradiation more robust and predictable because
switching of the main scan-paths shall prohibit the worst case scenario of a scan-path which
is perpendicular to the target motion.
Local-parameter re-scanning : Figure 2.10 shows that the spread out Bragg peak (SOBP) com-
posed of many Bragg-peaks. If, e.g., the most distal IES is irradiated with a re-scan number
of r all of the more proximal IESs get some pre-irradiation dose. If the energy is decreased
as to irradiated the next IES, parts of the IES have de facto already received r re-scans due
to the pre-irradiation. Therefore it is a rational assumption that the number of re-scans
can be decreased in case of the more proximal IESs which is illustrated in figure 3.3. The
re-scan number is then no longer a global but rather a local parameter. The calculation
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workflow is illustrated in figure 3.4. The rational of this method is: 1) the therapy systems
at Heidelberg Ion-Beam Therapy Centre (HIT) and GSI need a minimum particle number
of each rasterpoint. In case of high re-scan numbers when irradiating proximal IES the
particle number can fall below this threshold which is typical between 5000 and 10000
particles. 2) By using a constant re-scan number and intensity, the pencil beam needs to
sweep faster the more proximal the IES is. Eventually, the scanning speed might be too
high for the magnets. The local-parameter re-scanning approach will slow down the lateral
scanning speed.
Random-time-delay re-scanning : To allow for a more flexible number of random-pauses and to
make this number independent of the number of re-scans the factor µrandom is used to
calculate the number of random-pauses Nrandom(i) of each IES i as follows
Nrandom(i) = µrandom · Nrasterpoints(i), (3.1)
with Nrasterpoints(i) being the number of rasterpoints of the the corresponding IES. For
instance, taking µrandom = 0.1 an IES with 1000 points is halted for a random pause after
every 100 points. The number of random pauses does not increase with the re-scan number.
In contrast to the random-time-delay re-scanning flavor proposed in the literature, even
small re-scan numbers can be irradiated with a high number of random-pauses. Throughout
this thesis a random number generator automatically selects for each random-pause a time
length in the range of 0 s< Trandom pause  Trandom, max, with Trandom, max = 1 s.
The abbreviations listed in table 3.2 are commonly used when naming the different re-
scanning modes in figures.
full re-scan mode name abbreviation used in figures or legends
breath-sampled re-scanning BS
slice-by-slice re-scanning slice
volumetric re-scanning vol
random-time-delay re-scanning random
local-parameter re-scanning local
mixed-scanpath re-scanning mixed
Table 3.2.: Table of the commonly used abbreviations of the di erent re-scan modes in the fig-
ures.
The physical-beam-record simulation environment
This section refers to figure 3.1 (3. and 4.):
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Figure 3.3.: Illustration of the local-parameter re-scanning mode. The re-scan number r is no
longer a constant parameter throughout all IESs but generally decreases in case of
lower beam energies. Each IES is assigned with a local re-scan number r(i).
The PBRSimEnv, which was written in the scope of this thesis, is a beam delivery sequence
generation software which is needed in order that TRiP can calculate 4D dose distribution.
Mandatory input data are the PBP and parameters about the performance of the used acceler-
ator. In order to mimic the accelerator at GSI spill profiles were measured and normalized to
one particle per spill. In advance of each irradiation the therapy control system suggests an
appropriate intensity level for each IES of the PBP which can be multiplied with the normalized
spill profile. This results in a realistic scanning speed of the pencil beam in the simulation of the
beam delivery sequence. A sample spill profile measured at GSI with a resolution of 10 µs and
an artificially created square spill profile1 can be seen in figure 3.5. The accelerator data also
include other properties like spill length or spill pauses with and without energy variation which
are listed in table 3.3. In addition to the accelerator properties of the system at GSI, a virtual-
accelerator (ACCvirtual) was introduced. The accelerator properties of the ACCvirtual were
only used for simulating breath-sampled re-scanning mode. The spill length of GSI’s accelerator
in therapy mode is too short to match typical breathing periods.
spill length spill pause spill pause
[s] with energy variation [s] without energy variation [s]
GSI 2.2 3.3 2.3
ACCvirtual 10 3.3 2.3
Table 3.3.: Table of the spill on and spill pause times of the accelerators at GSI and the the virtual-
accelerator (ACCvirtual).
1 The spill profiles at HIT are quite close to an artificial square spill profile.
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Figure 3.4.: This flowchart shows how the local-parameter re-scanning numbers r(i) are calcu-
lated.
55
Figure 3.5.: shows a measured spill profile at GSI (red line) and an artificially created square spill
(black line). Both spill are normalized to one particle per spill and can be used in the
simulation environment to represent spill extraction behavior of accelerators.
The breath-sampled re-scanning mode needs an accelerator with a spill extraction time that is
as long as the breathing period. Therefore a square spill profile with a spill length of 10 s was
created and used in those cases. All other re-scanning modes used randomly selected spill files
measured at GSI with the appropriate spill pauses.
At GSI, the therapy control system checks every 12.5 µs (Haberer et al., 1993) if the prescribed
particle number is reached for each rasterpoint (see figure 3.6) of the PBP. Due to the fact that
these checks have finite spacing in time the signal to step over to the next rasterpoint is sent
for an actual particle value that always exceeds the prescribed value. This overdose is inversely
proportional to the total treatment time of this point. As re-scanning decreases the treatment
time of each rasterpoint roughly by the factor of the re-scans this overdose effect is expected
to get more severe. The therapy control unit at GSI subtracts the overdose of the previous
rasterpoint from the nominal dose of the next one within the same IES because due to the
lateral Gaussian beam width, each rasterpoint contributes to a major part to the dose of the
next rasterpoint.
At HIT, the system checks every 2 µs (Naumann, 2011) if the prescribed particle number is
reached for each rasterpoint but does not correct overdose (see 3.7).
To quantify the effect of re-scanning on the finite dose sampling rate, this feature was imple-
mented, as shown in the figures 3.6 and 3.7, in the simulation environment. Using the PBPplanned
as input data a corrected PBPcor r with the actual applied particle numbers is generated by the
PBRSimEnv. This plan is then used to calculate the dose distribution.
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Figure 3.6.: Treatment control at GSI. The sum of the blue and green segment represents the
prescribed particle number for each raster point in the PBPplanned . The red area
pictures the overdose that occurs because of the finite time increment of the control
system. The green segment is subtracted from the prescribed particle number due
to the overdose of the foregoing rasterpoint. Therefore the sum of the blue and red
parts equals the applied dose.
Figure 3.7.: Treatment control at HIT. Analog to figure 3.6.
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An elaborate analysis of the differences between PBPplanned and PBPcor r was done. For this
purpose the PBPplanned of patient 2 (see table 3.1) was chosen because of its big CTV so that the
largest effects can be expected.
The highest intensities at GSI (2 ·108 par t icles
spil l
) and at HIT (8 ·107 par t icles
s
), a re-scan number of
25, a measured and an artificial square spill profile (see figure 3.5) and slice-by-slice re-scanning
mode were taken as input parameters to calculate the simulated physical-beam-record (PBR)
data along with the PBPcor r files. The measured spill profile was used to calculate the effects at
GSI and the square spill profile the corresponding effects at HIT, respectively.
In general, the intensity decreases for proximal slices. It follows that this parameter selection
can be expected to have a larger impact on the PBPcor r than in real cases. Therefore, if this worst
case scenario will result in negligible changes of the applied compared to the planned particle
numbers it shall also be expected in case of lower intensities and smaller re-scan numbers. The
analysis includes several steps. First, the relative deviation of each rasterpoint i was calculated
⇠(i) =
Ä
N(i)cor r   N(i)planned
ä
N(i)planned
, (3.2)
with N being the particle number of the corrected and the planned PBP, respectively. Second,
rasterpoints closer to the proximal slices receive in general less dose because they have already
been pre-irradiated when applying the dose to the more distal slices. Therefore the deviation of
each point according to formula (3.2) shall be weighted to account for the pre-irradiation. In
the optimization the dose level was set to be constant across the whole tumor tissue. Therefore,
if a rasterpoint shall be irradiated with the maximum particle number of Nmax this correspond
to the prescribed dose. The weighted deviation for each rasterpoint can then be expressed as:
⇠(i)weighted =
Ä
N(i)cor r   N(i)planned
ä · N(i)planned
Nmax
N(i)planned
. (3.3)
Considering that the beam sweeps n-times over the area in slice-by-slice re-scanning mode, the
particle numbers N(i)cor r and N(i)planned , having the same x and y positions along with the
same energy, can be summed according to
Nsummed( j) =
all pointsX
i=1
for x,y and E
being identical
N(i) (3.4)
before calculating (3.2) and (3.3).
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Simulated physical beam record files - PBRsim
This section refers to figure 3.1 (3. and 4.):
Figure 3.8 shows the beam delivery sequence calculated by the PBRSimEnv in case of patient 5
for slice-by-slice re-scanning with r = 3. The spill status is represented by a logical signal and the
total number of rasterpoints is normalized to one. In case of slice-by-slice re-scanning, volumetric
re-scanning, local-parameter re-scanning and mixed-scanpath re-scanning the spill characteristics
of the GSI system were used (see table 3.3) along with randomly selected measured spill files
recorded at GSI.
Figure 3.8.: Slice-by-slice re-scanning simulated physical beam record file calculated for patient
5 with 3 re-scans . The black line represents the spill signal (a value of one means
that particles are extracted and the beam is on). The red points are the rasterpoint
counter. If the irradiation of a point is finished this value is incremented by one.
The rasterpoint counter is normalized to one. The blue points indicate when the
irradiation of an IES is finished and the green points display if the energy of the
particles was changed.
The same spill profiles were basically also used in case of random-time-delay re-scanning but
it was assumed that the spill profile is being "frozen" in time during the random-pauses and that
the spill extraction re-starts exactly after the random-pause is over. It follows that the total beam
extraction time per spill is still 2.2 s but expanded to a longer time duration which depends
on the random-pauses. The spill-on signal time Ton, random can therefore have a length between
2.2 s < Ton, random < (2.2 + Nrandom(i) · Trandom, max) s, with Trandom, max being the maximum
random-pause length.
This change of the accelerator behavior compared to the current GSI accelerator was necessary
because otherwise the random-pause will place the re-start of the irradiation to often into the
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period of spill pauses when no beam is available. However, these extraction characteristics can
be realized by using an accelerator with variable spill length.
In case of breath-sampled re-scanning a square spill profile with a length of 10 s was used
because the spill length needs to be at least as long as the breathing period. The intensity is then
adjusted in a way that the particle extraction time equals the breathing period. Using a square
spill is actually very close to the current spill shape implemented at HIT and the prolonged spill
duration shall not bias the outcome of the 4D dose calculation since the irradiation starts in
breath-sampled re-scanning anyway at an arbitrary phase for each IES. In addition, it will be
shown in chapter 4.3.3 that the breath-sampled re-scanning dose calculation shows almost no
dependence whether gained by a measured spill profile or by a square profile.
Figure 3.9.:Magnified cutout of the PBRsim files in case of a slice-by-slice re-scanning , b) random-
time-delay re-scanning with µrandom = 0.05 and c) breath-sampled re-scanning with
a spill length 10 s. The particle extraction time and the breathing motion period
have a duration of 4 s.
The differences in beam delivery sequence between slice-by-slice re-scanning, random-time-
delay re-scanning and breath-sampled re-scanning are illustrated in figure 3.9. The time which is
necessary to finish an IES in slice-by-slice re-scanning and random-time-delay re-scanningmode is
not constant and depends on the prescribed intensity and the total particle number of this slice.
In case of random-time-delay re-scanning µrandom = 0.05 was used. Not all 20 random-pauses are
visible in the chosen temporal resolution. As requested, breath-sampled re-scanning finishes the
irradiation of each IES in 4 s.
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3.2.2 Patient simulation studies
This section refers to figure 3.1 (4. and 5.):
The 4D dose calculation is performed with TRiP. In addition to 4DCT data, the PBPcor r and
PBRsim files other input data like the motion trajectory or the starting phase have to be defined.
A mandatory request for a treatment planning study is that it should include almost all relevant
clinical cases and that it shows the variation of the 4D dose distribution if the input parameters
are changed as it can happen in real patient treatments. Therefore the dose calculations have
been performed over a broad range of parameters.
Standard cases
The standard cases represent the fundamental dose calculations in the scope of this thesis.
The 4D dose distribution for all five patients (see table 3.1) and all re-scan modes (see table
3.2) were calculated over a broad range of parameters which should cover almost all relevant
clinical situations. An overview is given in table 3.4.
simulation parameter range or count
re-scan modes 6 (see table 3.2)
re-scan numbers 1, 3, 5, 9, 13, 17, 21
starting phase 0 , 90 , 180 , random (0  - 359 )
breathing period 3 s, 4 s and 5 s
patients 1, 2, 3, 4, 5
Table 3.4.: Overview of the parameter space for the standard calculations.
In addition to the fixed starting phases the 4D dose calculation was also performed with a
starting phase that was randomly selected from the range of 0  - 359  for each field. To describe
the trajectory of the tumors, Lujan-motion with n= 2 was used (Lujan et al., 1999).
The number of random-pauses was fixed to µrandom = 0.05 and the maximum random-pause
length to Trandom, max = 1 s, respectively.
The beam intensity for each treatment field is chosen to be the same as if this field is being
irradiated in normal therapy mode at GSI without re-scanning functionality. An exception is the
beam intensity selection in breath-sampled re-scanning mode which is being calculated in order
to match the irradiation time per IES with the breathing period.
In total, over 2500 4D dose calculations were performed for the standard cases.
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Special case I - breath-sampled re-scanning uncertainty
The standard cases assume perfect matching of the irradiation time of each IES with the breath-
ing period. In real patient treatment the breathing motion of the patient will always fluctuate
to some extent. Therefore, it is important to investigate the robustness of breath-sampled re-
scanning with respect to these variations. The PBRSimEnv was adjusted to generate beam
sequence files with an irradiation time per IES that perfectly matches the breathing period.
To include the uncertainty, the breathing cycle of the motion traces, which are mandatory to
calculate the 4D dose distribution with TRiP, were varied as listed in table 3.5. In total 480
4D dose calculations were performed with respect to variations in the motion period when
irradiating in breath-sampled re-scanning mode.
simulation parameter range or count
breath-sampled re-scanning length 4 s
breathing period 1 s , 3 s , 3.5 s, 3.75 s, 4 s, 4.5 s, 4.75 s, 5 s
re-scan numbers 1, 3, 5, 9, 13
starting phase 0 , 180 , random (0  - 359 )
patients 2, 3, 4, 5
Table 3.5.: Overview of the parameter space for breath-sampled re-scanning with uncertainties
in the motion period.
Special case II - variation of the number and the maximum length of the random-pauses
The number and the maximum length of the random-pauses were also varied to study their in-
fluence. Since each random-pause prolongates the treatment time it is worthwhile to investigate
the influence if these numbers are lowered. For these calculations only patient 5 with the largest
motion amplitude was used along with a motion period of 4 s.
The beam intensity for each treatment field is chosen to be the same as if this field is being
irradiated in normal therapy mode at GSI without re-scanning functionality. If the µrandom de-
pendence is studied, the maximum random pause is fixed to Trandom, max = 1 s. If the Trandom, max
is investigated, the number of random pauses is set to µrandom = 0.02.
Further details are listed in table 3.6. In total 72 4D dose calculations were performed with
respect to variations in the number and the maximum length of random-pauses.
3.2.3 Data analysis
The quantify and judge the quality of the dose distribution the measures Dx and Vx are used
according to the ICRU recommendations (ICRU, 1993). The general definition is as follows:
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simulation parameter range or count
µrandom 0.05, 0.2
Trandom, max 1 s, 0.1 s
re-scan numbers 1, 3, 5, 9, 13, 17
starting phase 0 , 180 , random (0  - 359 )
motion period 4 s
patient 5
Table 3.6.: Overview of the parameter space for a di erent number of random-pauses in the
random-time-delay re-scanning mode.
• Dx : x% of the volume of interest has received a dose of at least Dx .
• Vx : A dose of at least x% of the target dose has been received by the volume Vx .
For comparison of the different re-scanning techniques the V95 and the V107 of the CTV have
been analyzed as a measure for target coverage and overdose, respectively. In the ideal case
V95 = 100% and V107 = 0% should be reached. The difference D5  D95 is used to quantify the
level of homogeneity. A sharper dose fall-off leads to a smaller D5   D95 value and thus to a
more homogeneous dose distribution. The analysis of these quantities is exemplary shown in
figure 3.10.
The mean and standard deviation of the dose distributions were calculated over all motion
parameters for each re-scan mode and each re-scan number for the measures of V95, V107 and
D5 D95 for the standard and both special cases.
The values of all measures have been investigated for significant differences between the
re-scan modes at fixed re-scan numbers. Since the requirements for parametric test pro-
cedures were not met it was necessary to use non-parametric significance tests. Hence,
the different measures were tested by using the Kruskal-Wallis test in combination with the
Wilcoxon–Mann–Whitney test at a significance level of ↵= 5%.
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Figure 3.10.: Example of the analysis of V95, V107, and D5  D95 comparing two di erent DVHs.
The V95 and V107 are the volumes at the intersection of the vertical lines (at 95% and
107% dose level, respectiveley) and the according DVH curve. For the orange DVH
V95 = 64.7% and V107 = 4.2%, for the blue DVH V95 = 98.7% and V107 = 0.2%.
The D5 is the dose at the intersection of the horizontal line at 5% volume level and
the DVH curve. Accordingly, the D95 is the intersection of the horizontal line at 95%
volume level and the DVH curve. The di erence between these dose levels is the
D5 D95. For the orange DVH D5 D95 = 39% and for the blue DVH D5 D95 = 7%.
Figure and exemplary analysis are adopted from R. Luechtenborg (Lüchtenborg,
2012).
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3.3 Results
3.3.1 The physical-beam-record simulation environment
The effect on the dose application due to the overdose which results from the finite time spacing
of the therapy control units at GSI is shown in figure 3.11 a) - d) for a re-scan number of 25.
Figure 3.11 a) shows that the combination of high intensity irradiation in slice-by-slice re-
scanning mode with a re-scan number of 25 leads to a broad distribution of the relative errors
between the applied and the planned dose on the rasterpoints of patient plan. Some points get
only 50% of the prescribed dose while others receive up to 175%.
Taking the weighting into account, then figure 3.11 b) shows a a much narrower distribution,
the minima and maxima deviation values are very close to the ones of 3.11 c) which includes
the re-scan effect on the dose application.
Figure 3.11 d) accounts for the weighting as well as for the re-scan effect and therefore rep-
resents the case which is closest to reality. The distribution is very narrow with a maximal
deviation of 1% which can be seen in the enlarged detail.
Further calculations have been done in case of the re-scan numbers 5 and 11. The results are
shown in table 3.7. The distributions get rapidly smaller for lower re-scan numbers.
The total prescribed particle number Nplanned = 7,199,586,070 is identical for all re-scan
cases. The total applied particle numbers for NGSI re-scan=5 = 7,199,603,400, NGSI re-scan=11 =
7,199,603,386 and NGSI re-scan=25 = 7,199,602,986 are so close to Nplanned that they can be
considered as being identical in terms of total dose.
The effect on the total number of particles at GSI is so small because over- and underdosage
cancel each other out which is different from the therapy control system used at HIT which is
displayed in figure 3.11 e) - h).
Figure 3.11 e) shows that no rasterpoint is irradiated with too less dose and that the maximum
deviation of overdose is 20% in case of the same patient plan, the same re-scan number and the
identical intensity settings as for the calculations shown in figure 3.11 a).
Figures 3.11 f) and 3.11 g) illustrate that the deviation from the planned dose level is reduced
when including the weighting and the re-scanning of the individual rasterpoints, respectively.
Like in the former case at GSI, the best result at HIT is gained when combining both effects
which is presented in figure 3.11 h). The deviation of the dose level is then expected to be less
than 1% for all rasterpoints. Further calculations have been done in case of the re-scan numbers
5 and 11. The results are shown in table 3.7.
The corresponding numbers are NHIT re-scan=5 = 7,212,603,725, NHIT re-scan=11 = 7,228,041,989
and NHIT re-scan=25 = 7,294,277,434 which results in a total particle deviation of 1.3% in case
of 25 re-scans.
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Figure 3.11.: Histograms showing the influence of the therapy control units (SAMS) on the dose
application for a re-scan number of 25. More data can be found in table 3.7. Each
subfigure shows the relative deviation of the actually irradiated and the planned
dose. a) - d) displays the results for the TCU at GSI and e) - h) for the TCU at HIT,
respectively. a) for each rasterpoint (see formula 3.2), b) for each rasterpoint, but
weighted concerning its relative importance on the total dose for the TCU at GSI.
c) as a) and d) as b) but including formula 3.4 which basically sums up the deviation
for each individual rasterpoint over all re-scan runs. The width of each bin is 1%. e)
corresponds to a), f) to b), g) to c) and h) to d), respectively.
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re-scans facility min/max [%] min/max [%]
(individual, not weighted) (summed, weighted)
5 GSI - sample spill 0.89/1.14 1/1
11 GSI - sample spill 0.70/1.27 0.99/1.01
25 GSI - sample spill 0.51/1.75 0.99/1.01
5 HIT - sample spill 1.00/1.03 1.00/1.00
11 HIT - sample spill 1.00/1.07 1.00/1.00
25 HIT - sample spill 1.00/1.2 1.00/1.00
5 HIT - square spill 1.00/1.01 1.00/1.00
11 HIT- square spill 1.00/1.03 1.00/1.00
25 HIT - square spill 1.00/1.06 1.00/1.00
Table 3.7.: Quantitative results of figure 3.11 with additional values for the re-scan numbers 5
and 11.
Figure 3.12.: Comparison of the irradiation duration in case of slice-by-slice re-scanning , volumet-
ric re-scanning , random-time-delay re-scanning and breath-sampled re-scanning .
The information was gained by analyzing the PBRsim of patient 2. The choice for
this patient was arbitrary and shall not a ect the conclusion of the results.
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The time information of the generated PBRsim files can be used to compare the different re-
scanningmodes with regard to the individual irradiation length. The data were analyzed in case
of patient 2. Due to the implementation of the simulation environment mixed-scanpath, local-
parameter and slice-by-slice re-scanning exhibit identical irradiation times so that figure 3.12
shows only a comparison of the treatment duration of slice-by-slice, volumetric, breath-sampled
and random-time-delay re-scanning in case of r = 3 and r = 9. Slice-by-slice re-scanning is the
technique which finishes the irradiation fastest and shows no dependence on the re-scan number.
Breath-sampled re-scanning irradiation, which was planned in case of breathing period of 4 s, is
the second fastest mode and shows no dependence on the re-scan number, too. Random-time-
delay re-scanning is the only technique with an uncertainty of the irradiation time length due
to the random pauses. The number of random pauses was defined as µrandom = 0.02 with a
maximum length of 1 s. Nevertheless, this mode shows only a minor dependence on the re-scan
number. On the other hand, the irradiation time in case of volumetric re-scanning is almost
tripled. In the current implementation volumetric re-scanning is certainly the mode which uses
the accelerator beam most inefficiently.
3.3.2 Patient simulation studies
Standard cases
The results and data analysis of the dose distribution of patient 1 (smallest amplitude), patient
3 (medium amplitude) and patient 5 (greatest amplitude) will be presented in the following.
The V95, V107 D5   D95 data were analyzed and visualized in figures. In addition, some general
statements about quality of the individual re-scan modes with respect to their efficiency in re-
ducing interplay patterns shall be given in this section. The complete set of data can be found
in the appendix A.1.4 where the mean values, the standard deviation and the corresponding
significance test are summarized in tables.
Representative dose distributions of patient 5 are shown in figure 3.13. The dose cuts are
displayed for thee selected re-scan modes namely slice-by-slice, breath-sampled and random-
time-delay re-scanning for patient 5 in case of r = 1 and r = 9, respectively. The calculations
illustrated the outcome of a breathing period of 4 s, a starting phase of 0 . Distinct interplay
patterns can be seen in the case of r = 1 for all three re-scanning flavors. No dose inhomo-
geneities are visible inside the CTV when increasing the re-scan number to r = 9 in case of
breath-sampled and random-time-delay re-scanning, respectively. Slice-by-slice re-scanning also
shows an improved dose distribution at r = 9, but some cold and hot spots are still visible.
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Figure 3.13.: Exemplary dose cuts of three selected re-scan modes, namely slice-by-slice, breath-
sampled and random-time-delay re-scanning for patient 5 in case of r = 1 and
r = 9, respectively. It can bee seen that breath-sampled and random-time-delay
re-scanning reduce the interplay patterns very e ciently. The CTV represents the
target contour and is outlined in black.
The upper parts of figure 3.14 a), 3.14 b) and 3.14 c) show the V95 analysis of patients 1, 3
and 5, respectively. It can bee seen that a larger motion amplitude results in less target coverage
which cannot be efficiently compensated by slice-by-slice re-scanning, volumetric re-scanning,
mixed-scanpath re-scanning and local-parameter re-scanning in all cases even for re-scan numbers
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up to r = 17. Breath-sampled re-scanning and random-time-delay re-scanning on the other hand
can compensate the motion effects very well. The breath-sampled re-scanning mode requires a
maximum number of r = 9 to reach a mean value of V95 = 100% in case of all five different
patients. Random-time-delay re-scanning is also able to reach V95 = 100% for all patients but
usually needs a larger re-scan number with a maximum up to r = 17. Volumetric re-scanning
reaches total target coverage only in case of patient 3. Slice-by-slice re-scanning, local-parameter
re-scanning and mixed-scanpath re-scanning are very close to V95 = 100% in case of the two
patients with the smallest motion amplitude but they fail marginally. The significance analysis
shows that breath-sampled re-scanning performs almost in all cases better than slice-by-slice re-
scanning, volumetric re-scanning, mixed-scanpath re-scanning and local-parameter re-scanning. In
case of larger motion amplitudes and medium re-scan numbers it sometimes also performs better
than random-time-delay re-scanning. But altogether random-time-delay re-scanning is clearly the
second best choice to gain good target coverage. No significant difference between slice-by-slice
re-scanning, mixed-scanpath re-scanning and local-parameter re-scanning was found.
The lower parts of figures 3.14 a), 3.14 b) and 3.14 c) show the V107 analysis of patients 1,
3 and 5, respectively. It can bee seen that a larger motion amplitude results in larger overdose
of the CTV which cannot be efficiently compensated by slice-by-slice re-scanning, volumetric re-
scanning,mixed-scanpath re-scanning and local-parameter re-scanning in all cases even for re-scan
numbers up to r = 17. The breath-sampled re-scanning technique needs a maximum number of
r = 3 to reach a mean value of V107 = 0% in case of all five different patients. Random-time-
delay re-scanning is also able to reach a value of V107 = 0% for all patients with a maximum
re-scan number up to r = 5. The volumetric re-scanning, local-parameter re-scanning, slice-by-
slice re-scanning and mixed-scanpath re-scanning modes can efficiently reduce the overdose to
the CTV for patients 1 and 2. The V107 significance analysis shows the same trend as in the V95
case.
The corresponding D5   D95 values for the three patients are shown in figure 3.15. The
steepness of the dose volume histograms (DVHs) can be assessed by the corresponding D5 D95.
The lower this value the more homogeneous is the dose distribution of the CTV. In case of all
patients the breath-sampled re-scanning technique resulted for a re-scan numbers r   13 in
a dose distribution which is almost as homogeneous and steep as an irradiation in the static
case. For instance, the mean D5   D95 values of patient 5 irradiated with r = 13 are 1.9%
and 3.8% for breath-sampled re-scanning and random-time-delay re-scanning, respectively. The
corresponding DVHs of the random-time-delay re-scanning mode are in general less steep than
the ones of breath-sampled re-scanning. Volumetric re-scanning is less homogenous than those
two techniques but outperforms slice-by-slice re-scanning, local-parameter re-scanning andmixed-
scanpath re-scanning. Those three modes exhibit almost the same level of homogeneity. The
D5  D95 significance analysis shows the same tendencies as in the V95 and V107 cases.
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Figure 3.14.: V95 and V107 values for the di erent re-scan modes as a function of the re-scan
number in case of a) patient 1, b) patient 3 and c) patient 5, respectively. Every
case consist of twelve data points (due to the variation of the starting phases and
the breathing periods) which might not be visible due to clustering of the points
when increasing the re-scan number.
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Figure 3.15.: The D5   D95 values for the di erent re-scan modes as a function of the re-scan
number in case of a) patient 1, b) patient 3 and c) patient 5, respectively. Every
case consist of twelve data points which might not be visible due to clustering of
the points when increasing the re-scan number.
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Figure 3.16.: The results of the V95 , V107 and the D5   D95 significance tests are summarized in
this figure. If a technique was significantly better than the other it got a count.
Therefore the height of the individual bars indicates the quality of each re-scan
mode.
About 1500 significance test have been performed for the results of the standard cases. Figure
3.16 gives an overview which technique performed best. The V95, V107 and the D5  D95 results
were analyzed and if a significant difference between two re-scan modes was observed, the
technique which performed better got a count. The numbers illustrate that breath-sampled re-
scanning would be the best re-scanning choice to reduce interplay effects in the parameter space
of this section. The second best option was clearly random-time-delay re-scanning. Volumetric re-
scanning only got some counts when tested against the slice-by-slice re-scanning, mixed-scanpath
re-scanning, local-parameter re-scanning modes.
Special case I - breath-sampled re-scanning uncertainty
The results and data analysis of the dose distribution of patients 5 will be presented in the
following. The V95, V107 D5   D95 data was analyzed and visualized. The complete set of data
can be found in the appendix A.1.5 where the mean values and the standard deviation are
summarized in tables as well as significance tests of every case.
Figure 3.17 a) and b) illustrate that the deviations between the various motion periods get
smaller when increasing r form 1 to 5 as well for the V95 and V107 analysis but that there is
still a difference visible. Nevertheless, the data in the appendix shows that only one simulation
(motion period 4.5 s patient 4) is not able to reach mean values of V95 = 0%, V107 = 100% for
the investigated range of re-scan numbers.
The differences between the various motion periods are more apparent by looking at the
mean values of the D5   D95 analysis displayed in figure 3.17 c). The D5   D95 values show
that the motion period of 4 s which corresponds to perfect matching of the motion period and
73
Figure 3.17.: V95, V107 D5   D95 and values for non-perfect breath-sampled re-scanning period
matching as a function of the re-scan number in case of patient 5. The V95 is a
measure of the dose coverage, the V107 of the overdose and the D5   D95 of the
homogeneity, respectively.
the breath-sampled re-scanning irradiation process leads in general to more homogeneous dose
distributions than compared to the other motion periods. However, the difference is often not
significant.
In figure 3.18 the V95 data of patients 4 and 5 are arranged as a function of the motion period
to make dependencies of the period mismatch best visible. Independent of the re-scan number
and the patient the curves exhibit three local maxima and two local minima. The shape of the
"W" like curve is asymmetric. Small deviation of 0.25 s from the desired motion amplitude have
larger impact if the motion period is longer than the irradiation time per IES. If the motion
periods are 1 s and 5 s, respectively, the V95 results approach the level which was obtained when
using the perfect matching period of 4 s.
Special case II - variation of the number and the maximum length of the random-pauses
The results and data analysis of the dose distribution of patients 5 for two different numbers
of random pauses will be presented in the following. µrandom = 0.05 is equivalent to 20 and
µrandom = 0.2 equivalent to 5 random pauses, respectively. The complete set of data can be
found in the appendix A.1.6 where the mean values and the standard deviation are summarized
in tables along with the significance tests of every case.
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Figure 3.18.:Mean and standard deviation of the V95 data of patients 4 and 5 as a function of
the motion period in case of the re-scan numbers r = 3 and r = 5, respectively.
The blue line indicates the motion period of perfect breath-sampled re-scanning
matching.
Figure 3.19.: V95, V107 D5   D95 and values for two di erent numbers of random pauses as a
function of the re-scan number in case of patient 5. The maximum random pause
is fixed to Trandom, max = 1 s. The V95 is a measure of the dose coverage, the V107 of
the overdose and the D5  D95 of the homogeneity, respectively.
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Figure 3.20.: V95, V107 D5   D95 and values for two di erent values of the maximum random
pause length as a function of the re-scan number in case of patient 5. The number
of random pauses is set to µrandom = 0.02. The V95 is a measure of the dose cover-
age, the V107 of the overdose and the D5  D95 of the homogeneity, respectively.
Figure 3.19 shows that the variation between those two numbers of random pauses has very
little influence on the V95, V107 and the D5 D95 results. The statistical analysis showed only for
the D5 D95 values at r = 13 a significant better result of the higher number of random pauses.
Figure 3.20 shows that the variation of the maximum length of the random pauses has very
little influence on the V95, V107 and the D5   D95 results, too. The statistical analysis showed
that Trandom, max = 0.1 s is the better option in three cases and Trandom, max = 1 s in two cases.
However, the absolute difference is actually so small that it is not expected to influence the
outcome of a treatment.
3.4 Discussion
The simulation results of the patient study give an extensive overview of the properties of motion
mitigation when using scanned particle beams in combination with re-scanning.
Uncertainties in the beam application are addressed as well as specific uncertainties in the
breath-sampled re-scanning and the random-time-delay re-scanning mode. Especially these two
re-scan modes show very promising results and facilitate the irradiation of the CTV with a sat-
isfying quality even for large tumor motion. The consideration of uncertainties is essential to
predict the outcome of real patient irradiations.
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The adequately adapted parameter space ensures that the simulation results are not statisti-
cally unlikely outliners. Due to the experience at our group at GSI, the re-scanning technique
can be easily classified in a broader context by comparing the results with other motion mitiga-
tion techniques like beam tracking (Lüchtenborg, 2012; Eley, 2013) and the fractionation effect
(Woelfelschneider, 2011) investigated at our institute. In addition, the results were also com-
pared with the findings of other research groups from all over the world (e.g. (Mori et al., 2013;
Knopf et al., 2011; Phillips et al., 1992; Seco et al., 2009)).
3.4.1 The physical-beam-record simulation environment
The broad distribution of figure 3.11 a) reveals that some points would receive a particle level
which is over 50% off the prescribed values. At a first glance this seems to be unacceptable
because too much dosage can lead to necrotic tissue and too less will increase the surviving of
cancer cells inside the CTV. The error in the number of particles is inversely proportional to the
total treatment time of this point which means that the proximal IESs will certainly be the one
with the biggest variations because the nominal particle number is lowest in these slices. But
the rasterpoints in those regions receive pre-irradiation from the more distal slices which also
contributes to their integral dose (see figure 2.10). Weighting the rasterpoints relative to their
importance improves the error of the particle number to ±9% (see figure 3.11 b)) which is still
considered to be too large. Almost the same effect can be observed by including the influence
of re-scanning in the analysis (see figure 3.11 c)). The intrinsic feature of re-scanning, namely
statistical averaging, is not only limited to smoothing interplay patterns which emerge because
of the influence of intra- and inter fractional motion, but of a more general nature. Combining
the two features yields the best approximation to the real system and shows that only 4% of the
rasterpoints are irradiated with an error of ±1% in terms of the particle counts. Furthermore,
smaller re-scan numbers and a lower intensity, which might be sufficient to compensate interplay
patterns, will further decrease these deviations. Table 3.7 also includes calculations using an
artificial spill with a perfect square shape. The results are even better because large spikes in a
beam spill profile cause the largest deviations.
In contrast to the nearly gaussian shaped deviation curve which is caused by the therapy
control system at GSI the deviations at HIT yield a systematic tendency towards too large particle
numbers because the information of the previously irradiated rasterpoint is not used to correct
the particle number of the next one. Figure 3.11 e) shows that the most frequent particle
number is the one with an excess of 1%. Due to the finer sampling rate the maximum error is
reduced by 30% compared to GSI. Including the effects of pre-irradiation (see 3.11 f)) clearly
improves the irradiation quality better than the re-scanning effect (see 3.11 g)). The reason is
that the systematic errors at HIT cannot be compensated as efficiently as the random errors at
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GSI by statistical averaging. Figure 3.11 h) illustrates that the combination of both corrections
results in particle deviations below 1% of each rasterpoint.
Until now the focus was on the irradiated particle numbers of each rasterpoint which is a
slightly different issue than looking at the total dose deviation. The analysis of the particle
numbers according to equation 3.3 does not take the pre-irradiated dose contributions into
account which is in general a complex RBE-weighted value of the mixed radiation field2. The
purpose of the weighting factor in equation 3.3 is only to scale the rasterpoints with respect to
their relative importance like already mentioned.
The total dose corresponds therefore simply to the total number of particles which are ap-
plied in the investigated case. The total over- and underdosage contributions cancel out at GSI
whereas the overdose sums up to 1.3% of the total planned dose at HIT at 25 re-scans and
maximum intensity when using the measured spill profile. This is therefore a kind of worst case
scenario but nevertheless worthwhile to keep in mind.
Both approaches tackle the issue of the dose application from different sides and shall there-
fore be both considered. Only looking at the total dose can lead to overlooking cases when, e.g.,
two IES are irradiated with wrong dose levels which could cancel each other out. On the other
hand, only looking at the irradiated particle numbers could, e.g., underestimate to total applied
dose.
In order to mimic the existing systems as close as possible it is therefore advisable to use
the PBPcor r data input for the simulations environment since this data includes all the necessary
information as it was done throughout this thesis when calculating dose distributions with TRiP.
The analysis indicates that the influence of the therapy control systems at HIT and GSI should
be small enough to facilitate re-scan irradiation.
With respect to economic considerations a fast irradiation process is desirable. Figure 3.12
displays the duration of different re-scan modes to finish the dose application. Within the sim-
ulation environment which was created in the scope of this theses there is no difference of the
irradiation times of the mixed-scanpath re-scanning, local-parameter re-scanning and slice-by-slice
re-scanning techniques. Hence, only slice-by-slice re-scanning is shown which is also the fastest
method for this investigated case.
Volumetric re-scanning takes longer because after each re-scan run the energy is changed which
takes each time additional 3.3 s. When increasing the number to r = 9 re-scans the number of
additional pauses of the synchrotron to chance its energy is multiplied by three and therefore
the time duration increasing accordingly, too.
For the case of r = 3 random-time-delay re-scanning is even longer than volumetric re-scanning.
That is due to the fact that the number of random pauses was set to 20 (µrandom = 0.05). These
twenty random pauses of a duration with a maximum length of 1 s added up so that random-
time-delay re-scanning took longer than volumetric re-scanning. This is the only mode with an
2 These calculations are incorporated when performing the simulations with TRiP
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uncertainty with respect to treatment length. When increasing the number of re-scans to r = 9
the number of random pauses keeps constant. Therefore it could even happen that the time
duration is shorter than in case of r = 3. In this example it was slightly longer but this time
approximately 250% faster than the corresponding volumetric re-scanning irradiation. In the
current implementation of the breath-sampled re-scanning method the full spill length has to
pass even if the irradiation of has been finished before. Breath-sampled re-scanning is calculated
with a spill having a length of 10 s and slice-by-slice re-scanning with duration of 2.2 s which
therefore results in longer irradiation time of the breath-sampled re-scanning technique.
3.4.2 Patient simulation studies
Standard cases
In this treatment planning study six difference re-scanning modes slice-by-slice re-scanning, vol-
umetric re-scanning, mixed-scanpath re-scanning, local-parameter re-scanning, random-time-delay
re-scanning and breath-sampled re-scanning have been compared for the treatment of lung tu-
mors. Due to the very large number of simulation results the V95, V107 and the D5  D95 data is
an appropriate option to present the outcomes in a compact and instructive way.
As it is already shown in other reports (e.g. (Mori et al., 2013; Knopf et al., 2011; Phillips
et al., 1992; Bert and Durante, 2011)) the interplay effect is more distinct in case of greater
motion amplitudes. The data illustrates that in case of the patients with the smallest amplitude
the V95 and V107 saturate already for a re-scan number of r = 5. There is only a small difference
between the individual techniques. However, only random-time-delay re-scanning and breath-
sampled re-scanning reach a mean value of V95 = 100%. The other techniques generally yield
their maximum value already at r = 5 but they do not improve when increasing the re-scan
number. For instance, in case of patient 2 the mean values of V95 are 99.5% and 99.4% at r = 5
and r = 21, respectively. The reason might be that those four techniques do not exhibit an
extra feature which was merely introduced to break up a possible synchronicity between beam
application and tumor motion. Even if a certain correlation, which creates a distinct interplay
pattern, is broken up by changing the number of re-scans it can happen that another correlation
emerges. Those two interplay patterns are likely to look different but both prevent that a value
of V95 = 100% can be achieved.
The corresponding D5 D95 analysis backs up this explanation. It is a measure of homogeneity
and shows larger diversion of the data point than the V95 analysis. Two dose volume histograms
(DVH) can look different but both having values of V95 = 100% and V107 = 0%, respectively.
Hence, the D5  D95 data must be used to investigate the results more thoroughly. The analysis
of patients 1 and 2 reveals that breath-sampled re-scanning and random-time-delay re-scanning
both have lower D5   D95 values than the other modes. However, the more crucial point is
79
that the results of breath-sampled re-scanning and random-time-delay re-scanning not only get
significantly better when increasing r but the variation of the data points is also greatly reduced
so that both modes yield the same results independent of the starting conditions. It follows
that both techniques can break up correlation without introducing new synchronicity effects.
On the other hand, when inspecting the slice-by-slice re-scanning, volumetric re-scanning, local-
parameter re-scanning and mixed-scanpath re-scanning results the fluctuation of the data points
is almost constant in case of r   5 which means that the homogeneity is not really improved
when increasing the re-scan number.
In case of larger motion amplitudes (patients 3, 4 and 5) the differences between random-
time-delay re-scanning and breath-sampled re-scanning and the four other re-scanning modes get
more evident. Only random-time-delay re-scanning and breath-sampled re-scanning turn out to
be a possible treatment modality in case of larger motion amplitudes. Nevertheless, the reason
of these differences is again that only those two techniques can efficiently reduce the interplay
effect.
The analysis of patient 5 shows that a high correlation between beam application and tu-
mor motion was reached for a period of 5 s in case of the techniques slice-by-slice re-scanning,
local-parameter re-scanning and mixed-scanpath re-scanning, respectively. The three data points
having the worst results throughout all of the figures of this patient turned out to be related to
this breathing period.
But also for all other patients slice-by-slice re-scanning, local-parameter re-scanning and mixed-
scanpath re-scanning yield very similar results and the significance analysis showed in principle
no difference between these threes modalities. In case of the distal slices, the number of re-scans
per IES of the slice-by-slice re-scanning and random-time-delay re-scanning mode are identical or
deviated only slightly which has only minor influence on the outcome for r   5. The proximal
slices exhibit a larger difference between the number of re-scans. For instance in local-parameter
re-scanning mode, the most distal slice of patient 5 (field beam entrance angles of 20 ) is ir-
radiated with r = 17 and the most proximal IES with r = 2. But due to pre-irradiation, the
weighting of those more proximal slices with respect to the total dose is obviously so much less
that the irradiation quality stays on almost the same level like using the slice-by-slice re-scanning
technique.
Knopf et al. (Knopf et al., 2011) report more satisfying dose distributions in the presence of
motion if more fields are used and if the motion direction is parallel to the main direction of
the pencil beam. In the present simulations four individual fields contribute to the total dose
distribution which results in an effective re-scan number that is four times the re-scan number
which is displayed in all the figures. Hence, the dose distributions get rapidly better as a function
of the re-scan numbers compared to simulations using only a single field approach.
In the scope of this thesis (see section 4.3.3) it was also found that less interplay patterns
emerge when the motion direction is parallel to the main direction of the pencil beam. In fact,
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this was the motivation to introduce mixed-scanpath re-scanning. A re-scanning mode which
changes the main direction of the pencil beam for every consecutive run should be more ro-
bust than a mode with a fixed scanpath direction. However, the results show no significance
difference between slice-by-slice re-scanning and mixed-scanpath re-scanning. The data points
lie almost always on the same level. The reason is that in the experiments (see section 4.3.3)
the setup was designed so that the motion directions were parallel as well as perpendicular to
the main scanning path. When calculating the patient studies it is unlikely that these condi-
tions are met as accurate as in the designed experiments. In addition, even if one field would
meet the requirements, the other three fields will most likely not because in case of lung tumor
motion there is typically only one dominant motion direction. Therefore, it might be worth-
while to investigate the differences of mixed-scanpath re-scanning and slice-by-slice re-scanning
for irradiation with less irradiation fields than used in this study.
Figure 3.16 illustrates that breath-sampled re-scanning is the most efficient and in principle
the best method to reduce interplay effects because it is the technique which is in most cases
significantly better compared to all the other modes. Even if breath-sampled re-scanning is not
in many cases better than random-time-delay re-scanning, the difference in the height of the
corresponding bars emerges from the fact, that breath-sampled re-scanning is simply much more
often better significantly better as random-time-delay re-scanning compared to the other four
re-scanning flavors. This discrepancy of random-time-delay re-scanning and breath-sampled re-
scanning arises from the fact that the irradiation of random-time-delay re-scanning is not exactly
matched to the motion period so that some motion phases receive more irradiation than others.
In the simulations the number of random pauses was sufficiently high so that the irradiations
took longer than the motion period. If the number of random pauses is chosen too low it might
happen that correlations are not being broken as efficiently and that the irradiation is being
finished in a time duration which is shorter than the motion period. The later case could result
in motion phases which would receive no irradiation at all.
Figure 3.16 also confirms that slice-by-slice re-scanning, mixed-scanpath re-scanning and local-
parameter re-scanning are approximately identical efficient in reducing the interplay patterns
of the investigated patient studies but that they are less efficient than volumetric re-scanning.
However, since volumetric re-scanning has no extra feature to break up synchronicity it seems
that it could happen that the reduction of interplay patterns might be less efficient in case of
another combination of patients and beam application properties.
Mori et al. (Mori et al., 2013) also observed in their studies with a motion phantom that volu-
metric re-scanning yields better results than slice-by-slice re-scanning. In addition, they simulated
a technique called Phase-Controlled Volumetric re-scanning which is in principle beam applica-
tion in the volumetric re-scanningmode within one ore more gating windows. They matched the
intensity so that the irradiation is finished at the end of a gating window. In their case study
they used the whole motion period as a gating window and compared it to Phase-Controlled
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Layered re-scanning which is basically their implantation of breath-sampled re-scanning. In all
investigated cases Phase-Controlled Layered re-scanning was superior to Phase-Controlled Volu-
metric re-scanning. The data presented in the scope of this theses indicate a better reduction of
interplay effects for breath-sampled re-scanning than presented by Mori et al. One reason might
be due to the fact that they used a single field approach.
Furthermore Mori et al. show the effect of different dose levels on the interplay patterns.
Their data reveal no tendency as a function of the prescribed dose but only fluctuations. A
possible explanation could be that changing the dose levels simply can increase or decrease the
correlation between beam application and tumor motion because the sweeping velocity of the
pencil beam is changed. They further investigated the effect of motion amplitude and motion
direction. The results are qualitatively in accordance with the findings in the scope of this thesis.
In accordance to the initial studies by Seco et al. (Seco et al., 2009) who compared different
re-scan modes with respect of a box shaped target immersed in water in the presence of wa-
ter with a single field approach breath-sampled re-scanning turned out to be the most efficient
method to reduce interplay patterns.
R. Lüchtenborg (Lüchtenborg, 2012) performed studies in the presence of motion for exactly
the same patients as done in this thesis. R. Lüchtenborg investigated how efficiently beam
tracking (BT) and real-time dose compensation combined with beam tracking (RDBT) can reduce
interplay patterns. RDBT is an advanced version of BT. In this flavor the prescribed number
of particles of the rasterpoints which have not been irradiated yet are online corrected due to
unwanted pre-irradiation levels. The analysis in his thesis showed that the dose distributions
of a whole treatment course of RDBT and BT yield in general worse or similar results than all
re-scanning modes at r   9 for patients 1 and 2 with respect to the mean values of V95, V107 and
the D5  D95.
In case of the two patients with the largest motion amplitude, namely patient 4 and 5, the
results of RDBT and BT are worse than those of breath-sampled re-scanning and random-time-
delay re-scanning but better than slice-by-slice re-scanning, mixed-scanpath re-scanning and local-
parameter re-scanning in case of r   9. The analysis of R. Lüchtenborg showed for instance that
the dose distribution can get worse when using RDBT and BT even if the motion amplitude is
decreased when inspecting the data of patients 3 and 4, respectively3. This indicates that there
is still another factor which introduces some uncertainty but the size of the motion amplitude.
Van de Water et al. (van de Water et al., 2009) also simulated BT on heterogenous phantoms and
found that BT can produce dose inhomgeneities for heterogeneous targets. This might be the
reason why interplay patterns cannot be as efficiently be compensated as with breath-sampled
re-scanning and random-time-delay re-scanning.
3 The analysis of the patients 4 and 2 in the thesis of R. Lüchtenborg correspond to the patients 3 and 4 of this
thesis.
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On the other hand, the irradiation of the healthy tissue is greatly reduced in case of BT and
RDBT. Re-scanning needs an ITV which covers all motion phases whereas perfect BT or RDBT
stresses the healthy tissue virtually to the same level as in the case of static irradiation. This gets
especially important if organ at risk (OAR) are close to the tumor.
An even better sparing of healthy tissue is achieved by the 4D optimization for scanned ion
beam tracking of moving tumors developed and studied in the scope of the thesis of J. Eley (Eley,
2013). The principle idea of this method is that the dose levels are not constant over all motion
phases but increased if the tumor is farther away from the OAR. In addition, the 4D optimized
beam tracking also improves target dose homogeneity for the investigates lung tumor patients
compared with 3D optimized tracking which is used in the thesis of R. Lüchtenborg (Lüchten-
borg, 2012). 4D optimization does in general potentially allow better treatment characteristics.
An alternative option to the one of J. Eley has recently been reported by Graeff et al. (Graeff
et al., 2013). They showed a solutions based on dedicated structuring of the CTV and included
experimental studies which show the feasbility to actually apply such a treatment plan.
Furthermore, J. Eley (Eley, 2013) investigated the robustness of scanned ion beam tracking
with respect to realistic motion and beam application uncertainties. The investigated patient
was identical to patient 5 of this thesis. J. Eley confirmed the results of Van de Water et al.
(van de Water et al., 2009), namely that even perfect beam tracking cannot reduce inhom-
geneities as reliable as re-scanning when irradiating heterogeneous targets in the presence of
motion. By incorporating realistic motion detection and beam application related errors, J. Eley
received dose distributions in case of patient 5 which resulted in worse results of the V95, V107
and the D5 D95 measures than obtained with breath-sampled or random-time-delay re-scanning.
The dose levels to the OAR (heart, spinal cord and esophagus) for patients 1, 3, 4 and 5 were
already studied in the thesis of J. Wölfelschneider (Woelfelschneider, 2011) who investigated
the reduction of interplay effects as a function of the number of treatment fractions. For those
4 patients exactly the same ITV was used as in this thesis so that the dose distributions should
be very similar inside the OAR. For instance, the analysis of J. Wölfelschneider showed that the
mean dose of patient 5 to the heart exceeded the dose limit of 7 Gy (Hof et al., 2007). This OAR
could not be spared, because its location was close to the target volume. All other mean doses
were below the corresponding dose limits of the corresponding OAR.
The analysis of the efficiency of the number of the treatment fractions to reduce interplay
effects (Woelfelschneider, 2011) shows that breath-sampled re-scanning and random-time-delay
re-scanning yield significantly better results than increasing the number of fractions with respect
to the mean values of V95, V107 and the D5   D95. Only patient 1 with the smallest motion
amplitude reaches mean values of V95 = 100% and V107 = 0%, respectively. The inspection
of all the data points indicates that volumetric re-scanning is the re-scanning flavor whose re-
sults are closest to those of the fractionation effect. This is in accordance with the statement
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of J. Wölfelschenider that irradiating patients with four fields and ten fractions is physically
comparable to a 40 times volumetric re-scanning (Woelfelschneider, 2011).
Special case I - breath-sampled re-scanning uncertainty
As expected, the irradiation duration of 4 s which exactly matches the breathing period yields
the best results because all motion phases are equally covered. Figure 3.18 illustrates, if the
breathing period is  0.25 s shorter than the irradiation duration it has only a small impact on
the dose distribution. In this case all motion phases were irradiated even if some motion phases
receive more dose than others. On the other hand, if the breathing period is +0.25 s longer than
the irradiation duration the effect on the dose distribution especially for low re-scan numbers is
larger because not all motions phases received irradiation.
A further increase of the deviation leads to local minima at both arms of the "W" shaped
curve because the relationship of the dose levels of the individual motion phases gets most
disadvantageous. However, increasing the deviation even more improves the dose distribution
again. In case of a motion period of 1 s4 the target moves four times through all its motion phases
which decreases the imbalance of the motion phases. In addition, the total irradiation time in
this case is an integer number of times of the respiration cycle. Furukawa et al. (Furukawa
et al., 2010a) already stated that this is especially efficient in reducing interplay patterns.
If the motion period gets longer the target approaches the case of a static irradiation. There-
fore it is not surprising that dose distributions will also get better when increasing the breathing
period. However, it is quite surprising that already a breathing period of 5 s leads to a dose
distribution which is not much worse than the one with the perfect matching period. Another
smoothing effect compared to the standard cases could be the fact that the irradiation length
per IES is prolonged to 4 s whereas the spill length was 2.2 s in case of slice-by-slice, volumet-
ric, local-paramter and mixed-scanpath re-scanning modes in the corresponding simulations (see
section 3.3.2) with a breathing period of 5 s of the patients.
The study of Shirato et al. (Shirato et al., 2004) showed an average standard deviation of
0.5 s of the investigated lung tumor breathing periods from different patients. Those variations
in the breathing periods are in the range as to shift the dose distributions into the local minima.
Systematic shifts of the breathing period could be accounted for by measuring the breathing
period during the treatment and online adjustment of the spill intensity as to match the motion
period. However, there is no way to predict the duration of the next breathing cycle. Further
simulations could be performed to investigate the effect of changing breathing periods on the
outcome of the treatment course. For instance, a probability distribution of the breathing peri-
ods could be incorporated into a Monte-Carlo simulation environment as to calculate the dose
distributions. S. Hild et al. (Hild et al., 2013) report on new methods that allow quantification
4 this rather short breathing period was included in the simulations due to academic curiosity
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of uncertainties and their visual presentation for treatments of intra-fractionally moving tumors
using a scanned ion beam.
If those simulations would yield that breath-sampled re-scanning needs some improvements
due to the uncertainty in the breathing cycle, there are many possible ways to adapt the method.
For instance, the irradiation of each slice could be subdivided in several parts - the irradiation
of each part matching the best guess of the upcoming breaching cycle.
Special case II - variation of the number and the maximum length of the random-pauses
The results show almost no dependence if the number of random-pauses is reduced from
nrandom pauses = 20 to nrandom pauses = 5. The reason might be that it is especially important
to have a larger number of random-pauses than re-scans. Interplay patterns due to correlation
emerge if the subsequent re-scan runs start relative to the moving tumor at the same position. A
random-pause after every re-scan run reduces the probability that every re-scan run starts in the
same motion phase. Introducing even more random pauses during a re-scan run does therefore
not necessarily increase the probability that the correlation is broken more efficiently.
Therefore it is not surprising that both nrandom pauses = 20 and nrandom pauses = 5 yield similar
results in case of r  5. However, even for re-scan numbers r > 5 the outcomes for both
numbers of random-pauses yield dose distribution of the same quality. The reason should be
that the statistical averaging effect gets more and more dominant when increasing the re-scan
number. This is likely to compensate the lower number of random-pauses.
The variation (Trandom, max = 1 s, Trandom, max = 0.1 s) with respect to the maximum length of
the random pauses showed only very little difference of the measures V95, V107 and D5   D95,
respectively.
A shorter Trandom, max will slightly decrease the treatment time and the likelihood that the end
of a random-pause will be placed into a spill pause so that additional time will pass by until the
irradiation can continue if Ton, random is greater than the total spill length (see section 3.2.1). On
the other hand, if the Trandom, max is too short the correlation between the beam application and
the motion might not broken as efficiently than using longer random-pauses. The reason is, if the
length approaches Trandom, max = 0 s the dose distribution of the random-time-delay re-scanning
mode will also align with the dose distribution of slice-by-slice re-scanning. However, this was
obviously not the case when using Trandom, max = 0.1 s.
Furthermore, the longer Trandom, max is chosen the higher is the probability that all motion
phases are being irradiated which is likely to increase the quality of the irradiation process. Of
course, the irradiation time per IES can also be expanded by reducing the intensity of the beam.
Overall, it follows that random-time-delay re-scanning is a very effective and robust method to
reduce interplay patterns. No additional online motion monitoring and no online adaption of
the parameters of the therapy system should be necessary to yield satisfying irradiation quality.
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3.5 Conclusion and outlook
Six different re-scanning modes have been analyzed with respect to their effectiveness in reduc-
ing the interplay effects of tumor motion by simulating patient treatments. In the ideal case,
breath-sampled re-scanning is the best and random-time-delay re-scanning the second best option
to reduce interplay effects. Even the rather large tumor motion of 26mm of patient 5 can be
compensated very efficiently with both techniques.
Out of the six investigated re-scan flavors only breath-sampled re-scanning depends on patient
information (breathing period) during the treatment course. Prior to the irradiation of an IES,
the intensity needs to be adjusted according to the best guess of the upcoming breathing period.
However, this time duration cannot always be predicted with sufficient precision. If, e.g., a
patient needs to cough during the irradiation, it might follow that the motion pattern can be
changed so that the pre-adjusted intensity is too high or too low and the dose distribution is
being shifted to the local minima like displayed in figure 3.18. Nevertheless, the measures at
those two minima still outperform the corresponding values of slice-by-slice, volumetric, mixed-
scanpath and local-parameter re-scanning. Further investigations (e.g. a finer time spacing) with
respect to the period mismatch seem worthwhile.
On the other hand, random-time-delay re-scanning does not need any patient monitoring dur-
ing the treatment and no accelerator system with the capability to adjust the intensity according
to the breathing period. Random-time-delay re-scanning is very robust with respect to the inves-
tigated uncertainties and the efforts to implement this re-scanning flavor in an existing system
should be less complex than for breath-sampled re-scanning.
Overall, both random-time-delay re-scanning and breath-sampled re-scanning yield excellent
results with respect to reducing interplay effects in the presence of motion. These two modes
should be the first choice when clinics aim to compensate tumor motion by re-scanning.
It is a general trend in the field of medicine that the therapy approaches get more and more
adapted to the individual patient in consideration. Therefore, physicians aim for very flexible
treatment options. To meet these requirements, it is also possible to combine re-scanning with
gating (Furukawa et al., 2010a; Mori et al., 2013) or beam tracking (van de Water et al., 2009) to
increase the number of possible treatment options. For example, the combination of re-scanning
with either of the two techniques should decrease the ITV and hence reduce the irradiation of
healthy tissue - which might be most beneficial if organs at risk are located close to the tumor.
It seems especially worthwhile to perform extensive studies in the future which investigate if
re-scanning could improve the dose homogeneity of beam tracking. It is shown that even perfect
beam tracking causes dose inhomogeneities when irradiating heterogeneous targets (van de
Water et al., 2009; Eley, 2013). J. Eley (Eley, 2013) illustrated that realistic beam tracking is
biased by random and systematic errors of various kinds. The influence of theses errors could
be weakened by using re-scanning in combination with beam tracking. Compared to using re-
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scanning alone, the combination could lead to a greatly reduced ITV. Possible modes which
could be combined with beam tracking are slice-by-slice, volumetric, mixed-scanpath and local-
parameter re-scanning.
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4 Dosimetry and feasibility aspects of
re-scanning irradiation
4.1 Introduction
Clinical unacceptable under- and overdosages are likely to result when scanned particle therapy
is applied to a moving tumor (Phillips et al., 1992; Lambert et al., 2005; Bert et al., 2008b). This
chapter shows experimental and simulation results of re-scanning irradiation with carbon ions
in active scanning mode to mitigate the effects of target motion with respect to its dosimetric
feasibility and reproducibility.
If constant irradiation duration is planned, the delivery time per beam position is in general
proportionally reduced with the number re-scans r. Therefore, beam application in the re-
scan mode sets new demands on deflecting magnets, energy variation and dosimetry detectors
because the pencil beam has to sweep much faster across an iso-energy slice (IES).
This increased scan speed might manipulate the ionization chamber output that controls the
irradiation due to recombination effects which could result in a falsified dose application (Leroy
and Rancoita, 2009; Brusasco et al., 2000). Especially since some facilities tend to decrease the
number of fractions by simultaneously increasing the dose per irradiation (Tsujii and Kamada,
2012) a reliable dosimetry gets even more important because, for example, so called cold spots
(areas with underdosage in the clinical target volume (CTV) during the irradiation process) will
have larger impact when reducing the number of fractions as shown by Wölfelschneider et al.
(Woelfelschneider, 2011).
As a first step slice-by-slice re-scanning was implemented at GSI Helmholtzzentrum für Schw-
erionenforschung GmbH (GSI) and at Heidelberg Ion-Beam Therapy Centre (HIT) and funda-
mental irradiations were performed with regular target volumes to investigate whether the dose
can be delivered as prescribed. Step by step the complexity of the experiments was increased
and it was investigated how efficiently re-scanning is able to reduce interplay patterns which
result when irradiating moving radiographic Kodak X-Omat V films vertical and horizontal in
beams’s eye view free in air. Finally, 3D plans were irradiated at HIT in slice-by-slice re-scanning
and breath-sampled re-scanning in the presence of motion with the help of phantoms which were
designed to mimic real patient treatment (Steidl et al., 2012b). The question, if re-scanning can
be technically implemented at HIT so that it might be a treatment option in the future for pa-
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tient with moving tumors shall be discussed. For all experimental measurements a simulation
environment was created which took the setup parameters into account to validate the results.
4.2 Material & methods
4.2.1 Re-scan implementation - general aspects
The decision which re-scan technique to implement mainly depends upon the following two
criteria:
• Technical feasibility: In general, every therapy facility has its unique design of treatment
planning, accelerator, beam steering and detector systems. These combinations along with
the interaction of software and hardware can inhibit the implementation of one or more
of the different re-scanning techniques. For example, random-time-delay re-scanning inter-
rupts the irradiation many times for a random time interval or breath-sampled re-scanning
needs spill lengths of at least the duration of the breathing period. The currently existing
system at GSI has not been designed to inherently exhibit these features.
• Clinical relevance: Other re-scan modes might be technically feasible but they could have
other drawbacks. For example, volumetric re-scanning changes the beam’s energy after
each re-scan run of every single IES, so that the whole volume is scanned n-times. The
synchrotron of GSI needs 3.3 s to change the particle’s energy. So the additional time
duration for volumetric re-scanning compared to slice-by-slice re-scanning would roughly be
Taddit ional = 3.3 s · (r   1) · nIES, (4.1)
with r as the number of re-scans and nIES as the number of iso energy slices. If two
re-scanning techniques show similar dose distribution they choice will always be the one
with the shortest irradiation time. This will lower the costs of the clinical treatment and
more patients can benefit from the therapy. Other centers use range shifters to achieve a
fast energy variation. They report a time of 80 ms (Zenklusen et al., 2010) and 500 ms
(Furukawa et al., 2010b) to change the energy, respectively. In those cases volumetric
re-scanning becomes a sensible option.
In the scope of this thesis slice-by-slice re-scanning was integrated at GSI and slice-by-slice re-
scanning as well as breath-sampled re-scanning have been implemented at HIT. The rationale
of this choice is as follows. Slice-by-slice re-scanning required the fewest changes to the beam
application system of GSI and HIT. Moreover, it should be compatible with most of the existing
and planned therapy facilities and can therefore serve as reference basis if various institutes try
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to compare their results. Breath-sampled re-scanning is the most promising type (see chapter
3.3) but also more challenging in its demands of the accelerator properties. As mentioned: In
the ideal case, the irradiation time of every single IES should exactly match the motion period
of the tumor. Various groups showed that the large majority of breathing periods lies between
3 s and 5 s (Ionascu et al., 2007). Shirato et al. (Shirato et al., 2004) report an average value of
3.6±0.8 seconds by studying motion traces for 21 lung tumor patients. The prerequisite for the
therapy accelerator is therefore that its extraction time is at least as long as the corresponding
period. In addition the intensity has to be regulated in a way that the necessary dose can be
delivered in this period. The extraction time for the synchrotrons in standard therapy mode
of GSI and HIT are 2.2 s and 5 s, respectively. This means that even if a dedicated intensity
regulation could be implemented at GSI, the current maximum spill on time is too short for
experiments with realistic breathing periods. On the other hand one can expect the extraction
time of HIT’s synchrotron to be sufficient long in almost all cases.
4.2.2 Dosimetry - detectors & methods
Without reliable and accurate dose application of the static target it is not possible to deliver a
satisfying homogenous dose distribution to a target in the presence of motion. Therefore it is
crucial in a first step to validate if irradiation of a static target in re-scan mode is of comparable
quality to the currently used standard irradiation modes at GSI and HIT. It was necessary to
perform these initial experiments with static targets in order to isolate the effect of technical
re-scan implementation on the dosimetric outcome.
The minimum requirement is the fulfillment of the recommended ICRU-50 (ICRU, 1993)
bench marks, which aim a dose coverage of the target volume between 95% and 107% of
the prescribed dose. Since these limits must also include uncertainties due to motion it follows
that the static dose distribution needs to be even better. Compared to the standard irradiation,
re-scanning changes for instance the temporal charge distribution inside the sensitive volume of
the ionization chambers.
All detectors at GSI were designed to fulfill the demands of the patient irradiation mode and
due to the technology transfer from GSI to HIT both beam measuring system are very similar.
Before going into the experimental details an overview of the detectors and other measuring
devices used both at GSI and HIT shall be given:
• MP3 water phantom with Pin point chambers (PTW, Freiburg): A system for three-
dimensional dosimetric verification of treatment plans in intensity-modulated radiotherapy
with heavy ions. Its components are an array of 24 ionization chambers (pin points)
with 0.03 cm3 sensitive volume of air. The ionization chambers (IC) are connected to two
multichannel electrometers (Multidos, PTW, Freiburg, Germany), each of which controls
the measurement of 12 ionization chambers. Within one row, the spacing between two ICs
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is 12 mm. The distance between two rows is 10 mm and the ICs of each two consecutive
rows are shifted laterally by 6 mm against each other to prevent shading. At a nominal
voltage of 400 V the pin points have an ion collection time of 50 µs. The system was
routinely used for 3D plan verification at the heavy ion therapy project at the GSI (Karger
et al., 1999). It measures the dose with a high precision (uncertainty 1% 2%) at different
LET values. A similar device is currently used at HIT. The pin points are usually placed
in a water phantom for the dose verification measurements of the treatment fields (Karger
et al., 1999). This is a rational approach since the density of water is similar to the density
of soft tissue. The phantom has three computer controlled motorized arms, which can be
used to position the pin point chambers within a precision of 0.1 mm. The phantom is
made of polymethyl methacrylate (PMMA). A thin entrance window of 250 · 250 · 5 mm3
PMMA reduces the influence on the radian field compared to the thicker walls.
• Farmer chamber 30010 (PTW, Freiburg): The Farmer chamber 30010 is a wide spread
ionization chamber for absolute dose measurement in radiation therapy with 0.6 cm3 sen-
sitive volume of air. At a nominal voltage of 400 V the ionization chamber has an ion
collection time of 140 µs (PTW, 2013).
• Kodak X-Omat V films: The Kodak X-Omat V films are classical silver bromide films com-
monly used in conventional radiation therapy. The films consist of polyester coated with an
emulsion layer on each side, which is protected by an especially hard gelatine layer. Films
are still very useful because of their unmatched spatial resolution. For instance, foci and
interplay patterns can easily be checked and visualized. The size of a film is 24 · 30 cm2.
Each film comes in a light-tight ready pack. Detailed measurements have been done by
Spielberger et al. (Spielberger et al., 2001) to characterize the films for irradiation with
carbon ions at GSI. The film detector signal is called the net optical density (OD) (OD mi-
nus the background OD). For the sake of simplicity the term ‘optical density’ is used in the
following, when referring to net optical density. The general formula of the dose-response
curve can be expressed as
OD= ODmax
⇥
1  exp( mD)⇤ , (4.2)
with ODmax as the saturation optical density, m = m(Z , E) as the exponential slope which
is in general a function of the particle charge (Z) and the energy (E) and D as the dose
in Gray. The analysis of the dose-response curves revealed that the OD can strongly de-
pend on the processing conditions, such as temperature, concentration and activity of the
developer and probably also on the film batch (Bathelt, 2000). Therefore we always irradi-
ated a well defined referenced field on every single film. Comparing these reference fields
amongst each other and expressing the results relative to those reference fields made the
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experiments independent of the processing conditions. The Kodak X-Omat V films were de-
veloped as soon as possible after irradiation with a Kodak M35 processing machine, using
DX31 as developer and FX31 as fixer components from the company Typon. The
OD= log
I0
I
(4.3)
with I0 being the incident light intensity and I the transmitted light intensity was measured
using the Densonorm 21 E (Pehamed, PEHA med. Geräte GmbH) hand densitometer and
the VIDAR DosimetryPRO® film scanner. In the scope of this thesis these devices have been
calibrated and their performance was evaluated.
The homogeneity
H = 1   
µ
, (4.4)
which is a measure of the smoothness of a dose distribution, was calculated (standard
deviation   and mean film response µ) in the region of interest (ROI) was is set in the
center of the radiation field .
To isolate the dosimetric impact of re-scanning, some experiments were performed without tar-
get motion. In addition, the dose readings of the re-scan irradiations were normalized by the
outcome of a standard irradiation as formerly used for patient treatment.
The fact that a relative dose measurement was performed rather than an absolute one reduces
potential calibration errors and uncertainties. Therefore
relat iv e dose =
dosere-scan
dosenormal
(4.5)
was calculated as a function of the re-scan number.
In case of the Kodak X-Omat V films a reference band was irradiated in patient treatment
mode on every single film and compared to the rescan mode on the very same film. This pro-
cedure reduces the effect of fluctuations in the film processing. There is hardly any information
in data sheets on the precision of the ionization chambers when irradiated with heavy ions
(Karger et al., 2010). In addition there is also an uncertainty in beam properties. Therefore the
precision of a measured value was calculated as follows: For each experiment with the same
nominal irradiation parameters the standard deviation of the data (e.g. dose for the ionisation
chambers) was computed and the average of these values was defined as the standard error for
each ionization chamber with the spread as the corresponding uncertainty.
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A Pearson’s r-test at the ↵= 1% significance level was calculated to investigate the probability
of linear correlation between the output of the dosimetry devices and the number of re-scans.
4.2.3 Implementation & dosimetry at GSI
The basis of every re-scan irradiation is the original physical-beam-plan (PBP) that assigns a
unique energy, intensity, focus and particle number to every point of the irradiation grid. The
data, generated as a part of the treatment planning, are transferred to an external scanner
control unit.
At GSI, an essential part of the VME-based scanning control unit (Grözinger, 2004) is the fast
autonomously running treatment sequencer which consists of seven control modules (SAM),
which are responsible for beam measurement, beam request, beam positioning, data logging, in-
terlock measurement etc. These modules can be loaded with dedicated slice-by-slice re-scanning
programs so that a given PBP is automatically irradiated with the chosen re-scan number (Bert
et al., 2008a).
The treatment of patients with heavy ions requires to measure and control particle fluence
and beam position with high accuracy. At GSI the therapy control system checks every 12.5 µs
(Haberer et al., 1993) if the prescribed particle number is reached for each rasterpoint. Due to
the fact that these checks have finite spacing in time the signal to step over to the next raster-
point is sent for an actual particle value that always exceeds the prescribed value. The therapy
control unit at GSI subtracts this overdose of the previous rasterpoint from the nominal dose
of the next one within the same IES (see figure 3.6). This is a rational assumption since the
rasterpoint spacing is approximately one third of the full width at half maximum (FWHM) of
the Gaussian shaped beam width so that one rasterpoint contributes to its neighbors which have,
for example, a radial distance of 1 mm step size by a factor of 93% of its own dose. The effect of
over-irradiation gets more prominent for lower particle numbers and higher beam intensities.
Therefore the treatment planning system selects an appropriate intensity for each IES that is
determined by the rasterpoint with the lowest particle counts within that IES which means that
the system suggests a lower beam intensity when increasing the re-scan number. Changing the
intensity results in an altered signal-to-noise relationship inside the ionisation chambers. To
account for this, the amplification of the output signal of the chambers is automatically adjusted
as a function of the particle fluence. However, the automatically generated amplification set-
tings and intensity levels can be replaced independently from each other with a manual chosen
selection so that their influence can be studied.
For safety reasons interlock units can abort the irradiation within microseconds. For instance,
in patient irradiation mode at GSI the beam width and beam position are checked every 150 µs
by 2 Multi-Wire Proportional Chambers with a precision of 1 mm. It might happen when using
high speed re-scanning irradiation that the exposure time of a rasterpoint is beneath that thresh-
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old, which results in a termination of the treatment. Therefore, the interlock devices and the
position measurement are switched off for the measurements.
4.2.4 Testing the implementation & dosimetry at GSI
Initial attempts have been done to check if the SAM programs are actually able to perform re-
scan irradiation mode. It was tested if the system is able to irradiate 2D plans and 3D volume
with re-scanning as fast as in standard mode. The rectangular 2D plan was designed to have a
target area of 100 ·100 mm2, energy 200.28 MeV/u and 2 ·2 mm2 raster point grid. The sphere
was designed to have a volume of 1000 cm3, a rastergrid of 3 ·3 mm and a separation of the iso
energy slides of 3 mm. Both plans were optimized to a physical dose of 2 Gy.
The time duration of each irradiation process is logged in data files at GSI. This information
was used to compare the length of the slice-by-slice re-scanning versus standard mode irradiation
using the same intensity levels in both cases.
Further experiments were focused on how precise the dose can be applied in re-scan mode
compared to the standard irradiation. Karger et al. (Karger et al., 2010) state that the dose
uncertainty should be well below 3% for measurements in phantoms. This includes variations
in the beam application as well as the measuring accuracy of the detectors.
Hence a target area of 100 · 100 mm2 was planned to be irradiated homogeneously with
carbon ions (treatment plan parameters: single energy 200.28 MeV/u, 2 · 2 mm2 raster point
grid. 6.7 mm lateral beam FWHM, scan path: horizontal lines, 5 · 105 particlesrasterpoint) with different
numbers of re-scans as well as in the patient beam delivery mode for comparison.
The following setup was used (see figure 4.1): The pin points were placed in the MP3 water
phantom in a region around the Bragg Peak. In the entrance channel in air four detectors
were used. First a PPIC1 with a constant flow of Kr/CO2 gas (80/20 mass -%) with 2 l/h
at atmospheric pressure and a high voltage of  1000 V (Brusasco et al., 2000). The current
of the PPIC1, which is proportional to the beam current, is amplified1 and converted into a
voltage. This voltage is digitized by an analog-to-digital converter (ADC) with a sampling rate
of  t = 12.5 µs and summed up. This sum is constantly compared with the prescribed particle
number. PPIC1 controls the irradiation by sending a signal if the prescribed particle number has
been received. Its size in beam’s eye view (BEV) is larger than the maximum lateral extension of
the treatment field as to minimize position dependencies of the PPIC1 signals (Voss et al., 1998)
because the chamber’s efficiency decreases at its edges. Secondly, the PPIC3, which is identical
in construction to PPIC1 but with air as the sensitive volume was used. A charge-frequency
convertor gives the readout of PPIC3 in terms of monitor units (MU) into the therapy control
room (TKR). Thirdly, a Farmer chamber was placed in front of the water phantom as not to
1 The settings of the amplification factor are in general individually set for each IES as a function of the beam’s
intensity.
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Figure 4.1.: a) sketch of the dosimetry setup at GSI. Behind the beam exit window the particles
pass through PPIC3, PPIC1, Kodak X-Omat V films and the Farmer chamber in air.
The beam then enters the MP3 water phantom and irradiates the 24 pin points. The
first four detectors are placed in the beam’s plateau region while the pin points are
placed around the Bragg peak. The outline of the Bragg peak serves to guide the
eye. b) photograph taken in beam’s eye view of the MP3 water phantom made of
PMMA with its entrance window. The red rectangle outlines the size of the treat-
ment field. The detectors do not shadow each other with respect to the particle
beam.
shadow the pin point array. The last detector instruments were the Kodak X-Omat V films. Via
remote control new films could be moved into the beam with the help of a conveyor belt as
to save time between consecutive irradiations. The detectors were arranged without overlap in
BEV as indicated in figure 4.1.
Many experiments were performed with the same high intensity as in the case of re-scan
number r = 1 since it should be investigated if accurate dosimetry can still be obtained with an
irradiation as fast finished as possible. For this purpose, the intensity levels of the accelerator
and the signal amplification settings of the PPIC1 has to be adapted manually.
Figure 4.2 displays the corresponding workflow.
1.: The TCU selects the standard intensity levels I0 and the standard amplification settings for
the spill signals Amp0 in case of a standard PBP.
2.: The PBP is changed to the corresponding re-scan version so that the TCU selects new settings
Iauto and Ampauto.
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Figure 4.2.: Schematic workflow of the settings of the intensity levels and the amplification of
the beam signal of the TCU.
3a. and 3b.: Before starting the irradiation the settings for the intensity and amplification can
manually be replaced. Two different version have been measured. In both cases Imanual
was set to Imanual = I0, which means an irradiation with a beam fluence as high as in the
normal irradiation. Version 3a. was set to Ampauto and 3b. to Ampmanual = Amp0.
It was investigated if changing between 3a. and 3b. would alter the outcome of the measure-
ment
To summarize:
• The following parameters were measured with and without slice-by-slice re-scanning mode
by irradiating 2D plans: 1) the total dose with large ionization chambers with two different
amplification settings, local doses with small ionization chambers. 2) optical density with
Kodak X-Omat V films. 3) exposure time with recorded data of the therapy control system
4) different settings for the signal amplification of the PPIC1.
4.2.5 Implementation & dosimetry at HIT
The HIT facility is run by scientific staff of the university of Heidelberg. To guarantee safe patient
treatment the level to which experimental changes of the system are allowed is greatly reduced
compared to a research facility like GSI. Since the pilot project at GSI served as a prototype for
the HIT facility both systems are very similar. The implementation of the re-scan mode into the
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system at Heidelberg was done in collaboration with colleagues from HIT and with A. Gemmel
from Siemens.
Figure 4.3.: Data file conversion scheme at HIT. The input data PBP is translated into values
which are readable by the treatment control devices whose measured values are
again transformed into the PBR data format. [lib] means that the value is taken
from a pre defined library, [mm] is in millimeter and [C] represents the charge. The
PBR files at GSI also provide the time information about the treatment course.
The treatment control at HIT cannot convert a standard PBP online as to irradiate it in slice-
by-slice re-scanning mode. For this purpose dedicated software tools have been written which
transform the original PBP into a re-scan-PBP which is then uploaded to the system. In a phys-
ical sense both methods are equivalent. Before treatment, the PBP files are translated into
machine beam plan (MBP) files (see figure 4.3). In this process the input data is analyzed and
the appropriate values for the treatment devices are set. Like done at GSI, the HIT system au-
tomatically selects the intensity value with respect to the point with the lowest particle number.
Nevertheless, at this first level of re-scanning implementation at HIT it was possible to set the
intensity manually for the whole plan by editing a line of the PBP file. Nominally HIT supplies
10 intensity levels with a maximum of 8 · 107 particlessecond , but at the time when those measurements
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have been performed the maximum available particle rate was of 5 · 107 particlessecond . The prescribed
particle numbers of each voxel can then be written as a charge value into the MBP which can be
be compared directly to the output of the ionization chamber. This procedure is also done in a
similar way with the other parameters of the MBP. While performing the irradiation the values
of the MBP are measured by the TCU2 and written into a machine beam record (MBR) file which
also contains the time stamp at which the irradiation of each voxel was finished. Finally, this
plan is then translated into a PBR which contains the measured positions and particle numbers
(see figure 4.3).
Figures 3.7 and 3.11 display the properties of the dose application of the treatment control
system which checks every 2 µs if the prescribed dose has been irradiated.
Like at GSI, the position feedback loop and the corresponding interlocks had to be switched
of because the re-scanning irradiation is too fast for those measurements. Unlike at GSI, at HIT
the position data is still recored. Therefore a plan was irradiated as to investigate the influence
of increasing re-scanning number on dose and position accuracy of the treatment control system
by comparing PBP and PBR files. The course of the irradiation process uniquely relates each
planned and actually irradiated point so that the applied dose and the mean radial position
error can be calculated with reference to this information. The dose value is obtained by simply
summing the parts which belong to the same rasterpoint. The position accuracy was addressed
as the mean radial position error which was defined to be
 r(i) =
∆
(x(i)planned  x¯(i)measured)2 + (y(i)planned  y¯(i)measured)2, (4.6)
with x(i)planned and y(i)planned being the values of the corresponding PBP points of each raster-
point i and with x¯(i)measured and y¯(i)measured being the mean position3 of the corresponding
points of the PBR.
The second level of re-scanning implementation allowed the selection of each of the ten dis-
crete intensity levels for each individual IES by the following procedure: Like shown in figure
4.3 the PBP is transformed into the MBP. The irradiation process which then starts is inter-
rupted and the MBP is edited. Manually, the same intensity levels as in the standard irradiation
case are inserted in the appropriate lines and the process is being continued. This procedure
is therefore well suited for e.g. slice-by-slice re-scanning but of course not for breath-sampled
re-scanning which needs continuously intensity variation.
The third level of re-scanning implementation allows for active intensity regulation by means
of a feedback loop which controls the particle fluence by sending signals to the radio-frequency-
knout-out-exciter (Schoemers et al., 2011). The intensity levels for each IES of the MBR are
2 Three TCUs are implemented at HIT. Each TCU unit consists of an ionization chamber and a multiwire pro-
portional chamber (MWPC). TCU1 controls the treatment.
3 In case of a re-scan number r > 1 the mean of the vales was calculated.
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Figure 4.4.: Read-in table for the feedback loop at HIT. a) The coe cient µ= µ(E, I) represents
the nominal current value of the TCU output. The intensity is adjusted to meet the
value. b) an individual µ value is calculated for the used energy levels to match the
desired breath-sampled re-scanning intensity (reddish coe cients) and up-loaded to
the system which adjusts the intensity appropriately.
translated into intensity and energy dependent current values which are constantly compared
against the output of the TCUs. If the value of the TCU output is larger than the original control
parameters (see figure 4.4 a)) a signal is sent so that the particle fluence is reduced by the radio-
frequency-knout-out-exciter and vice versa. These original parameter values can be edited to
facilitate breath-sampled re-scanning. The desired intensity of each IES is being calculated as
a function of the breathing period and the modified control parameter is used to replace the
corresponding original values in the read-in table of figure 4.4. Therefore, independently of the
particle rate stated in the MBP, the feedback loop tries to match the current of the TCU output
with the modified values of figure 4.4 b). Because it is a priori not known which particle rate was
chosen by the system it is best to replace the whole row by the desired value. At the time when
the experiments were done, the spill extraction characteristics are approximately the following:
5 s spill extraction time, spill pause of 2.5 s without changing the particle’s energy and 5 s when
changing the energy. This means that purely breath-sampled re-scanning experiments require
breathing periods smaller than 5 s. Otherwise techniques which combine gating and re-scanning
must be used (Furukawa et al., 2010a).
4.2.6 Testing the implementation & dosimetry at HIT
To test the re-scanning implementation at HIT the following measurements were performed:
Sixteen 2D fields were irradiated by carbon ions with an energy of 270.55 MeV/u, 2 · 2 mm2
raster point grid, 6 mm lateral beam FWHM. The fields were divided in 4 rows with an increas-
ing particle number per rasterpoint 0.8 ·106, 1.6 ·106, 3.2 ·106 and 6.4 ·106, respectively. Then,
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the four fields of each row have been irradiated with increasing re-scan numbers of 1, 3, 9 and
19 in the slice-by-slice re-scanning mode and with intensity of 5 · 107 particlessecond .
The tests addressing the breath-sampled re-scanning implementation have been performed
with 3D plans of the density-variation-phantom (DeVarPho) (see figure 4.5), a motion period
was assumed to be 4 s and a re-scan number of r = 1 was used.
The purpose by analyzing PBR and MBR files was to check if the breath-sampled re-scanning
mode could actually be irradiated when changing the read-in parameters of the treatment
control according to figure 4.4 and to compare it against standard4 slice-by-slice re-scanning
irradiation of the same plan.
Irradiations with three different plans have been performed in order to test if the prescribed
dose can be applied at the isocentre. While testing the re-scan implementation with the 2D
plans described above, a Farmer chamber was placed at the isocenter and the relative dose (see
equation 4.12) was measured for the r = 3, 9 and 19. Only one Kodak X-Omat V film was
placed between the Farmer chamber and the beam entrance window so that the beam suffered
almost no energy loss and the chamber was basically free in air in the plateau region of the
dose.
In addition, phantoms have been used to study 3D motion mitigation by re-scanning. Before
performing measurements in the presence of motion, static dose distributions were measured
with one of the phantoms as to test the dosimetry for 3D re-scan irradiation. Hence, this phan-
tom is being introduced in this section and the properties of the motion parameters will be listed
in section 4.2.7.
Like addressed in (Rietzel and Bert, 2010; Graeff et al., 2012), heavy ion irradiation is much
more sensitive with respect to density variations than photon therapy, so that an expansion of
the CTV to an internal target volume (ITV) which simply geometrically covers all motion phases
is not sufficient. Recently, a new algorithm (Graeff et al., 2012) was incorporated in TReatment
planning for Particles (TRiP) which accounts for density variations and also includes all motion
phases in the optimization process. Therefore the phantoms have been designed to show density
variations.
The setup of the DeVarPho is illustrated in figure 4.5. Its main focus was on very defined
and large density variations. Therefore two slits have been cut into a block of PMMA (406
Hounsfield unit (HU)) and one has been filled with a slab of teflon (1990 HU) and the other
simply by air (-1000 HU). This phantom was placed in front of the MP3 water (0 HU) tank. With
these HU values (Schneider et al., 1996; Morin et al., 2007; Richter et al., 2008) a computed
tomography (CT) was created and an ITV with a prescribed dose of 5 Gy was optimized5 to
cover a CTV with a width of 50 mm, a hight 25 mm and a length of 40 mm in BEV.
4 with automatic intensity selection
5 The prescribed dose was taken to be 5 Gy because otherwise the particle numbers in the proximal slices would
have become too low when using high re-scan numbers.
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It was irradiated in slice-by-slice (r = 5 and 11) and breath-sampled re-scanning (r = 1) mode,
the relative doses are reported (see equation 4.12). The measurements werde done by using
the pin point array. Regions close to the ITV which exhibit large dose gradients were left out in
the analysis since even small set up uncertainties can have a large effect when reporting relative
doses in those areas.
Figure 4.5.: Schematic draw of the set up for the DeVarPho. The beam enters from the positive z-
direction. First traversing the phantomwith the density variations and then entering
the MP3 water tank filled with water. Details can be found in B.1.1.
To summarize, the following measurements have been performed to test the implementation
and to validate the dosimetry:
• Slice-by-slice re-scanning as well as breath-sampled re-scanning were implemented at HIT.
Experiments to validate the performance have been made with focus on the spill structure
as well as the position and the dosimetry data. These values were obtained by analyzing
the PBR files created by the TCUs.
• irradiation of a homogeneous plan 2D in slice-by-slice re-scanning mode without motion
with different re-scan numbers
• irradiation of a 3D phantom in slice-by-slice re-scanning and breath-sampled re-scanning
mode without motion with different re-scan numbers
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4.2.7 Motion e ects mitigation by re-scanning
This section is focused on experiments that show how efficiently motion effects can be reduced
by using the re-scanning technique. The various experimental setups and parameters have also
been incorporated in a simulation environment to validate the outcome and to further extent
the range of parameter sets.
All experiments have been performed with carbon ions even if the physicians at HIT also use
protons to treat patients. Carbon ions are more sensitive concerning interplay effects. Hence the
mitigation of motion effects when using carbon ion beams is even more challenging. The reason
is that their lateral deflection is smaller than for protons which results in a narrower FWHM of
the beam.
The focus of the initial simulations and experiments was on 2D plans because interplay effects
are not reduced due to pre-irradiation as in case of 3D plans. Furthermore, the most distal IES
of every 3D plans is de facto a 2D plans because it is not pre-irradiated. Hence, the dependence
of motion related parameters can be studied more accurate when simulating 2D plans.
The next step was the irradiation of 3D plans to two different phantoms in the presence of
motion in the slice-by-slice re-scanning and breath-sampled re-scanning mode as to investigate
how fast the dose distribution gets homogenous in these cases.
2D irradiation: Experiments - Amplitude, period, phase and scanpath dependence
The effectiveness of re-scanning on dose smoothing was studied by simulating target motion
with the Kodak X-Omat V films which moved sinusoidal vertical and horizontal in beam’s eye
view free in air (peak-to-peak motion amplitude: 1 cm ± 0.1 cm and 1.5 cm ± 0.2 cm and a
period of 3 s± 0.2 s).
A target area was planned to be irradiated homogeneously (90 · 60 mm2 and 60 · 90 mm2,
respectively, single energy 244.21 MeV/u, 3 · 3 mm2 grid, 9.2 mm beam FWHM scan-path: hor-
izontal lines). To account for target motion 1 cm and 1.5 cm margins were added in the motion
direction, respectively. Irradiation was performed in the slice-by-slice re-scanningmethod with up
to 21 re-scans. The rationale behind starting the reduction of interplay effects with re-scanning
by the irradiation of simple rectangular areas with a single energy is the following:
The temporal patterns of scanned beam application and respiratory motion are comparable
which means that a correlation can occur between beam application and motion of the target.
This would violate the basic assumption of re-scanning as being a process with an underlying
random nature (Rietzel and Bert, 2010). The probability that these correlations emerge is
higher when irradiating regular shapes with a homogeneously dose distribution. In general, the
geometrical field shape of patients will be more irregular.
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In addition, it was investigated if re-scanning is also able to mitigate motion effects for larger
motion amplitudes. Large amplitudes are in general more critical in the treatment course,
because of increased exposure of healthy tissue and more severe interplay effects.
These measurements are some sort of a worst case study, because if re-scanning will be able
to compensate interplay effects for large amplitudes it is highly unlikely to fail for smaller am-
plitudes. Since interplay patterns are very sensitive to the a priori unknown starting position of
the target, a multi-phase phantom was constructed (see figure 4.6) which can move up to six
films simultaneously, each separated by a phase shift of 60 degree. In contrast to the previous
experiment we could not change the motion direction of the phantom, therefore we changed
the primary scanning direction, so that it was parallel or perpendicular to the motion direction.
Figure 4.6.: The left part of the figure shows a picture of the multi-phase phantom. The right
part illustrates the most important features of it. The films were fixed in small slits
(indicated as dashed black lines) and moved perpendicular to beam’s eye view in the
x direction. The red arrows symbolize the velocity vector of each rod. The amplitude
of the motion could be changed by screwing the rods at a di erent radius with
respect to the crank.
A peak-to-peak amplitude of 5 cm ± 0.3 cm, a period of 4 s ± 0.2 s and 5 s ± 0.2 s, were
chosen respectively. A target area was planned to be irradiated homogeneously (50 · 50 mm2,
single energy 200.28 MeV/u, 2 · 2 mm2 grid, 6.7 mm FWHM, scan-path: horizontal lines and
vertical lines). To account for target motion, 5 cm geometrical margins were added in the
motion direction and irradiation was done in the slice-by-slice re-scanning method. Irradiations
were performed with up to 29 re-scans. Interplay patterns of the films were analyzed by visual
inspection and the homogeneity relative to a stationary irradiation within the ROI.
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All measured OD values were corrected for the re-scan effect which is shown in figure 4.9 d).
The corrected OD value is obtained by multiplying the measured OD value with the inverse of
the fit of the appropriate re-scan number.
2D irradiation: Simulations - Amplitude, period, phase, intensity, scanpath and spill
profile dependence
A simulation environment based on TRiP4D (Richter, 2012) was set up in order to recalculate
experiments or to predict results. The actual PBP, the spill shape, the intensity and the irradi-
ation mode were given as input parameters to the dedicated physical-beam-record simulation
environment (PBRSimEnv) which creates a file (with the temporal progress of the irradiation
of each rasterpoint) which is in the following referred as being the simulated-PBR. This file is
necessary for TRiP4D to include the temporal dimension of the irradiation. Dose distributions
resulting from the foregoing experiments have been compared with simulations to investigate
the dependence of motion mitigation by re-scanning.
The simulated intensity range varied from 106 to 1010 particles within a spill of a length of
2.2 s. In case of the breath-sampled re-scanning mode of spill of a length of 10 s was used and
breathing period of 4 s was assumed.
Starting phases varied from 0  to 360  in steps of 5 . Peak-to-peak amplitudes of 1 cm, 1.5 cm,
2 cm and 5 cm were simulated. The main beam application direction was simulated as being
parallel as well as being perpendicular to the motion of the target. The range of re-scan numbers
was varied from r = 1 to r = 29. The PBP used in the simulations were the same as in the
foregoing experiments. In addition, it was examined whether different spill shapes influence
the outcome of the simulations. If there would be a strong dependence on the spill shape it
would be questionable if forward calculations to predict clinical outcomes make any sense at
all. For this purpose different spills were measured and down-sampled to a time resolution of
10 µs and have been compared to an artificial square spill profile. All spills were normalized to
1 particle per spill, hence it was possible to multiply the spill profiles with an arbitrary particle
number to get the desired intensity.
The simulated results are reported in several ways: 1) dose area histogram (DAH) curves,
which are the projection of the well known dose volume histogram (DVH) to one CT slice in
depth. The ROI was analyzed with respect to variations in amplitude, period, intensity and spill
shape. 2) Visual display of dose distributions in 2D and 3D surface plots. 3) Quantitative analy-
sis of the dose distribution with focus on amplitude-, phase-, period and intensity dependence,
penumbra width and homogeneity.
To summarize:
• Interplay effects have been studied by irradiation and simulation of 2D plans.
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• The influence of motion was introduced by 1) moving Kodak X-Omat V films with a motor
(experiment) or 2) by incorporating the motion in the simulation environment.
• The dependence of re-scanning in the presence of motion was investigated with respect to
the following parameters: Amplitude, period, starting phase, intensity, scanpath and spill
profile shape.
3D irradiation: Experiments with phantoms
The 2D motion mitigation experiments were a good start to tackle the issue. The necessary next
step had been the irradiation of 3D phantoms in the presence of motion which is addressed in
this section. Two phantoms have been used, both planned and constructed at GSI to fit our
very specific demands. The DeVarPho has already been introduced in section 4.2.5. Now, the
motion related parameters are added. The DeVarPho was planned to be placed on the very
same sliding table as the MP3 phantom with the pin points. It follows that there was no relative
movement between the pin points and the MP3 phantom. The motion was adjusted to have a
period of 4 s±0.2 s, 2 cm±0.2 cm peak-to-peak amplitude in horizontal direction (x-axis) and
a sinusoidal motion trace. The fields have been optimized with a horizontal as well as with a
vertical scanpath of the pencil beam. A CT was constructed with 21 different amplitude based
phases in order to allow for the calculation of the ITV in the presence of motion. Measurements
in slice-by-slice re-scanning mode with the re-scan numbers of 1, 5 and 11 in horizontal as well
was vertical scan path have been performed. In addition, simulations have been performed with
parameters as to mimic the experiments. Nominal, the same intensity levels and motion traces
were chosen. The starting phase of the simulation was chosen to be 0 . The starting phase of
the phantom is subjected to an uncertainty of circa ±15 .
The second phantom is named breathing-thorax-phantom-with-6D-target-motion (BreThoPho).
It was build at GSI and its details and parameters can be found in the thesis of P. Steidl (Steidl,
2011). It was constructed as to mimic real patient cases better than any existing solution at that
time. It mainly consists of an artificial thorax which can mimic breathing motion and a robotic
arm with detectors which can independently mimic tumor motion inside the thorax. The HUs
of the CT scan have been converted into water-equivalent path length (WEPL) for the use of
particle irradiation.
The tumor is represented by an ITV of the size (35⇥ 35⇥ 35) mm3. The dose distribution is
measured with 20 pin points which are placed into a detector head that is made of PMMA. In
beam’s eye view, the pinpoints have a lateral distance of 1 cm from each other. The rows are at
a distance of 12 mm from each other (Steidl et al., 2012b). The setup up is shown in figure 4.7.
The ITV was optimized using a grid size of 2 mm with a horizontal as well as with a vertical
scan path. The motion parameters of the detector head were chosen to be 2 cm±0.06 cm peak-
to-peak amplitude in horizontal direction (x-axis) in a sinusoidal motion trace with a period
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Figure 4.7.: a) Overview of the setup with the BreThoPho phantom. The beam crosses the en-
trance window and enters the phantom where the detector head, shown in b), can
be moved by the robotic arm in predefined motion traces.
of 4 s± 0.01 s. The thorax was adjusted to mimic breathing with a period of 4 s± 0.1 s, too.
The plan was optimized with a prescribed dose of 5 Gy6. The measurements were performed
in the presence of motion in slice-by-slice re-scanning mode with the re-scan numbers 1, 3, 5, 9,
and 11 and in breath-sampled re-scanning mode with the re-scan number of 5. As done above,
simulations have been performed with same parameters as used in the experiments.
For both phantoms, regions close to the ITV, which exhibit large dose gradients were left out
in the analysis, because even small set up uncertainties can have a large effect when reporting
relative doses. In case of the BreThoPho phantom pin points inside the area of 10 mm  x 
30 mm and 12 mm  y  24 mm lie well inside the ITV region without sharp dose gradients.
The pin points of the DeVarPho experiments are within an area of 6 mm  x  36 mm and
10 mm  y  70 mm lie well inside the ITV region without sharp dose gradients. Therefore
these pin points were used when the efficiency of the two re-scan modes to mitigate motion
effects in case of 3D irradiations was analyzed by calculating the corresponding homogeneity
values. Additional information can be found in section B.1.1.
3D irradiation: Simulations with phantoms
A simulation environment was set up in order to recalculate experiments or to predict results for
the 3D irradiations in the presence of motion similar to the previous 2D case. The focus in this
section was to see if simulations and experiments agree with respect to their outcome. In case
of slice-by-slice re-scanning a measured spill with a length of 2.2 s and for the breath-sampled
re-scanning mode a square spill profile of a length of 10 s was used, respectively. The motion
6 At this time there was a minimal particle limit of 8000 particles per rasterpoint. Since it was a priori not obvious
which would be the highest re-scan number, it was necessary to increase the particle numbers per rasterpoint
by increasing the prescribed dose.
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parameters were adapted from the experimental conditions listed in the previous section. The
corresponding CT data was generated because they are mandatory to optimize the PBP which
are used to irradiated the phantoms. Starting phases were randomly chosen from 0  to 360  in
steps of 5 . The PBP used in the simulations were the same as in the foregoing experiments.
The range of re-scan numbers in the simulations was 1  r  11. The beam’s intensity was
nominally the same as in the MBP of the corresponding experiment.
To summerize:
• 3D motion mitigation experiments and simulations have been performed with two dif-
ferent phantoms (with density variations) in breath-sampled re-scanning and slice-by-slice
re-scanning mode with a re-scan number up to r = 11. The detectors moved sinusoidally
in horizontal direction with an amplitude of 2 cm peak-to-peak. The period was chosen to
be 4 s.
4.3 Results
Table 4.1 gives an overview of a selected number of experiments and simulations. Its purpose
is to give the reader a review of the foregoing material & methods section and an outlook of the
results section of this chapter which is focused on presenting the most important information of
the studies.
4.3.1 Implementation & dosimetry at GSI
If the interlock mask was set properly the modified SAM programs ran successfully until irradi-
ation was finished in re-scan mode.
The analysis of the physical beam records shows (see figure 4.8) that the mean irradiation
time variation is below 5 % in case of a single energy plan (left picture) as well as for a plan of a
sphere (right picture). Therefore, a re-scan number of 15 does not necessarily cause a significant
change in treatment time which can also be expected for other re-scan numbers.
To continue with the dosimetric measurements: The red data points in figure 4.9 symbolize
Ampauto setting. In this case the amplification of PPIC1 was adjusted for each re-scan case
individually according to the recommendation of the plan optimization procedure (see figure
4.2). The green data points represent experiments performed with Ampmanual , so that every
irradiation was done with the settings of the r = 1 case.
Figure 4.9 a) shows the results of the Farmer ionization chamber. The data points fluctuate
randomly about relat iv e dose = 1 with a maximum deviation of around 3%. Assuming PPIC17
works correctly in the re-scanmode (see chapter 4.4) the readout of the farmer chamber lies well
7 Any malfunctioning of PPIC1 has an influence on the dose measurements of all the detectors which are posi-
tioned behind PPIC1 in beam’s direction.
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Figure 4.8.: The left part of the figure shows the time duration for irradiating a rectangular
slice as a function of the rescan number, the right part for irradiation a sphere, re-
spectively. The time is normalized to the case which took the longest time. The
overall treatment time could be maintained by re-scan irradiation in the slice-by-slice
re-scanning technique if the intensity is kept at the values of the standard mode.
between the 95 – 107% intervention thresholds to reduce the risk of failure in tumor control
(ICRU, 1993). In addition, a Pearson’s r-test at the ↵ = 1% significance level that benchmarks
the probability of linear correlation was performed. It states that there is no correlation between
the dose in re-scan mode and the number of re-scans in case of the Farmer chamber. A summary
of the Pearson’s r values for all detectors is shown in table 4.2.
detector Pearson’s rP correlation ↵= 1%
Farmer chamber 0.11< rP < 0.12 no correlation
PPIC3 0.98< rP < 1 correlation
pin points  0.11< rP < 0.6 no correlation
Kodak X-Omat V films  0.88< rP <  0.85 correlation
Table 4.2.: The table shows the Pearson’s rP correlation coe cient regarding an significance
level of ↵= 1% for the di erent detectors.
The measurement of the pin points is shown in figure 4.9 b). This chart was created by
adding the output of the 24 individual pin points which were placed in six different linear
energy transfer (LET) regions to a single value. The data points are also randomly distributed
around relat iv e dose = 1 with a maximum variance less than 2.5% so that no correlation
could be observed. In addition, each of the six different LET regions was analyzed separately.
The position nearest to the Bragg-Peak did not show any tendency different from the global
one, as well as all the other positions. This indicates that there is no major LET dependence in
relat iv e dose measurements for the pin points with our settings.
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Figure 4.9.: Summary of dosimetric data without motion irradiated at GSI. For better visibility,
the points are distributed around the actual re-scan number. a) shows the relative
dose Drescan/Dnormal of the Farmer chamber with no linear correlation at the Pear-
son’s rP = 1% sig level. b) displays the corresponding pin point data with no linear
correlation Pearson’s rP = 1% sig level. c) PPIC3 shows a correlation between dose
and the number of rescans. The error bars are too small to be visible in this repre-
sentation. d) the relative optical density ODrescan/ODnormal of the Kodak X-Omat V
films with the corresponding fit function.
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Figure 4.9 c), on the other hand, reveals a dependency of the dose as a function of the rescan
number for PPIC3, but with a deviation of less than 2% which lies well between the limits of the
ICRU-50 report. All three types of ionization chambers demonstrate no systematic difference
between the settings for Ampauto and Ampmanual so that the settings of the charge to voltage
amplification of PPIC1 did not influence the relat iv e dose measurement strongly.
Figure 4.9 d) shows the result of the Kodak X-Omat V films. The correlation between the
OD, which is function of dose, and r is clearly visible. Underdosage up to 14% occurred in
our experiments. Using equation 4.2, an average value of ODmax = 4 (see (Spielberger et al.,
2001)), the absolute values ODre scan = 0.46 and ODnormal = 0.51 for r = 19 and the fact that
mre scan = mre f erence (both fields have been analyzed on the very same film) it follows:
Dre scan
Dnormal
=
ln(1 ODre scan/ODmax)
ln(1 ODnormal/ODmax) ⇡ 0.9. (4.7)
This means, that a dose verification calculated from the optical density values of the Kodak
X-Omat V films can have a relative deviation as large as 10% for r = 19.
Nevertheless, the films showed good homogeneity values in the range of 0.96 < H < 0.98
and can therefore still be used to analyze interplay patterns. The exponential function
relat iv e dose = a · e br + c, with a, b and c as free parameters and r as the re-scan num-
ber, was fitted to the data points. The result of the parameters (with 95% confidence bounds)
is:
a = 0.16 (0.097, 0.216) (4.8)
b = 0.10 ( 0.03, 0.231) (4.9)
c = 0.87 (0.779, 0.931) (4.10)
The motivation of the fit was to extract experimental correction factors of the optical densities
for the films which can compensate the decreasing of the OD with increasing re-scan number.
To summarize:
• Slice-by-slice re-scanning was successfully implemented at GSI. The overall irradiation time
can in principle be kept equal to the standard mode.
• The measurements of all gas filled ionisation chambers show relative errors smaller than
±3% when irradiated in slice-by-slice re-scanning mode with a re-scan number up to 19.
• The optical density of the Kodak X-Omat V films decreases significantly when increasing
the re-scan number.
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4.3.2 Implementation & dosimetry HIT
Figure 4.10 displays the mean irradiation time in slice-by-slice re-scanningmode of all rasterpoint
multiplied by the re-scan number (0.8 · 106 particlesrasterpoint and maximum intensity level at HIT).
Figure 4.10.:Mean irradiation time of all rasterpoints of a 2D field with 0.8·106 particlesrasterpoint is almost
independent of the re-scan number. In this case the total irradiation time of each
rastpoint is roughly 1.3ms.
The analysis of the corresponding MBR data shows that the re-scan irradiation can in principle
be finished as fast as in the normal irradiation mode.
As already mentioned, even if the position feedback loop is offline, the PBR and MBR data
are still recorded. The comparison of those data with the reference values of the PBP and MBP
exhibits the accuracy of the irradiation process.
Figure 4.11 a) depicts the nominal position versus the measured values as a function of the
re-scan numbers. Figure 4.11 b) is a magnified cutout of a). Without active position feedback
control the beam is not corrected due to the values obtained by the MWPCs. It can be seen that
there is a influence of < 1mm in y and x direction for the center of irradiation which increases
in case of increasing re-scan numbers.
Figure 4.12 a) shows the corresponding quantitative analysis of the mean radial position error
(see equation 4.6) for 0.8 · 106 particlesrasterpoint which yields a maximum mean radial position error of
2.9 mm. Figure 4.12 b) with a particle density of 6.4 · 106 particlesrasterpoint results in a maximum mean
radial position error of 2.1 mm. As seen many times before, irradiating with a slower sweeping
pencil beam generally yields better results.
In case of a 0.8 ·106 particlesrasterpoint the mean radial position error gets much better when irradiating
at higher re-scan numbers. This is due to the fact the re-scanning seems to have an averag-
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Figure 4.11.: The figure shows the spatial distribution of the planned and measured rasterpoints
as a function of the re-scan number with slice-by-slice re-scanning . In case of the
PBP the data points of each re-scan run lie exactly over each other. In case of the
PBR data points the re-scanning irradiation is clearly visible.
Figure 4.12.: The figure shows the mean radial position error in mm (see equation 4.6) for two
fields with a di erent particle density as a function of the re-scan number.
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ing effect which reduces the initial beam offset. For this measurement, that was done with a
horizontal scanpath, the smoothing effect was dominant for the x position of the beam.
No less important than hitting the right position is applying the right dose. This analysis
is addressed in figures 4.13 and 4.14. The first one sets up the same rasterpoint matrix as
above and shows as results the relative dose error for densities of a) 0.8 · 106 particlesrasterpoint and b)
1.6 · 106 particlesrasterpoint as a function of the re-scan number.
Figure 4.13.: Dose deviations by comparing the data of the PBP and PBR as a function of the
re-scan numbers for two di erent particle densities. a) 0.8 · 106 particlesrasterpoint and b)
1.6 · 106 particlesrasterpoint .
As predicted in chapter 3, the influence on the dose deviation is greater in case of lower
particle densities and higher re-scan numbers. A deviation of approximately 1% occurs only
four times in a) and not at all in b) by irradiation with the maximum available intensities.
Hence, accurate dose application can be expected considering the finite dose sampling intervals
of the TCUs at HIT.
Figure 4.14 is the experimental analog of to the simulations showed in 3.11 which displays the
data of 4.13 b) in a histogram. Whereas single visits of some rasterpoints might have a deviation
of 3%, which will most likely happen when irradiating with 19 re-scans, the comparison with
the summed dose of each rasterpoint versus the planned dose yields a deviation below 1%.
Figure 4.15 shows an extract of the spill structure when irradiating the DeVarPho 3D plan with
a) slice-by-slice re-scanning, b) breath-sampled re-scanning and c) as a cutout of b) with a re-scan
number of 1. Figure 4.15 a) illustrates the time structure of the spill when irradiating in slice-by-
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Figure 4.14.: Histogram of figure 4.13 b). The upper picture shows the deviation of each individ-
ual re-scan run and the lower picture the deviation of a rasterpoint if the fraction
dose of all re-scan runs are summed up to a total dose of the corresponding raster-
point.
slice re-scanning mode. As irradiation begins with the distal slices (these slices have in general
higher particle numbers) the duration to finish a slice is longer for the more distal and shorter
for the more proximal slices. In this case the treatment of the last slice was finished within
0.6 s. Figures 4.15 b) and c) on the other hand reveal a very regular irradiation pattern like
it is expected in the breath-sampled re-scanning mode. The spill-on time was planned to be 4 s
and the average irradiation time in the experiment was measured to be T¯breath-sampled re-scanning =
3.89± 0.1 seconds per IES.
A further comparison between slice-by-slice and breath-sampled re-scanning in terms of applied
dose: Figure 4.16 a) shows the particle numbers for both modes as a function of the IES number.
The differences between the two modes are only visible in figure 4.16 b) where the
relative deviation=
Nbreath-sampled re-scanning Nslice-by-slice re-scanning
Nslice-by-slice re-scanning
(4.11)
is plotted, with N being the particle numbers of each IES.
The relative deviation between both modes is below 0.07%. The deviation gets greater when
the difference in the intensities is larger. Differences in dose levels as low as presented in Figure
4.16 will not alter the outcome of a treatment.
Up next, the dosimetry results at the isocentre are presented:
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Figure 4.15.: Spill structure obtained when irradiating the DeVarPho 3D plan with a) slice-by-
slice re-scanning , b) breath-sampled re-scanning for a period of 4 s with a re-scan
number of 1. c) is a cutout of b). A spill signal of 1 means that beam is irradiating
an IES and 0 represents the spill o  status.
Figure 4.16.: Comparison of the particle numbers recorded in the PBR files after irradiating the
DeVarPho 3D plan with 1 re-scan in breath-sampled re-scanning and slice-by-slice
re-scanning mode. The relative deviation is calculated according to equation 4.11.
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Figure 4.17 illustrates that irradiating 2D plans with the re-scan numbers of 3, 9 and 19 results
in a relative dose deviation of well below 2.5 % when measured with the Farmer chamber. The
data points are randomly distributed around 1 and show no visible dependence with respect to
the re-scan number.
Figure 4.17.: Farmer chamber data obtained by irradiating the plans of section 4.2.5.
Figure 4.18 displays the pin point doses of breath-sampled re-scanning (1 re-scan) versus stan-
dard mode when irradiating the DeVarPho. All pin points inside the region without sharp dose
gradients have a relative deviation smaller than ±5% (red color). The analysis of those pin
points yields an average relative dose of 0.985± 0.021 which shows that 3D dose plans can be
irradiated at HIT in breath-sampled re-scanning mode.
Figure 4.19 displays the corresponding experiment but with slice-by-slice re-scanning and r =
5. The analysis of the pin points yields an average relative dose of 1.023 ± 0.031. One pin
point value inside the ITV region shows a relative deviation greater than ±5%. The pin point at
x = 12 mm and y = 50 mm is the pin point around the region with the sharpest dose gradients
and outside of the ITV (see figure B.2) so that its large relative deviation is not surprising. The
irradiation with slice-by-slice re-scanning and 11 re-scans results in an average relative dose of
1.037± 0.048.
To summarize:
• Slice-by-slice re-scanning and breath-sampled re-scanning have been successfully imple-
mented at HIT.
• The irradiation of a slice-by-slice re-scanning plan can be finished as fast in standard mode.
• With switched off position feedback loop, the maximum mean radial position error is 2.9
mm. Re-scanning even improves the positioning errors slightly.
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Figure 4.18.: Static pin point doses of breath-sampled re-scanning (1 re-scan) relative to the
standard mode. The pin points inside the area of 6mm  x  36mm and
10mm  y  70mm lie well inside the ITV region without sharp dose gradients.
Therefore these, pin point are used when quantitative results are reported.
Figure 4.19.: Static pin point doses of slice-by-slice re-scanning (5 re-scans) relative to the stan-
dard mode. The pin points inside the area of 6mm  x  36mm and 10mm 
y  70mm lie well inside the ITV region without sharp dose gradients. Therefore,
these pin point are used when quantitative results are reported.
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• The measured dose of the TCUs is within 1% to the prescribed one.
• Breath-sampled re-scanning can be irradiated with a intensity so that the irradiation of each
IES takes as long as the motion period.
• Irradiations of 2D and 3D plans (without motion) with breath-sampled re-scanning and
slice-by-slice re-scanning modes yield dose distributions with satisfying accuracy and preci-
sion.
4.3.3 Motion e ects mitigation by re-scanning
2D irradiation: Amplitude, period, intensity and scanpath dependence
Figure 4.20 and figure 4.21 show the experimental film responses and the influence of the
number of re-scans on the homogeneity for a horizontal scanpath, a motion period of 4 s in
vertical and horizontal direction and peak-to-peak amplitudes of 1 cm and 1.5 cm, respectively.
Visual inspection of figure 4.20 illustrates that the two motion directions yield very different
dose distributions. Interplay leads to a distinct interference pattern for a standard irradiation (1
re-scan) of the vertical moving film inside the ROI. There is even some chance that the outcome
gets worse when increasing the re-scans which is clearly visible for the re-scan 5 case. For the
re-scan numbers 13, 17 and 21 no significant difference is visible inside the ROI, CTV and ITV,
respectively. When the target was moved horizontally the blackening of all ROIs looks alike and
the movement is only visible because of the structure of the envelope outside the CTV.
Figure 4.22 displays the corresponding simulation results. The accordance with the experi-
mental results is visible. The basic features of the measured dose distributions can be found
in the forward calculations as well. As in the experimental case, the vertical motion results in
a much greater distortion in the simulations, too. Particularly, the comparison of the re-scan
numbers of 1 and 5 illustrates the power of the simulation environment to predict the outcome
of a re-scan simulation.
Figure 4.21 shows the quantitative analysis of the ROI of the Kodak X-Omat V films. For a small
number of re-scans interplay is not always reduced and can even decrease homogeneity for an
unfortunate combination of parameters like starting phase, motion amplitude, motion period,
scan path and beam application. Generally, a larger amplitude increases interplay effects. It
follows that more re-scans are needed to yield an acceptable dose homogeneity value. In these
experiments the peak-to-peak 1 cm vertical motion amplitude had a homogeneity minimum of
H = 0.61 at 5 re-scans and the 1.5 cm peak-to-peak vertical motion amplitude of H = 0.30 at
3 re-scans. For both amplitudes static irradiation quality is reached after 15 re-scans. For the
horizontal motion the minima of the homogeneity of both amplitudes had a value of H = 0.96
and was even for low re-scan numbers superior to the static reference irradiation. To reach static
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Figure 4.20.: Normalized measured film response as a function of the number of re-scans for 15
mm amplitude target motion and a horizontal scanpath. a) vertical motion b) hor-
izontal motion (ROI: solid line; CTV: dotted line; ITV: dashed line). In case of the
vertical motion distinct interplay patterns are visible. The specific combination of
all the irradiation parameters even yields to a decreasing homogeneity value when
increasing the re-scan number from 1 to 5. Figure 4.21 reports the corresponding
data. Even without re-scanning compensation the horizontal motion does not dis-
tort the dose distribution significantly. The impact of motion is only visible at the
shape of the envelope of the dose distribution. Measurement performed by C. Bert
(Bert et al., 2008a).
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Figure 4.21.: Homogeneity within the ROI of the irradiations and the corresponding simulations
as a function of the number of re-scans . The static Kodak X-Omat V films were irra-
diated without re-scan functionality on the very same film in normal therapy mode
to obtain reference homogeneity values. The simulation of a static target results in
a perfect homogeneity of H= 1 and is independent of the film developing process.
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Figure 4.22.: 2D simulation of interplay patterns irradiated in the slice-by-slice re-scanning mode
to compare with the experimental results of figure 4.20. a) - b) horizontal and c) -
f) vertical sinusoidal motion with a period of 3 s and a peak-to-peak amplitude of
1.5 cm.
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irradiation quality no re-scan irradiation is needed in case of both horizontal amplitudes for this
parameter set.
The corresponding simulation results are also presented in figure (4.21). In contrast to the
experiments three different starting phases (0 , 90  and 180 ) were used to calculate the dose
cubes. In these simulations the peak-to-peak 1 cm vertical motion amplitude has both the abso-
lute homogeneity minimum of H = 0.75 and the minimum of the mean homogeneity H = 0.76
at 1 re-scan. In case of the 1.5 cm vertical peak-to-peak motion amplitude, both the absolute
homogeneity minimum of H = 0.71 and the minimum of the mean homogeneity H = 0.77 oc-
curred at 3 re-scans. Again a larger amplitude increases interplay effects which is also visible in
the wider spread of the standard deviation error bars. For both horizontal motion amplitudes
static irradiation quality is almost reached after 5 re-scans. The 1 cm peak-to-peak horizontal
motion amplitude has both the absolute homogeneity minimum of H = 0.97 and the minimum
of the mean homogeneity H = 0.98 at 1 re-scan. The 1.5 cm horizontal peak-to-peak motion
amplitude has both the absolute homogeneity minimum of H = 0.96 and the minimum of the
mean homogeneity H = 0.97 at 1 re-scan. The simulated homogeneity values for a static target
results in a perfect homogeneity of H = 1 whereas the experimental homogeneity values can
even be smaller than those measured in the presence of target motion. The reason is that the
Kodak X-Omat V films are not perfectly homogeneous because errors can be introduced in the
developing and analyzing process as already mentioned. Furthermore, the transversal beam
profile always deviates more or less from a perfect circle which is used in the optimization pro-
cess. Re-scanning can smoothen these inhomogeneities resulting from an elliptical beam shape
by the same statistical means as it reduces interplay effects due to motion.
The simulations above were also calculated for breath-sampled re-scanning and the results are
shown in figure 4.23 for a peak-to-peak amplitude of 1.5 cm in vertical motion. The planned
dose was 1 Gy. Figure 4.23 a) and 4.23 c) show that the different temporal structure of the
beam application results in a dose profile which almost never matches the prescribed dose of
1 Gy.
Inherently re-scanning is best suited for small motion amplitudes because the exposure of
the healthy tissue will then be closest to the static case. But our investigations also include
larger motion amplitudes as a worst case scenario. Films have been irradiated with six different
starting phases at the same time by using the multi-phase phantom. The peak-to-peak amplitude
was set to A = 5 cm, the period to P = 4 s, the intensity to I = 0.8 · 107s 1 and the motion
direction was perpendicular to the scan path. Figure 4.24 a) shows the dependence of the
homogeneity on the starting phase and the re-scan number. There is a large phase dependence
for low re-scan numbers which means that even a small change in the starting phase can yield
a totally different interplay pattern. More re-scans are needed to reach the static irradiation
homogeneity (29 re-scans in the slice-by-slice re-scanning mode) than in the cases of smaller
amplitudes presented above. Figure 4.24 b) plots the minima, mean and maxima along with
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Figure 4.23.: Simulations with the breath-sampled re-scanning technique in case of vertical mo-
tion with a peak-to-peak amplitude of 1.5 cm. a) 1 re-scan b) 3 re-scans c) surface
plot of 1 re-scan d) homogeneity as a function of re-scan number.
Figure 4.24.: a) Homogeneity within the CTV. The peak-to-peak motion amplitude was 5 cm
and the motion period of 4 s. Six di erent starting phases (separated by 60 ) were
used and irradiation was done in the slice-by-slice re-scanning mode. The static
films were irradiated in normal therapy mode to get reference homogeneity values
on each film. b) Shows the absolute min, mean and max optical density values for
the same CTV area. These values converge to the static reference measurements
for increasing r.
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the mean optical density for static irradiation versus the re-scan number. For the case of 5 re-
scans the CTV was obviously not irradiated most of the time which results in large underdosage.
In addition to the foregoing irradiation, a simulation with the same nominal parameter space
was performed with breath-sampled re-scanning (see figure 4.25). For all motion amplitudes
the breath-sampled re-scanning simulations converge faster to static irradiation quality than the
slice-by-slice re-scanning simulations. But compared to figure 4.23 the homogeneity values are
1-2% lower for identical re-scan numbers in case of the 5 cm amplitude compared to the 1.5 cm.
Figure 4.25.:Mean homogeneity values within the CTV area as a function of r. The peak-to-peak
motion amplitude was 5 cm and the motion period of 4 s. Six di erent starting
phases (separated by 60 ) were used and simulations were in the breath-sampled
re-scanning mode.
Figures 4.26 (for slice-by-slice re-scanning) and 4.27 (for breath-sampled re-scanning) present
the simulation results for a wide range of parameters (see table 4.3) and display their influence
on DAHs8.
In Figure 4.26 a) the dependence of the motion amplitude on the DAHs was studied. As
expected, the DAH improves for smaller amplitudes. This is again in accordance with the ex-
perimental results shown before - the data of 4.21 demonstrate that re-scanning compensates
interplay effects for small amplitudes faster than for larger ones. Figure 4.26 b) exhibits the
influence of a variation and the duration of the motion. The shorter the period the worse be-
come the DAHs with this specific parameter set. Figure 4.26 c) shows the intensity dependence
and that our a priori chosen intensity (see table 4.3) apparently results in a DAH of minimum
quality. To gain the best possible DAH curve with this specific simulation setting one could use
very high or very low intensity values. In the limit of an infinite intensity value the target seems
8 DAHs are basically a special case of the well known dose volume histograms but with the depth dimension of
one CT voxel.
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Figure 4.26.: DAHs simulated for slice-by-slice re-scanning mode (motion being perpendicular to
the scan path) as a function of parameters which play a crucial role in shaping
interplay patterns. Table 4.3 gives an overview of the actual parameter set of each
figure.
Figure 4.27.: DAHs simulated for breath-sampled re-scanning mode (motion being perpendicu-
lar to the scan path) as a function of parameters which play a crucial role in shaping
interplay patterns. Table 4.3 gives an overview of the actual parameter set of each
figure.
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to be stationary whereas for very low intensity values the particles are evenly distributed many
times over all motion phases. Figure 4.26 d) displays the influence on the number of re-scans.
Analog to our experiments the quality of the DAH decreases when comparing the re-scan 1 and
5 cases and reaches static irradiation quality after 25 re-scans.
Compared to the foregoing results in slice-by-slice re-scanning mode the breath-sampled re-
scanning technique shows almost no influence on the used parameter set. In figure 4.27 a) the
variance of each single DAH curve is minimal and the dose values for all amplitudes are within
the limits of the ICRU-50 (ICRU, 1993) report. Inspecting figure 4.27 b) suggest that there
might be no influence of the chosen period at all. This point will be addressed in the discussion
section. Figure 4.27 c) was left empty to make clear that the dependence on the period and
the intensity are coupled and that there exists no subjection on the intensity on its own. The
relationship between the two parameters is
I =
N
TPE
, (4.12)
with I being the intensity, N the number of particles and TPE the period of the motion. Static
irradiation quality is already reached after 5 re-scans (see figure 4.27 d)).
figure re-scans amplitude [cm] intensity [1/s] period [s] phase [ ]
4.26 a) slice 25 - 0.5 · 107 4 0
4.26 b) slice 25 5 0.5 · 107 - 0
4.26 c) slice 25 5 - 4 0
4.26 d) slice 1 0.5 · 107 4 0
4.27 a) BS 25 - automatic 4 0
4.27 b) BS 25 5 automatic - 0
4.27 d) BS 1 automatic 4 0
4.28 a) slice 5 1 · 108 4 0
4.28 b) BS 5 automatic 4 0
4.3.3 slice 5 0.5 · 107 4 0
4.33 a) slice 1 1 · 108 4 0
4.33 b) BS 5 automatic 4 0
4.33 c) BS 1 automatic 4 0
4.33 d) BS 5 automatic 4 0
Table 4.3.: Summary of the parameters used for the simulation of the listed figures. The ampli-
tude length is meant to be from peak-to-peak.
Figures 4.28 a) and b) compare the DAHs for the rather large peak-to-peak amplitude of
A = 5 cm when irradiated in slice-by-slice re-scanning and breath-sampled re-scanning mode, re-
spectively. The left pictures indicates that, even in case of 25 re-scans, slice-by-slice re-scanning
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cannot guarantee satisfying irradiation quality9 for larger amplitudes. In contrast to this find-
ing, for 13 re-scans breath-sampled re-scanning is already very close the limits of the ICRU-50
report and the numbers 17 and 25 lie well between these limits even of they both show a small
overdosage of the target volume.
Figure 4.28.: DAHs simulated for slice-by-slice re-scanning and breath-sampled re-scanning mode
(motion being perpendicular to the scan path) in case of a large amplitude of A =
5 cm. Table 4.3 gives an overview of the actual parameter set of each figure. The
legend is valid far a) and b).
2D irradiation: Size of the field penumbra
Figure 4.29.: Comparison of the penumbra width: The moving target (peak-to-peak amplitude
1.5 cm, starting phase of 0  and 21 re-scans) results in a 90% to 10% penumbra
width of 18mm in case of the static target the width is 10mm, respectively.
9 The limits of the dose axis was kept constant in relation to the foregoing pictures as to make the comparison
more convenient.
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Irradiating a moving target leads to a blurred dose distribution which means that the sharp
dose gradients of the static case cannot be preserved so that the beam penumbra at the field
edges will increase. Mathematically, the blurring can be described by a convolution of the static
dose distribution that would result without motion with a characteristic motion kernel (Bortfeld
et al., 2004). The shape of the penumbra depends on the amplitude, the characteristics of the
motion, the re-scan number and on the sharpness of the static dose distribution. Figure 4.29
shows the comparison of the penumbra between the static dose distribution and the case of 21
re-scans, an amplitude of 1.5 cm and a starting phase of 0 . The distance between 90% and 10%
levels of the prescribed dose defines the width of the penumbra. The values were calculated as
10 mm for the static target and 18 mm for the moving one, respectively.
2D irradiation: Starting phase dependence
Figure 4.30.: Starting phase dependence for 1.5 cm peak-to-peak amplitude in vertical motion
direction, a horizontal scan path and a period of 4 s. The dose values were taken
from the voxel in the centre of the radiation field and normalized to the pre-
scribed dose. a) shows the results of slice-by-slice re-scanning and breath-sampled
re-scanning with the re-scan numbers 1, 9 and 19. b) magnified cutout of a)
The starting phase of any re-scan mode is in general unknown in advance and experiments
with a large number10 of phases are in reality very time consuming and often not feasible.
Therefore figure 4.30 shows the phase dependence of a single energy slice for slice-by-slice re-
10 For example with a phase shift of 5  for every irradiation.
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mode a) % of dose inside 95-107% b) deviation in % max vs. min
slice 1 0.06 338
slice 9 0.94 12
slice 19 0.41 22
BS 1 0.07 241
BS 9 1 3
BS 19 1 0.8
Table 4.4.: Analysis of figure 4.30. Column a) shows the percentage of dose of the centre voxel
inside the radiation field which is inside the limits of the ICRU-50 (ICRU, 1993) stan-
dard. Column b) compares the deviation of the values of the maximum andminimum
dose in percent.
scanning and breath-sampled re-scanning with a peak-to-peak amplitude of 1.5 cm, a period of
4 s and a motion perpendicular to the scan path direction. The dose was extracted at one voxel
in the centre of the radiation field. A strong phase dependence is clearly visible with both modes
at a re-scan number of 1. Surprisingly, the slice-by-slice re-scanning phase dependance is smaller
for 9 than for 19 re-scans, but in both cases the dose variance is largely reduced. Breath-sampled
re-scanning reduces the phase dependence by a much larger amount than the other technique
and gets constantly better by increasing the re-scan number. Interestingly, all slice-by-slice re-
scanning curves mimic the shape of the underlying sinusoidal motion. Despite all calculations
having exactly the same parameters11 the maxima are shifted by approximately 90  and 270 ,
respectively. The more the curve mimics a sinusoidal shape the greater the correlation between
beam application and motion must have been. To overcome this correlation is an important
prerequisite to ensure satisfying irradiation of the patient. Inspecting figure 4.30 b) shows that
breath-sampled re-scanning not only reduces the dose variance by a much larger amount but that
it is also able to break up the correlation between motion and beam amplification for the re-scan
numbers 9 and 19. The values are randomly distributed around the mean and no projection of
the underlying motion can be observed. Table 4.4 displays results from figure 4.30 concerning
the dose variations.
Bortfeld et al. (Bortfeld et al., 2002) calculated that the probability density function (PDF) of
the dose distribution of a voxel will transform into a Gaussian shape after a few fractions. Figure
4.31 shows histograms of the foregoing simulations. All distributions are centered around the
prescribed dose of 1 Gy. The asymmetry, which is most pronounced in a) and d), is most likely to
vanish by increasing the number of simulations. Both techniques indicate that it is very unlikely
for a point to receive the planning dose for 1 re-scan. The minima and maxima dose values
have the highest probability. In case of the slice-by-slice re-scanning mode this behavior tends
to vanish at first by applying 9 re-scans, but appears again for 19 re-scans. Breath-sampled re-
11 Besides the different re-scan numbers
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Figure 4.31.: Histograms of figure 4.30. a) - c) show the results of slice-by-slice re-scanning with
the re-scan numbers 1,9 and 19. d) - f) show the corresponding histogram for the
breath-sampled re-scanning mode. g) and h) are the magnified versions of e) and
f), respectively. For viewing purpose the limits of both axes are not constant.
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scanning is definitely much closer to the findings of Bortfeld et al., who assert that distributions
like a) and d) should transform into a Gaussian shape after a few re-scans.
2D irradiation: Spill profile dependence
Figure 4.32.: The dependence of the spill shape on the dose pattern. Simulation parameters are
listed in table 4.3. Qualitatively, the interplay between a) the ideal square and b)
the measured spill profile is almost identical in case of 1 re-scan . c) displays both
spill structures normalized to one particle per spill and d) the DAHs of 1 and 25
re-scans for both spill shapes.
In experiments with motion phantoms or when calculating simulations, the frequency, am-
plitude and re-scan number can be adjusted quite precisely, but there can be large deviations
between the actual intensity and the one used in the simulation. Furthermore, every spill shape
deviates from one another more or less. Therefore an ideal rectangular spill shape was com-
pared with a typical measured spill file, which was used for the previous simulations. Figure
4.3.3 a) and b) shows the interplay patterns of the measured spill and the ideal square pro-
file (see figure c)) for 25 re-scans in slice-by-slice re-scanning mode, respectively. Qualitatively,
both are basically identical so that cold and hot regions appear at the same position if all the
other simulation parameters are kept constant. The DAHs of figure 4.3.3 d) differ distinctly
for 1 re-scan but only marginally for 25 re-scans which is again due to an averaging effect of
re-scanning.
To extent theses findings figure 4.33 presents further simulation results. The core message
is that the DAH can deviate from each other independent of the used irradiation mode for 1
re-scan due to different spill profiles but that a re-scan number of 25 basically entirely reduces
the differences. Figure 4.33 d) shows that already a re-scan number of 5 yields in marginal
differences of the corresponding curves when irradiating in breath-sampled re-scanning mode.
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Figure 4.33.: Supplement of figure 4.3.3. It shows the dependence on the spill shape for a) slice-
by-slice re-scanning and b) - c) breath-sampled re-scanning technique (see table 4.3
for details).
Therefore realistic dose distributions can be calculated without knowing the exact spill shape in
advance.
To summarize:
• Experiments show:
– Slice-by-slice re-scanning efficiently reduces interplay patterns due to motion when
irradiating 2D plans. Interplay effects are being compensated faster if the motion is in
parallel with the primary scanpath.
– The larger the motion amplitude the stronger are the interplay patterns.
• Simulations show:
– The interplay patterns of the experiments can also be generated with the simulation
environment.
– Breath-sampled re-scanning reduces interplay patterns much faster than slice-by-slice
re-scanning.
– The dependence of the dose distribution on parameters like starting phase, spill shape,
period, amplitude and re-scan number is much smaller in case of breath-sampled than
with slice-by-slice re-scanning.
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– The re-scan number which is needed to guarantee satisfying to application cannot
be assessed with a general formula so far. Simulations with the specific irradiation
parameters are mandatory.
3D irradiation: Density variation phantom
Figure 4.34 reports experimental as well as simulation homogeneity results of the DeVarPho
in the presence of motion as a function of the re-scan number. As expected, the homogeneity
improves when increasing the re-scan number. Comparing the corresponding re-scan modes
along with the scan path it seems that saturation has almost been reached at a re-scan number
of 5. Both in the simulation as well as in the experiment only minor improvement regarding
the homogeneity can be observed when increasing the re-scan number to 11. Like observed
before, irradiations parallel to the scan path (horizontal) yield better results than irradiations
being perpendicular to the motion.
Figure 4.34.: Homogeneity values for a) experiments and b) simulations of the DeVarPho in the
presence of motion as a function of the re-scan number. Experiments have only
been performed in slice-by-slice re-scanning mode. Simulations were calculated for
breath-sampled and slice-by-slice re-scanning irradiations.
In addition, the simulations show that breath-sampled re-scanning is significantly better than
slice-by-slice re-scanning for a re-scan number r   7 and shows less scanpath dependence. In the
experiments as well as in the simulations, slice-by-slice re-scanning with a vertical scanpath is the
only mode which shows a small, but clearly visible, region of decreasing inhomogeneity when
increasing the re-scan number. The homogeneity of the static measurements was calculated to be
0.969± 0.007. Therefore the simulations predict that all breath-sampled re-scanning simulation
with a re-scan number r   7 and all simulation r   11 have at least static irradiation quality.
135
The experimental results for slice-by-slice re-scanning mode are a little bit worse than the static
measurements. They result in a homogeneity of H = 0.956 and H = 0.932 in case of the
horizontal and vertical scanpath, respectively. This shows that re-scanning was able to reduce
interplay effects very efficiently so that almost static irradiation quality is reached.
3D irradiation: Breathing thorax phantom with 6D target-motion
Figure 4.35 shows experimental as well as simulation homogeneity results of the BreThoPho in
the presence of motion as a function of the re-scan number.
Figure 4.35.: Homogeneity values for a) experiments and b) simulations of the BreThoPho in
the presence of motion as a function of the re-scan number. Experiments and
simulations have been performed for slice-by-slice and breath-sampled re-scanning
mode.
As expected, the homogeneity gets better when increasing the re-scan number. The general
tendency, especially of the simulation figure 4.35 b), is similar to what has been written when
reporting the results of figure 4.34. It shall be emphasized that figure 4.35 a) shows the only
irradiation that succeeded when trying to irradiate in breath-sampled re-scanning motion in the
presence of motion. Therefore it offers the possibility to actually compare experimentally breath-
sampled re-scanning and slice-by-slice re-scanning. Breath-sampled re-scanning was irradiated
with the unfavorable vertical scanpath, nevertheless it showed a much better homogeneity (H=
0.967) than slice-by-slice re-scanning in horizontal scanpath.
The homogeneity of the static measurements was calculated to be 0.977± 0.005. Therefore,
the simulations predict that all breath-sampled re-scanning simulation with a re-scan number
r   3 have at least static irradiation quality. The experimental results for slice-by-slice re-scanning
mode (vertical scnapath) with a re-scan number r = 9 and r = 11 result in a homogeneity of
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H= 0.966 and H= 0.981, respectively. This shows that re-scanning was able to reduce interplay
effects very efficiently so that almost static irradiation quality is reached.
Additional results can be found in section B.2.1.
To summarize:
• Experiments and simulations showed that interplay effects for both the DeVarPho- and the
BreThoPho have been efficiently reduced by slice-by-slice and breath-sampled re-scanning.
In experiments and in simulations breath-sampled was superior to slice-by-slice re-scanning.
4.4 Discussion
4.4.1 Implementation & dosimetry - a general view
In addition to the efforts done at GSI and HIT to implement the re-scanning technique other
groups work on that topic as well. Recently, the group at Paul Scherer Institut (PSI) provided
data for re-scanning experiments at their new Gantry 2 (Schätti et al., 2013). They report a
lateral scanning speed with protons of roughly 1 mm/ms and 80 ms to change the particle’s
energy (Zenklusen et al., 2010). The National Institute of Radiological Sciences (NIRS) on
the other hand presents both experimental and simulation results (Furukawa et al., 2010b).
Their efforts tend towards very short irradiation times12 and intensity control of the beam with
RF-knockout extraction (Furukawa et al., 2005). The Heavy-Ion Medical Accelerator in Chiba
(HIMAC) can accelerate up to 2·1010 ions, so that almost all irradiations require only one or two
injections. They chose to implement a very promising re-scanning variation which they named
phase-controlled re-scanning (PCR) - a combination of gating and re-scanning. This technique
is assumed to reduce the phase dependence very effectively since it is very similar to breath-
sampled re-scanning but with the advantage of sparing more healthy tissue. The drawback is
that PCR needs motion monitoring to determine the breathing period.
A very short treatment time can be important because of several reasons. If the tumor is
subjected to large baseline drifts or if patient monitoring13 is necessary, which stresses the body
with additional dose, a fast irradiation is preferable. In addition, economics and patient com-
fort must be considered, both will benefit by the fastest treatment that can preserve the quality
standards. In practice, the clinics will have to find the optimal compromise between irradiation
quality and irradiation speed, which are in general conflictive aims and might yield to individual
solutions for each patient. Furukawa et al. (Furukawa et al., 2010b) report a lateral scanning
speed with carbon ions of roughly 100 and 50 mm/ms and 500 ms to change the particle’s en-
ergy. Similar to the experiments done in the scope of this thesis, they did careful measurements
12 The system took only 20 s to deliver the physical dose of 1 Gy to a spherical target having a diameter of 60 mm
with eight re-scans.
13 with the use of X-rays
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to check if the prescribed dose can be applied in re-scan mode because even a sufficiently high
scanning speed, realized by the deflecting magnets, does not guarantee correct dosimetry since
it is only one element of the dosimetry chain.
Running the re-scan mode with a modified interlock mask (as it is currently done at GSI and
HIT), which basically means that the position feedback loop is switched off, is surely not an
ideal solution. The development of a complete interlock mask which also works in re-scanmode
is mandatory. A possible approach could be that some thresholds scale with the chosen re-scan
number in order to keep the system as flexible as possible. Furukawa et al. (Furukawa et al.,
2010b) briefly report about their interlock system and state a lateral position tolerance of 2 mm
but without going into re-scan specific details. They also switched off the position correction
loop.
Experiments which tackle the problem of correct dosimetry in the re-scan mode with heavy
ions without the interference of motion have also been reported by Furukawa et al. (Furukawa
et al., 2010b) and in the previous chapters. The fewer re-scans are being needed in the irra-
diation process the closer the dosimetry will be to the standard irradiation case. The goal was
therefore to investigate beam application for high re-scan numbers. If those can fulfill the crite-
ria of patient treatment quality, it can be expected that all lower numbers will also satisfy these
demands. Both GSI and NIRS use the raster scanning technique which means that the beam
is not switched off when moving from one spot to the next14. This reduces dead time but in
the case of high re-scan numbers the transient dose between spots may become significant com-
pared to low speed irradiation. Since especially NIRS tries to implement high speed irradiation
they included the influence of the transient dose in their planning software. Furukawa et al.
(Furukawa et al., 2010b) also cared about the influence of position, size, time and structure of
the beam, saturation of the electrons or recombination effects when irradiating in high speed
mode with sub millisecond delivery time of each rasterpoint. They irradiated a 3D box and re-
port that the precision of the scanned beam position was less than ±0.5 mm. In addition, they
report almost no difference when compering their standard irradiation with 8 re-scans.
4.4.2 Implementation & dosimetry at GSI
Figure 4.8 shows that slice-by-slice re-scanning irradiation can in principle be finished as fast as
standard irradiation by the treatment control system when a modified interlock mask is set.
As already mentioned, in the current implementation the read out of the MWPCs was switched
of because of the short sampling time when using re-scan irradiation mode. Therefore, it was
not possible to record the position data of the irradiated rasterpoints. Hence, every information
concerning the lateral position of the pencil beam could only be obtained at the isocentre with
14 PSI uses the discrete spot scanning method. Every time the irradiation position needs to be changed the beam
will be switched off.
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appropriate detector devices like Kodak X-Omat V films or pin points chambers. The interlocks
at GSI are not designed for the slice-by-slice re-scanning irradiation mode. Even if dosimetry
measurements at the iso-center show that a plan could be irradiated within the recommended
limits of the ICRU, it might be necessary to choose a lower re-scan number so that the interlock
system needs not to be switched off15. But a lower re-scan number can result in an interplay
pattern outside the 95% - 107% threshold. Therefore, the re-scan technique of choice would the
one which can guarantee homogeneous irradiation along with a low re-scan number in a short
irradiation time.
At GSI, if a certain re-scan number would be needed to yield satisfying homogenous dose
application one is able to reduce the intensity of every slice individually16 so that position feed-
back loop could be switched on. However, with the current system this will, in general, result
in unacceptable long irradiation times.
The influence of the treatment control system on dosimetry measurements has already been
addressed in chapter 3.3. Calculations yield a dose uncertainty of less than 1% for the individual
rasterpoints so that larger deviations should not be caused by this effect.
Beam application in the re-scan mode alters the temporal space charge distribution inside the
ionization chambers (see figure 4.36) which might lead to falsified dose measurements due to
recombination effects in chambers with a large sensitive volume like PPIC1 and PPIC3. The
applied electric field inside the chambers is parallel to the beam direction.
Figure 4.36.: Schematic drawing of the modified charged distribution due to re-scanning inside
PPIC1 and PPIC3. Assuming a homogeneous PBP: If T0 is the time to irradiate a
rasterpoint for one re-scan then five re-scans will deposit the charge across a larger
area. The height symbolizes the amount of charge.
15 It is mandatory that all interlocks are switched on when irradiating a patient
16 to a minimal value of roughly I= 1 · 106s 1.
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Experiments done by D. Schardt et al. (Schardt et al., 2011) show, for measurements done
with ions at the Bragg peak region with an ionization chamber filled with air, a strong depen-
dency of the recombination rate as a function of the orientation of the electric field. A field
angle of 90 , relative to the beam direction, results in a correction factor of approximately 2%
whereas a field parallel to the beam yielded a correction factor of over 20%. This clearly shows
that space charge effects play a role in the Bragg peak region for chambers like PPIC1 and
PPIC3. In the experiment of figure 4.1, both chambers were placed in the plateau region. The
re-scanning effect is not exactly the same as changing the orientation of the field, but a small
influence on the dose measurement can be seen in figure 4.9 c). PPIC1 and PPIC3 contain a
different sensitive volume which leads to different recombination coefficients ↵PPIC3 < ↵PPIC1
(see (Fridman and Kennedy, 2011)). The volumetric recombination rate can be expressed as
dn+
d t
= ↵ n+ n , (4.13)
with n+ as the ion and n  as the electron density. The larger value of the recombination rate
is responsible that PPIC1 is more sensitive to recombination effects. Therefore, PPIC3 measures
the particles more efficiently. PPIC1, which controls the course of the treatment, stops the
irradiation if the prescribed particle number is reached. The increasing space charge effects
due to re-scanning lead to less efficient measurement of this chamber. Since PPIC3 is not so
much affected by that effect its dose slightly increases relative to PPIC1. When designing the
ionization chambers in the starting phases of the therapy pilot project at GSI, test were done
to find the gas with an optimal W-value for the PPIC1 (Brusasco et al., 2000) because this is a
major source of dose uncertainty. Anyway, the variation between the two chambers according
to the data is only 2% for r = 19 and the maximum intensity of the particle beam.
The data of the Farmer chamber in figure 4.9 a) and the pin points in figure 4.9 b) show that
both of these chambers and the PPIC1 are not much influenced by space charge effects due to
the re-scanning irradiation. PPIC1 builds up a signal chain with each of the other two chambers.
Any systematical error in the output of PPIC1 would be transformed in a visible tendency in the
data points of those two other devices. For example, if the PPIC1 measurement with increasing
re-scan numbers yields in a distinct underdosage then the data points of 4.9 b) and 4.9 c) would
fluctuate around a curve with a negative slope. In addition, every systematical error of the small
chambers would also show a correlation with the re-scan number. Only if the systematical errors
of all three chambers exactly compensate each other, fluctuation around a relat iv e dose = 1
can occur but this is very unlikely, since the chamerbs are different from each other, filled with
different gases and placed at different LET positions. Therefore, the dosimetry is affected by a
level which still ensures safe patient irradiation inside the limits of the ICRU-50 (ICRU, 1993)
report.
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Several experiments, with different beam parameters, performed with the Kodak X-Omat V
films showed a decreasing of the OD with an increasing re-scan number. The re-scan results
were compared relative to a small reference field was irradiated on each film in therapy mode.
Hence, the decreasing of the OD cannot be caused by the developing procedure of the films.
Consequently, the photochemical reactions in the film do not only depend on the product
of intensity and time of exposure. This is called failure of reciprocity and is already known
for X-rays (Martens et al., 2002). To our knowledge, it is the first time that this phenomena
has been observed with heavy ions. Martens et al. state that for "photon and electron beams,
grains are normally rendered developable by the energy transferred during a single electron
hit. However, the highest energy secondary electrons produced in the phantom by mega voltage
photon beams have a very low linear energy transfer coefficient at the beginning of their paths
(Hamilton 1966b) that results, for some emulsions, in failure of the single hit theory, and thus
in failure of the reciprocity law. This is obviously the case for the KODAK X-Omat V films".
Apparently, these findings can be extended to irradiation with heavy ions as well. The films can
still be used to examine interplay patterns but without determination of appropriate correction
factors for re-scanning irradiation the films cannot be used for dose verification purposes.
To summarize:
• The implementation of slice-by-slice re-scanning at GSI was feasible. To guarantee a high
quality of the beam application the interlock mask has to be redesigned to facilitate re-scan
irradiation.
• The current system at GSI delivers the particle beam in slice-by-slice re-scanning mode to
the target with a dose which is well inside the ICRU-50 (ICRU, 1993) report.
4.4.3 Implementation & dosimetry at HIT
It could be shown that slice-by-slice and breath-sampled re-scanning have been successfully im-
plemented at HIT. In principle, it is possible to irradiate a patient in slice-by-slice re-scanning
mode as fast as in the standard patient mode without introducing severe changes to the dose
application so that patient treatment should be possible. Though, the position feedback loop
had to be switched off in re-scanning mode because the fast irradiation would have resulted in
interlocks. Figure 4.37 shows schematically why the position feedback loop is needed to achieve
precise irradiation in the lateral plane. The accuracy with which the beam can be tuned by the
accelerator team is limited. This has several reasons. Often it is not possible to tune the posi-
tion of the beam for every energy, focus and intensity separately17. That means, optimizing the
parameters of the accelerator for one energy and focus pair can make the accuracy of another
17 as I learned when implementing the Gantry along with the accelerator crew at HIT
141
set worse. The second source of uncertainty is simply that the accelerator is subjected to small
day-by-day changes.
Despite both perturbations, the position of the beam must lie inside a fine-tuning-grid with
the size of a few millimeters18. With the position feedback switched on, the deflection magnets
of the rasterscanning system can shift the beam to its prescribed position. This is indicated in
figure 4.37 with the help of the greenish arrows. To conclude: Comparing the irradiations for
Figure 4.37.: shows schematically the influence of the position feedback loop. The distance and
direction of the actual beam position is measured with respect to its reference po-
sition. The correctional factors are applied to the deflecting magnets which shift
the beam closer to the reference position.
1 re-scan (which is identical to the standard irradiation without position feedback loop) and
19 re-scans in figures 4.11 and 4.12 shows that re-scanning even improves position accuracy
slightly. It follows, if the position feedback functionality will be adapted to the increased speed
of re-scanning, irradiation in breath-sampled re-scanning and slice-by-slice re-scanningmode shall
be possible with almost the same precision as in the current standard mode - which means sub-
millimeter precision. The histograms of figure 3.11 (simulation) and 4.14 (measurement) are
in good agreement and small deviations might arise because of different particle numbers and
intensities. The measured doses by the TCU units and the prescribes ones deviate so less from
each other that (see figure 4.13) that no concerns regarding the dose level application should
arise.
The difference between the desired breath-sampled re-scanning period of 4 s and the average
irradiation time in the experiment of T¯breath-sampled re-scanning = 3.89± 0.1 lies within a tolerable
range for a feasibility study. Furthermore, the results can surely be improved by further opti-
mizing the control parameters for breath-sampled re-scanning at HIT. Efforts in this direction
are ongoing. Recently, it is even possible to irradiate individual rasterpoint with a predefined
intensity (Schoemers et al., 2011).
At first, the particle numbers per rasterpoint (0.8 ·106, 1.6 ·106, 3.2 ·106 and 6.4 ·106) which
have been used for the dosimetry measurements in figure 4.17 appear quite large compared
18 the size of the fine-tuning-grid is not for the public domain
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to conventional treatments with many fractions. However, in the regime of hypofractiona-
tion (Miyamoto et al., 2007), a particle number per rasterpoint of 0.8 · 106 is a fairly good
approximation with respect to the IESs at the distal region of the tumor.
Figure 4.18 shows that in case of breath-sampled re-scanning (1 re-scan) the continuously
variation of the intensity level can be executed without introducing additional errors to the
dosimetry. On the other hand, comparing these results with the slice-by-slice re-scanning with 5
(see figure 4.19) and 11 re-scans, the average dose increases by 3.8% and 5.3%, respectively. It
can be observed that the pin points within one row of the same z-value have very small standard
deviations but that the values from rows with other z-values show different dose values. In gen-
eral, it was observed that the more distal the row, the lower the dose value of the corresponding
pin points. This leads to the finding that the pin points might be less accurate when the dose
per rasterpoint visit gets smaller. This was not observed when performing the experiments of
section 4.3.1 (see figure 4.9). This could be due to following facts: The irradiated plans were
2D and 3D plans. Therefore, the proximal pin points receive many pre-irradiations with low
doses which did not happen in the 2D case. Especially those proximal pin points showed the
largest deviation. The distal pin points showed almost no dependence on the re-scan number,
like observed before. Furthermore, all measurements lie within a relative deviation of ±4%.
Even irradiation under the same conditions can sometimes result in deviations of this order.
To summarize:
• First experiments to implement slice-by-slice re-scanning and breath-sampled re-scanning at
HIT were successful. To guarantee a high quality and safe beam application the interlock
mask has to be redesigned to facilitate re-scan irradiation.
• Irradiations of 2D and 3D plans with breath-sampled re-scanning and slice-by-slice re-
scanning modes at HIT yield dose distributions with respect to the reference irradiation
which are well between the limits of the ICRU-50 report. The pin point doses at proximal
regions should be carefully analyzed when irradiating with higher re-scan numbers.
4.4.4 Motion mitigation
This section is focused on motion mitigation with re-scanning. Motion mitigation by gating (Bert
et al., 2009) and tracking (Bert et al., 2007) are addressed elsewhere. In principle it is always
possible to combine re-scanning with tracking and gating.
Van de Water et al. (van de Water et al., 2009) compared re-scanning, perfect tracking (no
position error, no time delay), imperfect tracking (with position errors and time delays) and
retracking (a hybrid solution combining tracking and re-scanning) for dose homogeneity (dif-
ference between D5 and D95 in the CTV) in a homogeneous and a heterogeneous (simulated
rib proximal to target) phantom. They found that the nominal dose homogeneity could not be
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obtained with perfect tracking as well as imperfect tracking for pencil irradiation with protons
in case of a heterogeneous phantom, which was moving with an amplitude of 15 mm. Retrack-
ing with 4 re-scans was not really superior to perfect tracking but better as re-scanning with 4
re-scans. The best results yielded re-scanning with 8 re-scans. They state that the results are due
to the highly sensitive nature of proton beams to small spatial errors.
Furukawa et al. worked out that the total-irradiation-time (Ttotal) for each IES needs to be:
Ttotal = n ·Tbreathing, with n being an integer number and Tbreathing the duration of the respiration
cycle, that re-scanning reduces interplay effects very efficiently. Hence they introduced so called
PCR in which the intensity is adjusted to exactly match into a predefined gating window. In
principle this is the same as combining breath-sampled re-scanning with gating. They moved
their phantom with a period of 4 s and an amplitude of 10 mm. In the comparison between the
static measurements and the moving measurements with the PCR method, they report a dose
difference of less than 2% for the pin point chambers in the target volume, which also agrees
with their simulations.
Seco et al. (Seco et al., 2009) analyze dose distributions of five different re-scanning tech-
niques. Even if the tools written in the scope of this thesis could mimic each of those five
methods, the simulations in this chapter have only been performed for the cases that have
also been implemented in the facilities at HIT and GSI, namely slice-by-slice re-scanning and
breath-sampled re-scanning.
The investigations of re-scanning started in almost all research groups with irradiation or sim-
ulation of 2D fields or simple 3D phantoms. Some publications at facilities without an active
beam scanning system tackled the effect of statistical averaging of re-scanning only in simula-
tions (Kraus et al., 2011; Bortfeld et al., 2002). The report very useful results but the they
neglect the influence of an real existing beam scanning system which can influence the dose
distribution to a degree which transforms a dose distribution beyond the limits of the ICRU-50
report. Therefore it is strongly recommended to validate the simulation tools versus the experi-
ment as it was done many times at GSI with TRiP (Richter, 2012; Gemmel et al., 2011) and at
NIRS (Furukawa et al., 2010a).
2D irradiation: Amplitude and scanpath dependence
The visual inspection of figure 4.20 as well as the quantitative analysis of figure 4.21 reveals a
strong dependence of the interplay pattern concerning the relative orientation of the primary
scanning path and the motion direction. If the motion direction is parallel to the scanpath only a
few re-scan numbers are needed to yield a very homogeneous dose distribution. Similar findings
have been observed by Knopf et al. (Knopf et al., 2011). Since the complete scanning for one
complete line of the PBP was, with the used settings, roughly ten times faster than the tumor
motion period for r = 1, the dose distortion will be very small if the motion direction is along
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that line (see figure 4.38 a). In case of high re-scan numbers the target may even be considered
as being quasi static so that small fluctuations will only occur if the irradiation of each line
always starts at the same motion phase.
Figure 4.38.: shows the origin of dose patterns of the CTV due to the relative moving direction of
the pencil beam versus the target. a) the pencil beam and the target move parallel.
The relative dose error of each point long the line its very small. b) the pencil beam
and the target move perpendicular. The further the beam moves to the right the
larger is the spatial separation  s between the planned and the actual irradiated
rasterpoint which leads to massive underdosage if s is too large.
Being roughly ten times faster in this experiment is not enough if the motion is perpendicular
to the scanpath. If one assumes that the irradiation starts at the 1st point of figure 4.38 b) then
the target moves down while the pencil beam moves to the right. Taking the maximum velocity
of the sinusoidal motion and multiplying it with the time the pencil beam needs to cross the line
yields that the target has moved down by roughly  s = 0.8 cm in this experiment. Hence, the
Gaussian beam profile of the pencil beam can deliver approximately 10% of the prescribed dose
to the planned rasterpoint and as a consequence the diagonal stripes appear which can easily be
seen for the r = 1 case. Increasing the re-scan number while maintaining the intensity reduces
 s. In case of r = 7,  s will be so small that the dose error is within ±5%. In fact it can be seen
that for r = 5 the diagonal stripes have disappeared, unfortunately there is a strong temporal
correlation between beam application and motion which results in the horizontal stripes. For
r = 9 this correlation is strongly reduced and the CTV gets homogeneous. This illustrates that
increasing both the re-scan number and decreasing the intensity by a factor of e.g. two will not
cause those diagonal stripes to disappear if the irradiation time of the IES and the motion cycle
are strongly correlated. Therefore, whenever it is possible the beam angles should be chosen
that the motion of the tumor is perpendicular to the IESs and that the scanning direction is
parallel to the motion direction. As expected, interplay effects get worse for larger amplitudes
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and the measurements indicates that slice-by-slice re-scanning might be of limited use when the
motion amplitudes get large. On the other hand, the simulation results of figure 4.25 show that
breath-sampled re-scanning can even compensate an peak-to-peak amplitude of 5 cm. A general
finding in all experiments and simulations done in the scope of this thesis is that the interplay
effect of smaller amplitudes can be compensated more easily than for larger ones. This is not
surprising because reducing the amplitude more and more will end in the well known static case.
A general expression which states how the dose distributions change with increasing amplitude
is hard to find because it depends strongly on the specific treatment parameters.
2D irradiation: Reducing the size of the field penumbra
The lateral motion of the target still yields in a widespread penumbra (see figures 4.29 and
4.39 b)) and in additional irradiation of healthy tissue. Figure 4.39 displays a proposal how to
optimize the irradiation field in order to reduce the additional dose which is more sophisticated
than a simple geometrical extension of the CTV (Engelsman et al., 2006) to account for lateral
motion. An inhomogenous particle number distribution can spare organ at risk (OAR) in the
presence of motion even if the nominal dose is identical for all rasterpoints inside the CTV.
2D irradiation: Correlation e ects, phase dependence and the statistical nature of
re-scanning
Very surprisingly at first glance, the experiments in figure 4.20 and the corresponding simula-
tions in figure 4.21 display a drop in homogeneity for 5 and 3 re-scans compared to 1 re-scan
in the case of the peak-to-peak amplitude of 1.5 cm and motion direction perpendicular to the
scan path. The reason is that the effect of the vertical stripes are less severe than the correlation
between beam application and motion which results in those thick horizontal lines. These hori-
zontal lines which emerge at low re-scan numbers are very sensitive with respect to the starting
motion phase, intensity and field properties which is also indicated by the rather large error
bars in figure 4.21 where six different motion phases have been used wheres the corresponding
experiments have been measured at a random starting phase. Basically, this explains the differ-
ence between the simulation and the measurements for low re-scan number. Qualitatively (see
figures 4.20 and 4.22), both basically look identical but small deviations can shift the horizontal
lines in or outside the ROI which leads to these deviations. Larger ROIs and the averaging when
using the mean of more different starting phases effect should align the results.
The implication for treatment planning is therefore that precise knowledge about all starting
parameters is needed to do forward calculations which show how a patient can be irradiated
with the largest benefit. It follows that the system should be as reproducible as possible, because
fluctuations will influence the interplay pattern. In real treatment it is favoured that re-scanning
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Figure 4.39.: Optimization of treatment planning in the presence of motion. a) The CTV is as-
sumed to be very close to an OAR. To account for the moving target an ITV has
to be used. b) the standard procedure is to simply extend the spatial dose region
homogeneously to include the motion. Some percentage of the applied dose will
than be shifted inside the OAR. c) Weighting the planned dose distribution by the
use of a probability function of the target results in a non homogeneous target
dose distribution (upper part) which shall spare the OAR in the presence of motion
(lower part) (Muessig et al., 2012).
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starts at a random motion phase because this reduces tumor monitoring efforts and therefore
additional dose from diagnostic devices. The variations in slice-by-slice re-scanning are too large
to ensure satisfying dose homogeneity even for moderate motion amplitudes in case of low re-
scan numbers and scan path being perpendicular to the motion direction. On the other hand,
if motion and scanpath are parallel the homogeneity gets, even for low re-scan numbers, better
than the static measurement19 on the same film. The explanation is that the planned circular
beam profile look sometime more or less elliptical which can lead to small fluctuations in spatial
dose deposition which is compensated by re-scanning. If a distorted beam focus sweeps only
once over the film the homogeneity is of course worse than planned. In the re-scan mode the
pencil beam sweeps many times over the area, the center point of the pencil beam and the beam
focus will be slightly shifted every time, resulting in averaging the dose distribution. Since the
corresponding simulations are computed with perfectly circular beam profiles this effect is not
visible in 4.21.
The statistical nature of re-scanning leads to the fact that there is always some likelihood of
fluctuations. These fluctuations get severe if a correlation between the beam application and
the target motion exists. The conclusion shall not be drawn that r = 5 is in general worse than
no compensation.
Independently to our interference effects for low re-scan numbers it is shown that the aver-
aging effect really begins to start at r = 5. Bortfeld et al. (Bortfeld et al., 2002) showed that
fractionated treatment (see also (Woelfelschneider, 2011)) has a much smaller cumulative error
as the irradiation on a single day which can be described by statistical methods. With the as-
sumption that there is no correlation between beam scanning and target motion in the re-scan
irradiation, their results can be adapted to re-scanning. They calculate that the expected dose
value hDi is a weighted average of the dose distribution without motion. The deviation  D of
a well defined rasterpoint can be expressed as a probability density function f ( D) which will
converge to a Gaussian shape after about five fractions (or re-scans); the width of the distri-
bution is a function of the treatment technique, the motion amplitude and other factors. Their
analysis for a sinusoidal motion yields the following: At a low re-scan number the probability dis-
tribution has two peaks symmetrically distributed around hDi with a high likelihood of getting a
large deviation. For higher re-scan numbers the curve turns into a Gaussian shape with a distinct
peak and a low probability of a large dose deviation. Calculating the foregoing simulations with
breath-sampled re-scanning instead of slice-by-slice re-scanning reveals that the treatment field
reaches already at r = 3 static homogeneity values in case of the most unfavourable parame-
ter set presented above. The large variation in the calculated dose values in figure 4.23 d) for
1 re-scan vanishes abruptly. Therefore breath-sampled re-scanning is very robust compared to
slice-by-slice re-scanning because it minimizes the correlation effects between motion and beam
application.
19 The static measurements have been irradiated without re-scanning.
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A recently published article by Knopf et al. (Knopf et al., 2011) presents simulation results for
proton beam therapy which show only small a dependence on the starting motion phase within
the CTV. This could be due to the fact that they used liver patient data and that they only
investigated three different staring phases wheres the outcome of figure 4.30 was calculated
with 72 different starting phases. Interestingly, the underlying sinusoidal motion characteristics
are transferred into the shape of all the slice-by-slice re-scanning rescan numbers which further
strengthens the statement that target motion and beam application are much more correlated in
case of slice-by-slice re-scanning than for breath-sampled re-scanning. For the breath-sampled re-
scanning numbers 9 and 19, the data points fluctuate randomly around the nominal dose value.
The sinusoidal shape of the slice-by-slice re-scanning curves lead the the following consequence.
If a plan is to be irradiated with a precise starting phase than small deviations related to the
starting phase shall yield only in small deviations of the expected dose. If this statement can
remain valid when using other parameter sets has to be investigated for every single case indi-
vidually. The dose values for breath-sampled re-scanning indicate that the deviations from the
nominal dose value is anyhow very small so that any effort to start the irradiation at a distinct
starting phase seems to be needless.
Phillips et al. (Phillips et al., 1992) and Bortfeld et al. (Bortfeld et al., 2004) predict that re-
scanning improves the dose uniformity roughly as the square root of re-scans. Bortfeld et al. state
that the PDF is lowest at the expected dose value when using only 1 re-scan and that the central
limit theorem transforms the shape of the PDF to a Gaussian centered around the expected
dose value for about 5 re-scans. A central assumption in their works is that no correlation
between beam application and motion shall be present. In the case of 1 re-scan the histograms
displayed in figure 4.31 look for both slice-by-slice re-scanning and breath-sampled re-scanning
like the ones shown in (Bortfeld et al., 2002). Increasing the re-scan number transform the PDF
of breath-sampled re-scanning to a Gaussian shape with very small deviations from the expected
dose value. In contrast, the PDF of slice-by-slice re-scanning even gets broader when comparing
9 re-scans with 19 re-scans leaving the expected dose value with the lowest likelihood. This
is an additional evidence that the correlation between target motion and beam application is
present even when irradiating with higher re-scan numbers in slice-by-slice re-scanning mode.
Therefore the proposed improvement of dose uniformity as being roughly the square root of
re-scans cannot be applied in heavy ion therapy with active beam scanning. Therefore it was not
possible to fit the data points to a curve which reflects the square root behavior.
2D irradiation: Intensity and spill profile dependence
When irradiating static tumors, the intensity level is selected to minimize irradiation time to
a value which can at the same time ensure proper beam monitoring, i.e. position and dose
measurement for safe treatment delivery.. Figure 4.26 c) demonstrates that the intensity level
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can influence the DAH strongly in slice-by-slice re-scanning mode and unfortunately the highest
intensity level at GSI is the one with the worst DAH curve. It follows that the intensity that would
be selected for static treatment is most unfavorable when motion is present. The switching to
lower intensities, which will increase dose coverage, should be easy. Selecting higher intensities,
which will increase the facilities’ efficiency, might require extensive hardware upgrade.
Figure 4.27 displays simulations for the breath-sampled re-scanning mode with an otherwise
identical parameter set to figure 4.26. The intensity level is in this technique adjusted ac-
cording to the motion period, therefore both dependencies are merged into a single one. The
shorter the period the faster the beam application so that each rasterpoint will be irradiated
in the same motion phase, independent of the period. In all cases breath-sampled re-scanning
compensates interplay patterns almost perfectly and reveals almost no dependence on patient-
and machine-specific parameters. This reduction of parameter dependence is immensely im-
portant to guarantee quality assurance of the treatment. Prior to every patient irradiation with
re-scanning with moving tumors, forward calculations have to be performed as to check if the
selected mode results in DVH curves which satisfy the physicians. The input parameters used in
theses simulations will deviate to a certain degree from the actual treatment, therefore a method
- like breath-sampled re-scanning- which is robust with respect to those deviations is desirable.
The temporal beam spill profile is a further source of error. The input sample spill profile
which is used to predict the dose distribution will deviate more or less form the actual used
beam. Figures 4.3.3 and 4.33 display that the fluctuations due to the spill shape are largest when
using only 1 re-scan. For instance, the DAH curves of breath-sampled re-scanning show almost
no dependence with respect to the spill shape when using 5 re-scans because the statistical
averaging effect of re-scanning already smoothes the influence of spikes in the spill profiles. The
difference between the two chosen spills, used in this calculations, will most likely be much
larger than the difference between two spills of a reliable therapy system. Therefore a sample
spill which reflects the average properties shall be well suited to perform forward calculations
in the breath-sampled re-scanning mode.
To summarize:
• Breath-sampled re-scanning reduces interplay effects much more efficiently as slice-by-slice
re-scanning. In addition, breath-sampled re-scanning is far less dependent on all investi-
gated parameters like amplitude, re-scan number, motion period, intensity and spill profile.
3D irradiation of phantoms
The simulation data of figures 4.35 and 4.34 are in both cases better than the experimental
results. This is not surprising since the simulation is not affected by the uncertainty of experi-
mental parameters which are numerous in such measurements. For instance, its homogeneity
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value in for the static dose distribution depends only on the optimization process and the dose
calculation algorithm and is generally very close to 1 as seen in section 4.3.3.
Actually one has to mention another source of uncertainty. Some pin points have not been
considered in the calculation. As mentioned in section 4.2.7, these are the pin points which lie
very close to sharp dose gradients so that even small set up errors can lead to large differences in
dose measurement. This means that the most distal IES slices are not included in the calculation
of the homogeneity, but exactly these slices are subjected to the largest interplay effects because
they do not benefit from the intrinsic re-scanning effect due to pre-irradiation. On the other
hand, the irradiated 2D plans of section 4.3.3 are basically the equivalent of the most distal IES
slice of a 3D plan and there it could be shown that re-scanning was able to reduce interplay
pattern very efficiently, too.
Due to limited availability of beam time and an increasing level of complexity much more
measurements have been performed in slice-by-slice re-scanning mode than in breath-sampled
re-scanning. The measurement of the breath-sampled re-scanning mode is very promising. All
simulations show that breath-sampled re-scanning is by far less dependent on parameters like
starting phase etc., so that uncertainty of a single breath-sampled re-scanning dataset is certainly
much smaller than in case of the slice-by-slice re-scanning mode.
In case of the DeVarPho the detector head and the phantom do not have relative motion. Such
a setup would perhaps not be appropriate when performing experiments with beam tracking or
gating, because both techniques rely on the time dependent position information of the detector
head relative to the phantom. The presented case would therefore be closer to a periodical mo-
tion of the whole patient during treatment. Since re-scanning does not need any time dependent
position information of the detector head this experiment was a sensible choice when making
re-scanning experiments. One plan with different CT phases was optimized with the goal that
re-scanning should be able to deliver satisfying dose distribution to all motion phases, therefore
it does actually not matter if the motion of the detector head is relative (as it had been in case
of the BreThoPho phantom) or parallel to it.
To summarize:
• The demands for re-scanning to effectively reduce interplay effects in case of the used 3D
phantoms can be compared to those of real patients. Therefore the results of section 4.3.3
are quite promising and suggest that re-scanning shall be a sensible treatment option for
moving tumors.
4.5 Conclusion
This chapter shows that re-scanning is an option to treat moving tumors with carbon ions at HIT
and at GSI20.
20 Patient treatment stopped at GSI in the year 2008.
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Dosimetry measurements showed that these new irradiation modes can deliver dose distribu-
tion to the static target which are well inside limits of the ICRU-50 (ICRU, 1993) bench marks,
which aim a dose coverage of the target volume between 95% and 107% of the prescribed
dose. It was illustrated that interplay effects are reduced more efficiently in breath-sampled
re-scanning mode. Breath-sampled re-scanning shows only very little dependence on treatment
parameters like amplitude of motion, breathing period and spill shape. In case of breath-sampled
re-scanning, static homogeneity quality is almost reached for r = 5 for a peak-to-peak amplitude
of 5 cm and the uncertainty is greatly reduced compared to slice-by-slice re-scanning. It follows
that simulated dose distributions for breath-sampled re-scanning irradiation will only slightly de-
viate from irradiated ones, which is very important if a physician needs to judge the outcome of
a patent treatment on the basis of simulations. It is even possible to combine re-scanning with
gating and with beam tracking as improve their outcome.
To conclude:
• Breath-sampled re-scanning is a very promising technique to treat moving tumor with car-
bon ions and showed that it can efficiently reduce interplay patterns. It is easier to im-
plement than beam tracking and can therefore be the one of the first options at facilities
which use heavy ions treatment. If the interlock mask at HIT is changed to enable breath-
sampled re-scanning irradiation with an active position feedback loop it shall be possible
and sensible to treat patients with moving tumors in the clinic in the near future.
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5 Discussion and summary
The re-scanning method has been assessed via simulations in a patient treatment study (chapter
3) and via experiments performed at GSI Helmholtzzentrum für Schwerionenforschung GmbH
(GSI) and Heidelberg Ion-Beam Therapy Centre (HIT) (chapter 4). This chapter shall provide a
summarizing discussion including an outlook on possible research directions.
Intensity modulated radiotherapy (IMRT) as well as intensity modulated particle therapy
(IMPT) aim to deliver the dose as conformal as possible to the tumor in order to reduce the
integral dose to the body and especially to the organs at risk (OARs) (Durante and Loeffler,
2013). The corresponding treatment fields got more complex (Krämer and Durante, 2010) and
the applied radiation fluence is usually a function of space and time F = F(~r, t) to facilitate a
very conformal tumor irradiation.
Hence, interference effects can emerge if moving tumors (e.g., in the lung) are treated with
scanned ion particle beams (Phillips et al., 1992). As a consequence, the dose distribution of
a tumor can exhibit sub-volumes with under- and overdosage. This effect, which is also called
interplay, is most severe if the beam application and the intra-fractional tumor motion happen on
a comparable time scale (Rietzel and Bert, 2010), which unfortunately is the case with existing
therapy systems (Rietzel and Bert, 2010; Furukawa et al., 2010a).
Especially in scanning particle therapy, these interplay effects get so severe in case of thoracic
tumors that, up-to date, almost no center performs treatments. Exceptions are the Rinecker
Proton Therapy Center (RPTC) in Munich that uses apneic oxygenation to allow treatments
of tumors in the thorax and upper abdomen (Bert and Durante, 2011) and, recently, the MD
Anderson Cancer Center (MDACC) in Texas (MDACC, 2013). Both clinics only treat indications
with rather small motion amplitudes.
Hence, techniques which mitigate the effects of tumor motion to the dose distribution are in
the focus of many research groups (Bert and Durante, 2011). The most prominent techniques
are:
• Re-scanning: This method is investigated in the scope of this thesis, but is also studied
by other research groups (Seco et al., 2009; Zenklusen et al., 2010; Mori et al., 2013).
Re-scanning is based on statistical averaging. Repeated applications of the treatment field
reduce dose inhomogeneities as to facilitate patient treatment in presence of tumor mo-
tion. The total number of repetitions is called the re-scan number r. Re-scanning exists
in various flavors (see sections 2.3.6 and 3.2.1) which differ in the efficiency to reduce
interplay patterns and the technical application complexity. Re-scanning is technically less
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complex and hence easier to implement in an existing therapy system than the other meth-
ods mentioned below. The re-scanning techniques investigated in the scope of this thesis
do not require spatio-temporal knowledge of the tumor position during treatment which
makes this method especially suitable for patients with non-periodic motion trajectories.
The drawback is the loss of tumor conformity because the corresponding internal target
volume (ITV) (Graeff et al., 2012) needs to cover the clinical target volume in all motion
states.
• Gating: This technique aims to irradiate the tumor only when its location is in or close
to the exhale state which can increase the treatment time considerably. In this position
the tumor motion is greatly reduced which decreases the interplay effects. In general, the
motion monitoring of the tumor causes additional dose to the patient but compared to
re-scanning the tumor conformity is increased since the ITV can be decreased. Uncertain-
ties are being induced because the position of the tumor cannot be located with absolute
precision (Steidl, 2011). Gating is currently already used in passive particle beam delivery
(Miyamoto et al., 2003) and intensity modulated radiotherapy (IMRT) (Keall et al., 2006).
The first liver patients have recently been treated with a particle scanning system at HIT
by using gating (Richter, 2012).
• Beam tracking: This technique is technically the most challenging approach. It needs pre-
cise spatio-temporal knowledge of the tumor’s location. The beam positions are adapted
to the tumor motion and, in principle, the tumor can be irradiated as conformal as without
motion. The beam adaption cannot be performed instantly and with perfect spatial preci-
sion which might violate accurate dose application (Eley, 2013). Recently, a 4D treatment
planning concept that considers motion during particle number optimization was imple-
mented at GSI (Graeff et al., 2013; Eley, 2013). By using this method, an even better
sparing of OARs is possible.
In the scope of this thesis, patient simulations with scanned carbon ion beams were per-
formed by using slice-by-slice, volumetric, mixed-scanpath, local-parameter, random-time-delay
and breath-sampled re-scanning (see chapter 3). The aim was to investigate which technique
can most efficiently reduce the interplay patterns in the presence of motion.
The MDACC kindly provided the time resolved computed tomography (4DCT) data of the five
lung cancer patients which were used in the study. The patients in the study covered a tumor
motion range from 1mm to 25mm. The investigation was based on a fractionation scheme
applied in passive carbon radiotherapy at National Institute of Radiological Sciences (NIRS)
(Miyamoto et al., 2007). The treatment planning approach in this works mimics the case that
a patient is being irradiated with four different fields on a single day. Based on the clinical
findings at NIRS, the relative biological effectiveness (RBE) weighted dose for one fraction was
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calculated using local effect model (LEM) to be 17.70 Gy(RBE). The dose per field was the
fraction dose divided by the number of fields (Woelfelschneider, 2011; Lüchtenborg, 2012).
Different measures were used to judge the quality of the simulations results of the different
re-scanning modes inside the clinical target volume (CTV). The dose coverage was evaluated
by V951, the overdose via V107 and the homogeneity by D5  D952. The different measures were
tested by using the Kruskal-Wallis test in combination with the Wilcoxon–Mann–Whitney test at
a significance level of ↵= 5%.
At first, 4D dose distribution for all five patients and all re-scan modes were calculated over
a broad range of parameters which should cover almost all relevant clinical situations. The
influence of different re-scan numbers r, various breathing periods or changing starting phases
were investigated in the presence of tumor motion.
It was shown that a larger motion amplitude> 5mm results in less target coverage which can-
not be efficiently compensated by slice-by-slice, volumetric, mixed-scanpath and local-parameter
re-scanning even for higher re-scan numbers because the correlation between tumor motion and
beam application cannot be broken up efficiently.
On the other hand, breath-sampled and random-time-delay re-scanning compensate the motion
effects very well. In case of all patients breath-sampled and random-time-delay re-scanning reach
mean values of V95 = 100% and V107 = 0% for r   9 and r   17, respectively. Consequently,
both methods also yielded the lowest D5 D95 values. The D5 D95 analysis shows that the dose
distribution can get nearly as homogeneous as in the static case without motion, if the re-scan
number is chosen appropriately (r   17). The corresponding significance analysis shows that
breath-sampled re-scanning turns out to be the best and random-time-delay re-scanning to be the
second best re-scanning mode.
The reason might be that those two techniques exhibit an extra feature which was merely
introduced to break up a possible synchronicity between beam application and tumor motion.
In case of breath-sampled re-scanning the irradiation of each iso-energy slice (IES) is matched
to the breathing period and in case of random-time-delay re-scanning a predefined number of
random-pauses is integrated in the irradiation process.
The robustness of the two modes was also investigated. In case of breath-sampled re-scanning,
the irradiation duration was varied so that the perfect matching with the breathing period was
no longer valid. In case of random-time-delay re-scanning, the number and the maximum length
of the random-pauses were varied.
In case of a period mismatch of 0.5 s - 1 s, the measures of breath-sampled re-scanning de-
graded but still stayed on a level which clearly outperforms the corresponding values of slice-by-
slice, volumetric, mixed-scanpath and local-parameter re-scanning. Further investigations (e.g., a
1 Vx : A dose of at least x% of the target dose has been received by the volume Vx
2 Dx : x% of the volume under consideration has received a dose of at least Dx
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finer time spacing) with respect to the period mismatch seem worthwhile. Random-time-delay
re-scanning turned out to be very robust with respect to the investigated uncertainties.
Overall, both random-time-delay re-scanning and breath-sampled re-scanning yield excellent
results with respect to reducing interplay effects in the presence of motion. These two modes
should be the first choice when clinics aim to compensate tumor motion by re-scanning.
Due to the same 4DCT data set and the identical simulation environment (TReatment plan-
ning for Particles (TRiP)), the results of this thesis can be compared in a very instructive way
with other studies of the medical physics group at GSI which investigated beam tracking (Lücht-
enborg, 2012; Eley, 2013).
Breath-sampled and random-time-delay re-scanning show better dose coverage measures of
the CTV than any beam tracking flavor. On the other hand, the tumor conformity of re-scanning
can certainty be increased if the technique is used in combination with gating or beam tracking
which will be most beneficial of organ at risk (OAR) could be spared.
Mori et al. (Mori et al., 2013) recently published results of method called phase-controlled
re-scanning (Furukawa et al., 2010a). This is a combination of gating and re-scanning which
reduces the size of the ITV in contrast to using only re-scanning. They performed a study, with
phantoms and the 4D data set of one patient (lung tumor patient, motion amplitude of 13mm),
which showed that slice-by-slice re-scanning was not able to improve the dose distributions for
an increasing number of re-scans. This confirms the results of this work, namely, that slice-by-
slice re-scanning is not always able to break up the correlation between beam application and
target motion. On the other hand phase-controlled re-scanning could improve the dose distri-
butions efficiently. The patient study, using the phase-controlled re-scanning technique, shows
less improvement of the dose distributions than the corresponding results (i.e., similar motion
amplitude and re-scan number) presented in this work in case of breath-sampled or random-time-
delay re-scanning. This deviation might be due to the fact that the treatment planning studies
in this work include the usage of four fields from different directions whereas Mori et al. use
a single field approach. It was already reported by Knopf et al. (Knopf et al., 2011) that an
increasing number of fields has the capability to improve the dose distribution as multiple field
also provide additional averaging
It seems especially worthwhile to perform extensive studies in the future which investigate if
re-scanning could improve the dose homogeneity of beam tracking. It is shown that even perfect
beam tracking causes dose inhomogeneities when irradiating heterogeneous targets (van de
Water et al., 2009; Eley, 2013; Lüchtenborg, 2012). Due to the statistical averaging effect, it
can be expected that the combination of re-scanning and beam tracking might lead to a robust
and homogeneous dose distributions along with a greatly reduced ITV.
In addition, in the scope of this thesis slice-by-slice (at GSI and at HIT) and breath-sampled
re-scanning (at HIT) were also successfully implemented in a research version and irradiations
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with carbon ions were performed. Compared to the normal therapy mode, re-scanning sets
higher demands on the beam irradiation system because the pencil beam moves much faster
over the irradiation volume. This might cause errors with respect to dosimetry and the beam
application in general (e.g., position accuracy). Therefore, dedicated experiments were planned
and performed to validate if satisfying dose application is possible with this new technique.
Furukawa et al. (Furukawa et al., 2010b) also cared about the influence of position, size, time
and structure of the beam, saturation of the electrons or recombination effects when irradiating
in high speed mode with sub millisecond delivery time of each rasterpoint. They successfully
implanted re-scanning and found their system to be able to deliver the dose with satisfying
quality for r = 8. They did not observe recombination effects of more than 1% with their beam
monitoring system. The precision of their scanned beam position was less than 0.5mm.
At GSI and at HIT, the position feedback loop and the corresponding interlocks had to be
switched off because the re-scanning irradiation is too fast for those measurements. In normal
therapy mode, positioning errors of the pencil beam are detected by the therapy control unit
(TCU) and the beam can be shifted by the magnets with the help of the position feedback loop
to the prescribed position.
The implementations were tested by slice-by-slice and breath-sampled re-scanning irradiations
with different re-scan numbers. At first, the experiments were performed without the presence
of motion as to isolate the effects of the new techniques.
The physical-beam-plans (PBP) could successfully be irradiated. Due to the deactivation of
the position feedback loop, the maximum mean radial position error was detected to be 2.9mm
inside the TCU system. In normal therapy mode, deviations of this order would be in the
acceptable range inside the TCU detection system because the fine-tuning is done by the position
feedback loop along with the beam steering magnets. Hence, re-scanning irradiation dose not
overload the system in case of the investigated re-scan numbers. The maximum error was
measured at r = 1 (rmax = 19 in this experiment) which basically exhibits the same scanning
speed as normal therapy mode. The corresponding dose levels were also measured by the TCU
devices. The dose slightly increased with an increasing re-scan number but all values were
within 1% to the prescribed dose.
As a next step, it was investigated, if the dose levels in the isocentre are also in accordance
with normal therapy mode. The measurements of all the gas filled ionisation chambers showed
relative errors smaller than±3%when irradiated in slice-by-slice re-scanningmode with a re-scan
number up to r = 19 and a 2D plan.
Then, experiments have been designed which also included a moving target as to study the
efficiency in reducing interplay patterns by using slice-by-slice and breath-sampled re-scanning.
In case of each experiment setup, a simulation environment was created (see section 3.2.1 and
4.2.7) to mimic the experiment and to check if the findings of simulations and experiments are
in accordance.
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For this purpose Kodak X-Omat V films were irradiated with 2D plans in slice-by-slice re-
scanningmode in the presence of motion studying the following parameters: Amplitude, period,
starting phase, intensity, scanpath and spill profile shape. The corresponding investigations in
the breath-sampled re-scanning mode were only assessed via simulations which were designed
as to mimic the experimental setup. The experiments were in accordance with the simulations.
This was expected because the capability of our simulation environment TRiP was already testet
and validated elsewhere (see (Richter, 2012; Krämer and Durante, 2010; Bert et al., 2010)).
The experiments showed that slice-by-slice re-scanning efficiently reduces interplay patterns
due to motion when irradiating 2D plans. Interplay effects are being compensated faster if the
motion is in parallel to the primary scanpath. The larger the motion amplitude the stronger are
the interplay patterns. The corresponding simulations showed that breath-sampled re-scanning
reduces interplay patterns much faster than slice-by-slice re-scanning and shows less dependence
on the investigated parameters.
To mimic real patient treatment more closely, two heterogenous phantoms (see section 4.2.5
and (Steidl et al., 2012a)) were irradiated with 3D plans. Appropriate ITVs (Graeff et al., 2012)
were generated to account for the motion. The detectors moved sinusoidally in horizontal direc-
tion with an amplitude of 2 cm peak-to-peak. The period was chosen to be 4 s. Experiments and
simulations showed that interplay effects for both phantoms have been efficiently reduced by
slice-by-slice and breath-sampled re-scanning. In experiments and in simulations breath-sampled
was superior to slice-by-slice re-scanning.
It follows that the therapy systems at HIT and GSI show no technical objections against a
re-scan implementation under therapy conditions. On all accounts, the position feedback loop
needs to be adapted to high-speed re-scanning irradiation so that the beam position can be
corrected during treatment. Figure 5.1 illustrates in a schematic way how the position cor-
rection might be influenced by the re-scan irradiation. Figure 5.1 a) represents the case of
standard patient irradiation. A rasterpoint is irradiated and after a predefined time TPCL
(position-correction-loop-reaction-time) the pencil beam can be shifted to the prescribed lat-
eral position. In this example, 75% of the prescribed dose can be delivered to the corrected
position. Figure 5.1 b) shows the same process for a rasterpoint in case of r = 2. The relativ
fraction of the particles which are shifted due to the information of the position feedback loop
has decreased to 50 %. In Figure 5.1 c) the system is not able to correct the pencil beam position
at all. The influence of this effect needs to be investigated further and to be considered when
defining new parameters and limits for the position feedback loop.
Further research efforts should also include the implementation and investigation of random-
time-delay re-scanning in experiments since it showed very promising results in the treatment
planning studies (chapter 3). For example, at HIT its implementation could be imagined in
the following way which makes use of the existing gating functionality. The physical-beam-
plan (PBP) is to be irradiated in slice-by-slice re-scanning mode. Then, a gating signal, which is
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Figure 5.1.: The relative fraction of the particles of a rasterpoint which are corrected with re-
spect to their lateral position due to the information of the position feedback loop
decreases with the number of re-scans .
no longer coupled to the motion state, is send after a pre-defined irradiation progress. If the
lengths of the gating pauses are produced by the use of a random number generator then this
combination corresponds to the random-time-delay re-scanning flavor investigated in this thesis.
Moreover, a method should be implemented that accounts for changes in the breathing period
when using breath-sampled re-scanning. So far, the intensity is pre-defined according to a given
period. The breathing of a real patient might deviate from the planning breathing period or be
subjected to a tendency towards a longer or shorter period. The corresponding motion patterns
could be assessed via motion monitoring systems (Evans, 2008; Steidl, 2011) and the intensity
could be adapted by sending signals to a radio-frequency-knock-out-exciter (Schoemers et al.,
2011) in order that the irradiation time per IES gets again more aligned to the breathing period.
Even if the technical feasibility was investigated for a broad range of re-scan numbers, it is not
guaranteed that the systems will still work properly if the re-scan number needs to be increased
even further. Up to now, no real patient plan was irradiated in re-scanningmode. In general, the
PBPs of patients exhibit large dose gradients. It needs to be investigated if this will introduce
uncertainties in the beam application. In addition, the systems at GSI and at HIT have a defined
minimal particle limit Nmin. This basically means that irradiations will not be executed if a
single rasterpoint has a prescribed particle number which is smaller than Nmin. A rather high
re-scan number in combination with a standard fraction schema of 2Gy/day might fall below
this limit. Therefore, further measurements need to be performed before patient treatment in
the re-scanning mode can begin.
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Including the findings of chapter 3 it is likely that a re-scan number of about r = 9 shall be suf-
ficient when treating lung tumors in the breath-sampled or random-time-delay re-scanning mode
in a four field scenario. This is well inside the experimentally investigated re-scan numbers.
If clinics try to implement re-scanning in the therapy workflow it would be desirable that prior
to each treatment the resulting dose distribution is being simulated with the motion charac-
teristics of the patient’s tumor. It is important to investigate if the specific treatment plan of a
patient and the beam application may result in dose inhomogeneities due to an unlucky combi-
nation of the used parameters. For instance, in case of r = 9 the simulation results of patients 5
(see figure 3.14) showed satisfying dose coverage in 9 out of 12 cases. Therefore, a dedicated
pre-irradiation simulation environment in the clinical environment might be necessary to detect
outcomes with an unacceptable dose distribution. In addition, especially for fractionated dose
delivery, the quality assurance should incorporate 4D dose reconstruction based on the treat-
ment records. Richter et al. showed the technical feasibility of such a process for liver patients
treated with abdominal compression or gating at HIT (Richter et al., 2013).
Moreover, it must be stated that the experimental and simulation results obtained in the scope
of this theses may not easily be transferred to other particle therapy systems. The efficiency in
reducing the interplay effect in scanned particle therapy is highly depend on the individual
combination of patient specific parameters and the beam application system.
This statement is also confirmed by the findings of a group from the Massachusetts General
Hospital (MGH) (Dowdell et al., 2013). Via 4D Monte Carlo simulations, they studied the
interplay effect in scanning proton therapy for lung cancer patients. They investigated the de-
pendencies of the dose distribution with respect to the beam delivery parameters and state that
the initial breathing phase can have a significant effect on the interplay patterns - particularly for
shorter delivery times. This is in accordance with the findings in this work. They further report
that increasing the spot size of the beam will decrease the interplay patterns - similar studies
were performed at GSI for liver cancer patients (Richter, 2012). However, this procedure will
result in less tumor conformity.
If a system provides gating or beam tracking functionality studies which combine any of these
modes with re-scanning shall be made in order to investigate which individual technique or
which combination of the methods will be most beneficial with respect to therapeutic consider-
ations.
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6 Conclusion
In the field of radiotherapy, heavy ion scanned particle therapy provides the best ratio of sparing
healthy tissue versus damaging tumor cells when treating stationary tumors. Thus, carbon
ion therapy has become a popular treatment option for some indications in the recent years.
Currently, only tumors which exhibit very small motion amplitudes are being treated at a few
therapy centers since the interaction of tumor motion and scanned beam application is likely to
cause severe interference patterns. This so called interplay effect jeopardizes a uniform delivery
of the prescribed therapeutic dose across the whole tumor volume.
Repeated application of the treatment dose within a therapy fraction has been shown to ef-
ficiently reduce such over- and underdosing of subvolumes within the tumor due to statistical
averaging. The corresponding treatment fields need to be enlarged to cover all motion phases
of the tumor. This approach, which exists in various flavors, is called re-scanning. The main dif-
ference between the modes is the spatial-temporal behavior of the scanned pencil beam which
delivers the dose in localized packets across the tumor volume. Within the scope of this the-
sis, the possible dosimetric benefit of six different re-scanning modes has been assessed. These
treatment planning studies were based on time resolved computed tomography (4DCT) data of
five lung cancer patients.
The 4D dose distributions were calculated with the GSI treatment planning software TReat-
ment planning for Particles (TRiP). The studies were performed by incorporating a wide range
of realistic motion related parameters which cover typical lung tumor cases. For all five pa-
tients, two techniques, called breath-sampled and random-time-delay re-scanning, could increase
the dose application quality to a level which shall enable successful treatment of lung tumor
patients in the future. Especially random-time-delay re-scanning was very robust with respect to
treatment related uncertainties.
In addition, research versions of slice-by-slice and breath-sampled re-scanning were imple-
mented, tested and verified at GSI Helmholtzzentrum für Schwerionenforschung GmbH (GSI)
and Heidelberg Ion-Beam Therapy Centre (HIT). First, it was investigated if these new tech-
niques, which greatly increase the scanning speed of the pencil beam, could technically be
applied with acceptable dosimetric outcomes. The measurements showed that a re-scan imple-
mentation in the therapy workflow should technically be possible. However, some function-
alities, which guarantee safe and precise dose application, like the position monitoring of the
pencil beam, still need to be adjusted to the increased demands of the re-scanning functionality.
Second, the efficiency of re-scanning with respect to reducing dose inhomogeneities in the pres-
ence of motion was assessed by irradiating radiographic films and phantoms. Both, slice-by-slice
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and breath-sampled re-scanning were able to reduce dose inhomogeneities significantly, whereas
the latter showed better results.
Further investigation of the re-scanning method, especially on the experimental side, will be
needed before this technique can be used in patient treatment. Nevertheless, re-scanning shows
very promising results and it can be expected to enable the treatment of moving tumors with
scanned particle beams in the near future.
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A Appendix of chapter 3
Results and additional information of the treatment planning studies chapter which have not
been not presented in the text are shown here.
A.1 Results
The captions of many of the following tables will be identical. In order to make the presentation
more compact, the captions are presented right now. A reference is than displayed under each
table so that the appropriate caption can be easily found.
A.1.1 Caption: Mean and standard deviations of the Vx or D5 D95 measures along with
the corresponding significance tests
Mean and standard deviations of the Vx or D5   D95 measure, respectively. The results are
calculated for the whole treatment course and for different re-scan modes as a function of the
re-scan number.
The corresponding significance test shall be interpreted as follows: The re-scan modes were
labeled with numbers (e.g. slice (1)) in the table for presentation purposes. If the number of a
certain re-scan mode is listed in the column of any other re-scan technique within the same row
- than these modes differ significantly. For this purpose, the Wilcoxon-Mann-Whitney-Test and
the Kruskal-Wallis-Test have been used at the 5% level.
A.1.2 Caption: Breath-sampled re-scanning uncertainty: Mean and standard deviations of
the Vx or D5 D95 measures along with the corresponding significance tests
Mean and standard deviations of the Vx or D5   D95 measure, respectively. The results are
calculated for the whole treatment course. The dose distribution was investigated for a possible
mismatch between the breath-sampled re-scanning spill extraction time per iso-energy slice (IES)
(varying from 1 s to 5 s) and the breathing period of the patient (4 s) as a function of the re-scan
number.
The corresponding significance test shall be interpreted as follows: The irradiation periods
were labeled with numbers (e.g. 1s(1) or 3.75s(4)) in the table for presentation purposes. If
the number of a certain period is listed in the column of any other period within the same row
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- than these results differ significantly. For this purpose, the Wilcoxon-Mann-Whitney-Test and
the Kruskal-Wallis-Test have been used at the 5% level.
A.1.3 Caption: random-time-delay re-scanning uncertainty: Mean and standard
deviations of the Vx or D5 D95 measures along with the corresponding
significance tests
Mean and standard deviations of the Vx or D5   D95 measure, respectively. The results are
calculated for the whole treatment course. The dose calculations are obtained in case of a
different number of random-pauses or a different length of the maximum random-pause. as a
function of the re-scan number.
The corresponding significance for the number random-pauses test shall be interpreted as
follows: The number of the random-pauses were labeled with numbers (µrandom = 0.05(1)) in
the table for presentation purposes. If the number of a certain random-pause is listed in the
column of any other random-pause within the same row - than these results differ significantly.
The corresponding significance for the maximum length of random-pauses test shall be in-
terpreted as follows: The maximum length of the random-pauses were labeled with numbers
(Trandom, max = 1 s(1)) in the table for presentation purposes. If the maximum length of a cer-
tain random-pause is listed in the column of any other random-pause within the same row - than
these results differ significantly.
For this purpose, the Wilcoxon-Mann-Whitney-Test and the Kruskal-Wallis-Test have been used
at the 5% level.
A.1.4 Standard cases: Figures, mean V95, V107 D5  D95 values along with corresponding
significance testing
Patient 1
patient 1 V95 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 98.4 (0.6) 98.3 (0.5) 98.1 (0.8) 98.3 (0.6) 99.5 (0.2) 98.4 (0.2)
3 99.7 (0.2) 99.4 (0.5) 99.6 (0.3) 99.6 (0.3) 99.8 (0.1) 99.9 (0.0)
5 99.7 (0.2) 99.7 (0.2) 99.8 (0.2) 99.7 (0.2) 99.9 (0.0) 100.0 (0.0)
9 99.8 (0.2) 99.7 (0.2) 99.8 (0.2) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
13 99.9 (0.1) 99.8 (0.1) 99.8 (0.2) 99.8 (0.1) 100.0 (0.0) 100.0 (0.0)
17 99.8 (0.2) 99.8 (0.2) 99.8 (0.2) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
21 99.8 (0.2) 99.8 (0.0) 99.8 (0.2) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
Table A.1.: Patient 1 (caption: see section A.1.1)
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patient 1 V95 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5 5 5 5 1/2/3/4/6 5
3 6 5/6 6 6 2 1/2/3/4
5 6 5/6 6 5/6 2/4 1/2/3/4
9 6 5/6 6 6 2 1/2/3/4
13 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
17 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
21 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
Table A.2.: Patient 1 (caption: see section A.1.1)
patient 1 V107 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 0.3 (0.1) 0.3 (0.1) 0.3 (0.1) 0.3 (0.1) 0.0 (0.0) 0.2 (0.1)
3 0.0 (0.0) 0.1 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
5 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
17 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
21 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.3.: Patient 1 (caption: see section A.1.1)
patient 1 V107 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5 5 5 5 1/2/3/4/6 5
3 5/6 6 6 2 2/3/4
5 5/6 6 2 2/4
9 4/5/6 2 2 2
13 5/6 2 2
17 2 1/4/5/6 2 2 2
21 5/6 2 2
Table A.4.: Patient 1 (caption: see section A.1.1)
patient 1 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans slice vol mixed local random BS
1 7.1 (0.9) 7.1 (0.8) 7.3 (0.5) 7.1 (0.8) 5.7 (0.3) 7.4 (0.2)
3 5.1 (0.5) 5.5 (1.1) 5.2 (0.7) 5.3 (0.6) 4.5 (0.1) 3.8 (0.0)
5 4.8 (0.7) 5.1 (0.7) 4.7 (0.8) 5.0 (0.7) 3.9 (0.2) 3.1 (0.0)
9 4.5 (0.8) 4.9 (0.7) 4.6 (0.8) 4.7 (0.7) 3.5 (0.1) 2.7 (0.1)
13 4.4 (0.8) 4.8 (0.5) 4.6 (0.8) 4.4 (0.7) 3.1 (0.1) 2.5 (0.0)
17 4.4 (0.8) 4.8 (0.6) 4.5 (0.9) 4.4 (0.8) 3.0 (0.1) 2.5 (0.0)
21 4.4 (0.8) 4.7 (0.4) 4.6 (0.9) 4.5 (0.8) 2.9 (0.1) 2.5 (0.0)
Table A.5.: Patient 1 (caption: see section A.1.1)
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patient 1 D5 D95 significance test [% prescribed dose]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5 5 5 5 1/2/3/4/6 5
3 6 6 6 5/6 4 1/2/3/4
5 6 5/6 6 5/6 2/4 1/2/3/4
9 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
13 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
17 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
21 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
Table A.6.: Patient 1 (caption: see section A.1.1)
Patient 2
Figure A.1.: V95 and V107 values for the di erent re-scan modes as a function of the re-scan num-
ber in case of patient 2. The V95 is a measure of the dose coverage and the V107 of
the overdose, respectively. Every case consist of twelve data points (due to the vari-
ation of the starting phases and the breathing periods) which might not be visible
due to clustering of the points when increasing the re-scan number.
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Figure A.2.: The D5   D95 values for the di erent re-scan modes as a function of the re-scan
number in case of patient 2. The D5   D95 is a measure of the homogeneity. Every
case consist of twelve data points which might not be visible due to clustering of the
points when increasing the re-scan number.
patient 2 V95 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 96.6 (0.8) 96.3 (0.8) 95.0 (1.1) 96.4 (0.8) 98.3 (0.4) 96.5 (0.5)
3 99.4 (0.3) 99.3 (0.4) 99.3 (0.4) 98.9 (0.4) 99.8 (0.1) 99.9 (0.0)
5 99.6 (0.2) 99.5 (0.4) 99.7 (0.2) 99.4 (0.4) 99.9 (0.1) 100.0 (0.0)
9 99.8 (0.2) 99.5 (0.2) 99.9 (0.1) 99.7 (0.2) 100.0 (0.0) 100.0 (0.0)
13 99.8 (0.2) 99.5 (0.3) 99.8 (0.1) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
17 99.8 (0.2) 99.5 (0.3) 99.9 (0.1) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
21 99.8 (0.2) 99.4 (0.4) 99.9 (0.1) 99.8 (0.2) 100.0 (0.0) 100.0 (0.0)
Table A.7.: Patient 2 (caption: see section A.1.1)
patient 2 V95 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 3/5 5 1/5/6 5 1/2/3/4/6 3/5
3 6 6 6 5/6 4 1/2/3/4
5 6 6 6 5/6 4 1/2/3/4
9 6 5/6 6 5/6 2/4 1/2/3/4
13 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
17 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
21 5/6 5/6 6 5/6 1/2/4 1/2/3/4
Table A.8.: Patient 2 (caption: see section A.1.1)
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patient 2 V107 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 0.7 (0.3) 0.6 (0.2) 1.2 (0.3) 0.7 (0.2) 0.2 (0.1) 0.7 (0.2)
3 0.1 (0.0) 0.1 (0.1) 0.1 (0.1) 0.1 (0.1) 0.0 (0.0) 0.0 (0.0)
5 0.0 (0.0) 0.1 (0.1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.2 (0.1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.2 (0.1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
17 0.0 (0.0) 0.2 (0.1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
21 0.0 (0.0) 0.2 (0.1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.9.: Patient 2 (caption: see section A.1.1)
patient 2 V107 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 3/5 3/5 1/2/5 5 1/2/3/4/6 5
3 6 6 6 5/6 4 1/2/3/4
5 6 5/6 5/6 2/4 1/2/4
9 2 1/3/4/5/6 2 2 2 2
13 2 1/3/4/5/6 2 2 2 2
17 2 1/3/4/5/6 2 2 2 2
21 2 1/3/4/5/6 2 2 2 2
Table A.10.: Patient 2 (caption: see section A.1.1)
patient 2 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans slice vol mixed local random BS
1 9.0 (0.4) 9.0 (0.3) 9.9 (0.4) 9.1 (0.4) 7.5 (0.3) 9.1 (0.3)
3 6.2 (0.5) 6.0 (0.8) 6.2 (0.6) 6.8 (0.4) 5.4 (0.1) 4.5 (0.1)
5 5.4 (0.8) 5.4 (1.1) 5.2 (0.7) 5.8 (0.6) 4.5 (0.4) 3.3 (0.1)
9 4.9 (0.8) 5.8 (0.4) 4.7 (0.8) 4.9 (0.9) 3.6 (0.2) 2.1 (0.1)
13 4.8 (0.9) 5.5 (0.9) 4.8 (0.8) 4.8 (0.9) 3.2 (0.1) 1.9 (0.0)
17 4.7 (0.9) 5.4 (1.0) 4.6 (0.8) 4.8 (0.9) 2.8 (0.1) 1.9 (0.0)
21 4.7 (0.9) 5.5 (1.2) 4.6 (0.8) 4.7 (0.8) 2.5 (0.1) 1.8 (0.0)
Table A.11.: Patient 2 (caption: see section A.1.1)
patient 2 D5 D95 significance test [% prescribed dose]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 3/5 3/5 1/2/4/5 3/5 1/2/3/4/6 5
3 6 6 6 5/6 4 1/2/3/4
5 6 6 6 5/6 4 1/2/3/4
9 6 5/6 6 5/6 2/4 1/2/3/4
13 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
17 5/6 5/6 6 5/6 1/2/4 1/2/3/4
21 5/6 5/6 6 5/6 1/2/4 1/2/3/4
Table A.12.: Patient 2 (caption: see section A.1.1).
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Patient 3
patient 3 V95 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 90.3 (3.1) 90.3 (3.4) 89.1 (2.8) 90.0 (3.3) 96.5 (2.3) 95.7 (1.2)
3 96.1 (1.8) 98.7 (1.5) 95.0 (2.2) 95.7 (1.7) 98.9 (0.3) 99.7 (0.2)
5 96.5 (1.5) 99.8 (0.1) 94.4 (3.1) 96.2 (1.7) 99.5 (0.2) 100.0 (0.0)
9 96.4 (1.9) 100.0 (0.0) 95.6 (2.6) 96.7 (1.6) 99.9 (0.1) 100.0 (0.0)
13 97.0 (1.5) 99.9 (0.1) 94.6 (4.2) 96.4 (2.2) 100.0 (0.0) 100.0 (0.0)
17 96.1 (2.1) 100.0 (0.0) 95.0 (3.6) 96.1 (2.2) 100.0 (0.0) 100.0 (0.0)
21 97.0 (1.6) 100.0 (0.1) 95.4 (2.5) 97.0 (1.9) 100.0 (0.0) 100.0 (0.0)
Table A.13.: Patient 3 (caption: see section A.1.1)
patient 3 V95 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
3 6 3/4 2/5/6 2/5/6 3/4 1/3/4
5 2/6 1/3/4 2/5/6 2/5/6 3/4 1/3/4
9 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
13 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
17 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
21 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
Table A.14.: Patient 3 (caption: see section A.1.1)
patient 3 V107 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 3.1 (1.8) 3.0 (2.0) 3.3 (2.1) 3.1 (1.8) 0.4 (0.4) 0.9 (0.4)
3 1.3 (1.2) 0.1 (0.2) 1.5 (1.2) 1.3 (0.8) 0.1 (0.0) 0.0 (0.0)
5 1.0 (1.0) 0.0 (0.0) 1.1 (1.1) 1.2 (1.1) 0.0 (0.0) 0.0 (0.0)
9 0.7 (0.7) 0.0 (0.0) 1.2 (1.1) 0.9 (0.8) 0.0 (0.0) 0.0 (0.0)
13 0.8 (0.8) 0.0 (0.0) 0.9 (0.9) 0.7 (0.7) 0.0 (0.0) 0.0 (0.0)
17 0.7 (0.7) 0.0 (0.0) 1.0 (0.8) 0.8 (0.8) 0.0 (0.0) 0.0 (0.0)
21 0.9 (1.0) 0.0 (0.0) 1.0 (0.8) 0.7 (0.7) 0.0 (0.0) 0.0 (0.0)
Table A.15.: Patient 3 (caption: see section A.1.1)
patient 3 V107 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
3 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
5 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
9 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
13 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
17 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
21 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
Table A.16.: Patient 3 (caption: see section A.1.1)
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patient 3 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans slice vol mixed local random BS
1 12.2 (1.4) 12.2 (1.4) 12.7 (1.3) 12.4 (1.4) 8.5 (0.9) 9.5 (0.6)
3 9.4 (1.1) 6.5 (1.1) 9.9 (1.4) 9.6 (1.2) 6.6 (0.5) 4.9 (0.3)
5 9.0 (1.2) 4.8 (0.3) 9.6 (1.7) 9.2 (1.3) 5.6 (0.3) 3.4 (0.1)
9 8.7 (1.2) 4.0 (0.6) 9.5 (1.7) 8.8 (1.3) 3.9 (0.4) 2.4 (0.1)
13 8.6 (1.2) 3.9 (0.6) 9.4 (1.7) 8.6 (1.3) 3.4 (0.1) 1.9 (0.1)
17 8.8 (1.3) 3.6 (0.8) 9.4 (1.8) 8.8 (1.4) 3.1 (0.2) 1.8 (0.0)
21 8.5 (1.3) 3.4 (0.9) 9.3 (1.6) 8.6 (1.3) 3.0 (0.2) 1.8 (0.0)
Table A.17.: Patient 3 (caption: see section A.1.1)
patient 3 D5 D95 significance test [% prescribed dose]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
3 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
5 2/6 1/3/4 2/5/6 2/5/6 3/4 1/3/4
9 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
13 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
17 2/5/6 1/3/4 2/5/6 2/5/6 1/3/4 1/3/4
21 5/6 3/4 2/5/6 2/5/6 1/3/4 1/3/4
Table A.18.: Patient 3 (caption: see section A.1.1)
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Patient 4
Figure A.3.: Exemplary dose cuts of three selected re-scan modes, namely slice-by-slice, breath-
sampled and random-time-delay re-scanning for patient 4 in case of r = 1 and
r = 5, respectively. It can bee seen that breath-sampled and random-time-delay
re-scanning reduce the interplay patterns very e ciently. The CTV represents the
target contour and is outlined in black.
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Figure A.4.: V95 and V107 values for the di erent re-scan modes as a function of the re-scan num-
ber in case of patient 4. The V95 is a measure of the dose coverage and the V107 of
the overdose, respectively. Every case consist of twelve data points (due to the vari-
ation of the starting phases and the breathing periods) which might not be visible
due to clustering of the points when increasing the re-scan number.
Figure A.5.: The D5   D95 values for the di erent re-scan modes as a function of the re-scan
number in case of patient 4. The D5   D95 is a measure of the homogeneity. Every
case consist of twelve data points which might not be visible due to clustering of the
points when increasing the re-scan number.
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patient 4 V95 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 88.0 (5.2) 88.7 (5.6) 83.4 (5.0) 86.9 (5.6) 90.0 (2.7) 92.6 (1.0)
3 94.6 (4.0) 93.0 (6.8) 94.9 (3.2) 94.1 (4.0) 96.5 (1.6) 99.2 (0.4)
5 96.6 (3.0) 96.4 (5.0) 96.4 (3.4) 95.1 (5.0) 97.7 (1.0) 99.9 (0.1)
9 97.3 (3.2) 96.6 (4.9) 96.9 (3.9) 96.7 (3.6) 99.8 (0.2) 100.0 (0.0)
13 96.8 (4.1) 96.5 (5.3) 97.4 (3.3) 97.4 (3.3) 99.9 (0.0) 100.0 (0.0)
17 95.9 (6.8) 97.1 (4.3) 98.0 (3.0) 96.4 (5.5) 100.0 (0.0) 100.0 (0.0)
21 97.5 (3.0) 97.1 (4.4) 96.7 (4.9) 97.7 (3.0) 100.0 (0.0) 100.0 (0.0)
Table A.19.: Patient 4 (caption: see section A.1.1)
patient 4 V95 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 1/3/4/5
9 6 6 6 6 1/2/3/4
13 5/6 6 5/6 5/6 1/3/4 1/2/3/4
17 5/6 6 5/6 5/6 1/3/4 1/2/3/4
21 5/6 6 5/6 5/6 1/3/4 1/2/3/4
Table A.20.: Patient 4 (caption: see section A.1.1)
patient 4 V107 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 6.2 (4.9) 6.4 (4.4) 9.5 (3.9) 5.2 (2.6) 4.2 (1.6) 2.2 (0.5)
3 1.8 (2.6) 3.0 (4.0) 3.2 (4.1) 1.9 (2.6) 0.8 (0.6) 0.0 (0.0)
5 2.1 (3.8) 1.6 (2.4) 1.3 (1.8) 1.0 (1.8) 0.3 (0.3) 0.0 (0.0)
9 1.4 (2.7) 1.3 (2.1) 0.9 (1.6) 0.6 (1.0) 0.0 (0.0) 0.0 (0.0)
13 0.5 (0.9) 1.4 (2.2) 1.4 (2.6) 1.2 (1.8) 0.0 (0.0) 0.0 (0.0)
17 0.7 (1.0) 1.5 (2.5) 1.4 (2.4) 0.5 (1.0) 0.0 (0.0) 0.0 (0.0)
21 0.8 (1.3) 1.6 (2.6) 0.7 (1.2) 1.1 (1.9) 0.0 (0.0) 0.0 (0.0)
Table A.21.: Patient 4 (caption: see section A.1.1)
patient 4 V107 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 5/6 6 3 1/2/3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 6 1/2/3/4/5
9 6 6 6 1/3/4
13 5/6 5/6 5/6 1/3/4 1/3/4
17 5/6 5/6 1/3 1/3
21 5/6 5/6 1/4 1/4
Table A.22.: Patient 4 (caption: see section A.1.1)
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patient 4 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans slice vol mixed local random BS
1 14.6 (2.9) 14.5 (3.1) 17.9 (1.9) 14.8 (3.1) 13.4 (1.7) 11.3 (0.4)
3 10.1 (2.4) 11.3 (4.7) 10.6 (2.5) 10.4 (2.1) 8.8 (0.3) 6.1 (0.3)
5 9.1 (3.0) 7.8 (4.4) 8.8 (2.6) 8.9 (2.6) 7.4 (0.9) 4.0 (0.3)
9 8.2 (2.7) 7.1 (4.2) 7.8 (2.8) 7.9 (2.3) 5.0 (0.5) 2.9 (0.1)
13 7.5 (2.4) 6.9 (4.8) 7.8 (3.1) 8.0 (2.8) 4.1 (0.2) 2.0 (0.1)
17 7.8 (2.8) 6.7 (4.6) 7.5 (2.8) 7.5 (2.6) 3.8 (0.2) 1.9 (0.1)
21 7.5 (2.5) 6.7 (4.8) 7.4 (2.9) 7.6 (2.6) 3.4 (0.1) 1.8 (0.0)
Table A.23.: Patient 4 (caption: see section A.1.1)
patient 4 D5 D95 significance test [% prescribed dose]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 5/6 6 3 1/2/3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 6 1/2/3/4/5
9 5/6 6 6 5/6 1/4 1/2/3/4
13 5/6 6 5/6 5/6 1/3/4 1/2/3/4
17 5/6 6 5/6 5/6 1/3/4 1/2/3/4
21 5/6 6 5/6 5/6 1/3/4 1/2/3/4
Table A.24.: Patient 4 (caption: see section A.1.1)
Patient 5
patient 5 V95 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 85.3 (11.0) 85.4 (9.9) 78.3 (9.4) 85.9 (9.6) 90.9 (1.8) 93.7 (1.3)
3 92.7 (9.4) 93.9 (3.1) 93.2 (6.9) 91.9 (9.1) 96.8 (1.2) 99.5 (0.2)
5 92.0 (11.1) 97.3 (0.7) 91.6 (11.5) 93.3 (10.7) 98.7 (0.5) 100.0 (0.0)
9 93.2 (10.0) 99.0 (1.0) 94.3 (9.2) 94.0 (9.3) 99.7 (0.2) 100.0 (0.0)
13 94.2 (9.3) 99.3 (0.8) 93.0 (10.4) 93.0 (10.4) 100.0 (0.0) 100.0 (0.0)
17 94.1 (9.4) 99.4 (0.8) 93.7 (9.5) 93.5 (9.8) 100.0 (0.0) 100.0 (0.0)
21 93.9 (9.7) 99.1 (1.3) 94.2 (9.4) 94.9 (9.1) 100.0 (0.0) 100.0 (0.0)
Table A.25.: Patient 5 (caption: see section A.1.1)
patient 5 V95 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 6 6 1/2/3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 6 1/2/3/4/5
9 6 6 6 6 1/2/3/4
13 5/6 6 5/6 5/6 1/3/4 1/2/3/4
17 5/6 6 5/6 6 1/3 1/2/3/4
21 5/6 5/6 5/6 1/3/4 1/3/4
Table A.26.: Patient 5 (caption: see section A.1.1)
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patient 5 V107 mean (standard deviation) [% CTV volume]
re-scans slice vol mixed local random BS
1 7.5 (6.0) 7.2 (5.9) 15.6 (6.8) 7.0 (5.9) 3.4 (1.0) 1.8 (0.4)
3 3.5 (5.3) 2.0 (1.4) 4.6 (7.5) 3.6 (4.9) 0.6 (0.2) 0.0 (0.0)
5 2.8 (4.2) 0.6 (0.4) 3.2 (4.7) 2.6 (4.1) 0.2 (0.1) 0.0 (0.0)
9 2.2 (3.4) 0.4 (0.5) 2.3 (3.7) 2.7 (4.2) 0.0 (0.0) 0.0 (0.0)
13 2.8 (4.2) 0.4 (0.6) 2.3 (3.8) 2.7 (4.1) 0.0 (0.0) 0.0 (0.0)
17 2.7 (4.0) 0.5 (0.7) 2.1 (3.8) 1.9 (3.2) 0.0 (0.0) 0.0 (0.0)
21 2.1 (3.7) 0.3 (0.4) 2.8 (4.3) 2.2 (3.4) 0.0 (0.0) 0.0 (0.0)
Table A.27.: Patient 5 (caption: see section A.1.1)
patient 5 V107 significance test [% CTV volume]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 5/6 6 3 1/2/3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 6 1/2/3/4/5
9 6 6 6 2/3/4
13 5/6 5/6 5/6 5/6 1/2/3/4 1/2/3/4
17 5/6 5/6 5/6 1/3/4 1/3/4
21 5/6 5/6 5/6 1/3/4 1/3/4
Table A.28.: Patient 5 (caption: see section A.1.1)
patient 5 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans slice vol mixed local random BS
1 16.4 (5.7) 16.2 (5.5) 21.6 (2.8) 16.1 (5.5) 12.5 (0.7) 10.7 (0.2)
3 11.3 (5.5) 10.7 (1.5) 11.6 (3.9) 11.8 (5.4) 8.8 (0.4) 5.9 (0.4)
5 10.6 (5.6) 8.8 (0.6) 10.8 (5.2) 10.0 (5.0) 7.1 (0.5) 3.9 (0.2)
9 9.3 (5.2) 6.4 (2.3) 9.3 (5.2) 9.4 (5.3) 5.3 (0.3) 3.1 (0.2)
13 9.4 (5.4) 6.2 (2.1) 9.3 (5.2) 9.4 (5.8) 3.8 (0.2) 1.9 (0.0)
17 9.1 (5.6) 5.9 (2.3) 9.0 (5.0) 8.7 (5.1) 3.6 (0.1) 1.9 (0.0)
21 8.9 (5.4) 5.7 (2.6) 9.3 (5.5) 8.6 (5.0) 3.3 (0.3) 1.8 (0.0)
Table A.29.: Patient 5 (caption: see section A.1.1)
patient 5 D5 D95 significance test [% prescribed dose]
re-scans slice(1) vol(2) mixed(3) local(4) random(5) BS(6)
1 6 6 5/6 6 3 1/2/3/4
3 6 6 6 6 6 1/2/3/4/5
5 6 6 6 6 6 1/2/3/4/5
9 6 6 6 6 1/2/3/4
13 5/6 6 5/6 5/6 1/3/4 1/2/3/4
17 5/6 6 5/6 5/6 1/3/4 1/2/3/4
21 5/6 6 5/6 5/6 1/3/4 1/2/3/4
Table A.30.: Patient 5 (caption: see section A.1.1)
A.1.5 Special case I - breath-sampled re-scanning uncertainty: Mean V95, V107 D5  D95
values along with corresponding significance testing
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Patient 2
patient 2 BS period mismatch:V95 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 99.4 (0.1) 97.7 (0.1) 96.2 (0.6) 97.1 (0.2) 96.8 (0.5) 95.6 (0.4) 96.1 (1.2) 95.5 (0.4)
3 99.9 (0.0) 99.7 (0.1) 99.7 (0.1) 99.9 (0.0) 99.9 (0.0) 99.9 (0.0) 99.9 (0.0) 99.8 (0.0)
5 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
9 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
13 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
Table A.31.: Patient 2 (caption: see section A.1.2)
patient 2 BS period mismatch: V95 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/8 6 1/2 1
3 5/7 7 2 2/3
5 5 2
9
13
Table A.32.: Patient 2 (caption: see section A.1.2)
patient 2 BS period mismatch:V107 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 0.0 (0.0) 0.3 (0.0) 1.0 (0.1) 0.4 (0.1) 0.8 (0.0) 1.3 (0.2) 0.9 (0.1) 1.0 (0.1)
3 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
5 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.33.: Patient 2 (caption: see section A.1.2)
patient 2 BS period mismatch: V107 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 3/6 6 1 6 1/2/4
3 6 6 6 1/4/5/7 6
5
9
13
Table A.34.: Patient 2 (caption: see section A.1.2)
patient 2 BS period mismatch:D5 D95 mean (standard deviation) [% prescribed dose]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 6.3 (0.0) 8.2 (0.1) 9.5 (0.2) 8.7 (0.0) 9.1 (0.1) 9.7 (0.2) 9.3 (0.2) 9.7 (0.1)
3 4.3 (0.1) 5.5 (0.0) 5.2 (0.0) 4.9 (0.1) 4.4 (0.1) 5.0 (0.0) 4.3 (0.1) 5.1 (0.0)
5 3.5 (0.0) 3.9 (0.0) 3.7 (0.0) 3.4 (0.0) 3.3 (0.1) 3.5 (0.0) 3.4 (0.0) 3.6 (0.0)
9 3.3 (0.0) 2.8 (0.0) 3.0 (0.0) 2.3 (0.0) 2.1 (0.0) 2.2 (0.1) 2.5 (0.1) 3.2 (0.1)
13 1.9 (0.0) 2.7 (0.1) 2.1 (0.1) 1.9 (0.0) 1.9 (0.0) 1.9 (0.0) 2.1 (0.1) 3.0 (0.0)
Table A.35.: Patient 2 (caption: see section A.1.2)
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patient 2 BS period mismatch: D5 D95 significance test [% prescribed dose]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/8 6/8 1/2 1/2
3 2/3 1/5/7 1/7 2 2/3
5 4/5/7 5 2 2/3 2
9 4/5/6 1 1/8 1 5
13 5 2/8 8 5/6
Table A.36.: Patient 2 (caption: see section A.1.2)
Patient 3
patient 3 BS period mismatch:V95 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 99.4 (0.2) 97.8 (0.1) 93.1 (1.4) 96.4 (0.9) 95.7 (0.3) 88.6 (4.6) 87.5 (6.0) 93.4 (0.7)
3 100.0 (0.0) 99.6 (0.2) 99.3 (0.2) 99.6 (0.1) 99.9 (0.1) 99.6 (0.1) 99.8 (0.1) 99.5 (0.2)
5 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 99.9 (0.0) 100.0 (0.0) 100.0 (0.0)
9 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
13 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
Table A.37.: Patient 3 (caption: see section A.1.2)
patient 3 BS period mismatch: V95 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 7 1 1/2
3 3 1/5 3
5
9
13
Table A.38.: Patient 2 (caption: see section A.1.2)
patient 3 BS period mismatch:V107 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 0.0 (0.0) 0.3 (0.1) 2.8 (0.4) 0.7 (0.3) 0.7 (0.3) 2.2 (1.3) 3.9 (2.3) 1.4 (0.3)
3 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
5 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.39.: Patient 3 (caption: see section A.1.2)
patient 3 BS period mismatch: V107 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 3/6/7 7 1 1 1/2
3
5
9
13
Table A.40.: Patient 3 (caption: see section A.1.2)
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patient 3 BS period mismatch:D5 D95 mean (standard deviation) [% prescribed dose]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 6.0 (0.1) 7.9 (0.2) 11.4 (0.1) 9.1 (0.0) 9.5 (0.1) 12.0 (0.4) 13.2 (1.1) 10.7 (0.2)
3 4.3 (0.1) 5.5 (0.0) 5.9 (0.1) 5.3 (0.0) 4.6 (0.2) 5.5 (0.2) 5.4 (0.2) 5.5 (0.1)
5 3.5 (0.0) 4.1 (0.1) 3.8 (0.1) 3.5 (0.0) 3.4 (0.0) 3.7 (0.1) 3.9 (0.2) 3.8 (0.1)
9 3.4 (0.1) 2.9 (0.1) 3.2 (0.1) 2.5 (0.0) 2.5 (0.0) 2.5 (0.1) 3.4 (0.2) 3.5 (0.0)
13 2.0 (0.1) 2.9 (0.1) 2.4 (0.1) 2.1 (0.0) 2.0 (0.1) 2.1 (0.2) 2.9 (0.6) 3.4 (0.0)
Table A.41.: Patient 3 (caption: see section A.1.2)
patient 3 BS period mismatch: D5 D95 significance test [% prescribed dose]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 6/7 1/2 1/2
3 3/8 1/5 3 1
5 2 1/5 2/8 5
9 5 8 1/8 8 4/5/6
13 8 8 1/5
Table A.42.: Patient 3 (caption: see section A.1.2)
Patient 4
patient 4 BS period mismatch:V95 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 95.0 (0.5) 93.6 (1.9) 88.5 (1.3) 92.6 (0.6) 92.8 (0.4) 82.6 (1.6) 85.5 (3.1) 91.8 (1.0)
3 99.4 (0.1) 98.7 (0.1) 98.1 (0.5) 99.2 (0.1) 99.3 (0.6) 98.5 (0.4) 97.0 (1.3) 99.0 (0.0)
5 99.9 (0.0) 99.2 (0.4) 99.9 (0.0) 99.8 (0.0) 100.0 (0.0) 99.9 (0.1) 99.4 (0.5) 100.0 (0.0)
9 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 99.9 (0.1) 100.0 (0.0)
Table A.43.: Patient 4 (caption: see section A.1.2)
patient 4 BS period mismatch: V95 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 1 1
3 7 7 1/5
5 5/8 2 2
9
Table A.44.: Patient 4 (caption: see section A.1.2)
patient 4 BS period mismatch:V107 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 1.3 (0.3) 2.1 (0.7) 4.9 (1.0) 2.6 (0.9) 2.1 (0.4) 8.6 (0.6) 11.3 (3.1) 2.3 (0.2)
3 0.0 (0.0) 0.2 (0.1) 0.1 (0.1) 0.0 (0.0) 0.0 (0.0) 0.1 (0.1) 0.5 (0.8) 0.0 (0.0)
5 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.45.: Patient 4 (caption: see section A.1.2)
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patient 4 BS period mismatch: V107 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 1 1
3 2 1
5 2 1/3/4/5/6/8 2 2 2 2 2
9
Table A.46.: Patient 4 (caption: see section A.1.2).
patient 4 BS period mismatch:D5 D95 mean (standard deviation) [% prescribed dose]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 9.8 (0.3) 10.9 (0.2) 14.0 (0.5) 11.5 (0.4) 11.2 (0.2) 17.9 (0.6) 19.0 (0.2) 11.7 (0.3)
3 5.7 (0.1) 7.1 (0.1) 7.3 (0.1) 6.1 (0.1) 5.9 (0.4) 7.3 (0.1) 7.8 (0.6) 6.3 (0.0)
5 4.4 (0.1) 6.0 (0.4) 4.6 (0.2) 4.5 (0.1) 3.8 (0.0) 4.5 (0.2) 5.0 (0.4) 4.0 (0.2)
9 3.8 (0.1) 3.2 (0.1) 3.6 (0.1) 3.1 (0.1) 3.0 (0.0) 3.0 (0.0) 3.6 (0.1) 3.4 (0.1)
Table A.47.: Patient 4 (caption: see section A.1.2)
patient 4 BS period mismatch: D5 D95 significance test [% prescribed dose]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 7 1 1/2
3 3/6/7 1 1 1
5 5/8 2/7 5 2
9 4/5/6 1 1/7 1 5
Table A.48.: Patient 4 (caption: see section A.1.2)
Patient 5
patient 5 BS period mismatch:V95 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 97.7 (0.3) 94.4 (0.7) 89.3 (1.4) 93.8 (0.9) 94.0 (0.3) 85.0 (3.5) 74.7 (5.7) 92.9 (1.2)
3 99.7 (0.2) 99.4 (0.2) 99.1 (0.1) 99.5 (0.1) 99.6 (0.1) 98.9 (0.2) 97.9 (0.8) 99.5 (0.1)
5 100.0 (0.0) 99.5 (0.1) 99.9 (0.0) 99.9 (0.0) 100.0 (0.0) 99.9 (0.0) 99.6 (0.1) 100.0 (0.0)
9 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 99.9 (0.0) 100.0 (0.0)
13 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.0)
Table A.49.: Patient 5 (caption: see section A.1.2)
patient 5 BS period mismatch: V95 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 7 1 1/2
3 7 1
5 2/7 1/5 2/7 1/5
9 7 7 2/5
13
Table A.50.: Patient 5 (caption: see section A.1.2)
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patient 5 BS period mismatch:V107 mean (standard deviation) [% CTV volume]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 0.6 (0.4) 1.6 (0.3) 4.7 (0.3) 1.8 (0.3) 1.6 (0.2) 8.3 (1.1) 13.7 (4.0) 1.5 (0.3)
3 0.0 (0.0) 0.1 (0.0) 0.1 (0.0) 0.0 (0.0) 0.0 (0.0) 0.1 (0.1) 0.6 (0.2) 0.0 (0.0)
5 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
9 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Table A.51.: Patient 5 (caption: see section A.1.2)
patient 5 BS period mismatch: V107 significance test [% CTV volume]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 1 1/8 7
3 3/7 1 7 1/5
5 7 7 7 7 1/3/5/6/8 7
9
13
Table A.52.: Patient 5 (caption: see section A.1.2)
patient 5 BS period mismatch:D5 D95 mean (standard deviation) [% prescribed dose]
re-scans 1s 3s 3.5s 3.75s 4s 4.25s 4.5s 5s
1 8.5 (0.3) 10.4 (0.3) 13.6 (0.2) 10.8 (0.1) 10.6 (0.1) 16.5 (0.5) 23.2 (0.1) 10.9 (0.2)
3 5.6 (0.0) 6.5 (0.1) 6.7 (0.1) 6.0 (0.2) 5.6 (0.1) 7.1 (0.1) 8.4 (0.4) 5.8 (0.1)
5 3.9 (0.0) 5.8 (0.0) 4.2 (0.1) 4.7 (0.1) 3.7 (0.0) 4.2 (0.1) 5.8 (0.4) 4.1 (0.2)
9 3.5 (0.0) 3.2 (0.1) 3.5 (0.1) 3.0 (0.1) 3.1 (0.1) 3.1 (0.1) 4.6 (0.6) 3.5 (0.1)
13 2.1 (0.4) 2.9 (0.0) 2.7 (0.2) 2.0 (0.0) 1.9 (0.0) 2.2 (0.0) 4.3 (0.5) 3.3 (0.1)
Table A.53.: Patient 5 (caption: see section A.1.2)
patient 5 BS period mismatch: D5 D95 significance test [% prescribed dose]
re-scans 1s(1) 3s(2) 3.5s(3) 3.75s(4) 4s(5) 4.25s(6) 4.5s(7) 5s(8)
1 6/7 7 7 1 1/2/5
3 6/7 6/7 1/5 1/5
5 7 5 2/7 1/5
9 7 7 7 4/5/6
13 7 7 7/8 1/4/5 5
Table A.54.: Patient 5 (caption: see section A.1.2)
A.1.6 Special case II - variation of the number and the maximum length of the
random-pauses : Mean V95, V107 D5  D95 values along with corresponding
significance testing
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Variation of the number of the random-pauses
patient 5 V95 mean (standard deviation) [% CTV volume]
re-scans µrandom = 0.05 µrandom = 0.2
1 91.9 (2.3) 92.0 (2.2)
3 96.9 (1.3) 96.7 (1.2)
5 98.2 (0.1) 98.1 (0.2)
9 99.7 (0.3) 99.6 (0.3)
13 100.0 (0.0) 100.0 (0.0)
Table A.55.: Patient 5 (caption: see section A.1.3)
patient 5 V95 significance test [% CTV volume]
re-scans µrandom = 0.05(1) µrandom = 0.2(2)
1
3
5
9
13
Table A.56.: Patient 5 (caption: see section A.1.3)
patient 5 V107 mean (standard deviation) [% CTV volume]
re-scans µrandom = 0.05 µrandom = 0.2
1 2.8 (0.9) 2.8 (0.9)
3 0.4 (0.0) 0.5 (0.0)
5 0.3 (0.2) 0.4 (0.1)
9 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0)
Table A.57.: Patient 5 (caption: see section A.1.3)
patient 5 V107 significance test [% CTV volume]
re-scans µrandom = 0.05(1) µrandom = 0.2(2)
1
3
5
9
13
Table A.58.: Patient 5 (caption: see section A.1.3)
patient 5 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans µrandom = 0.05 µrandom = 0.2
1 12.0 (0.7) 11.9 (0.5)
3 8.9 (0.3) 8.7 (0.3)
5 7.6 (0.4) 7.9 (0.3)
9 5.4 (0.2) 5.4 (0.2)
13 3.6 (0.0) 4.4 (0.8)
Table A.59.: Patient 5 (caption: see section A.1.3)
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patient 5 D5 D95 significance test [% prescribed dose]
re-scans µrandom = 0.05(1) µrandom = 0.2(2)
1
3
5
9
13 2 1
Table A.60.: Patient 5 (caption: see section A.1.3)
Variation of the maximum length of the random-pauses
patient 5 V95 mean (standard deviation) [% CTV volume]
re-scans Trandom, max = 1 s Trandom, max = 0.1 s
1 91.9 (2.3) 91.4 (1.2)
3 96.9 (1.3) 98.3 (0.2)
5 98.2 (0.1) 99.2 (0.2)
9 99.7 (0.3) 99.8 (0.1)
13 100.0 (0.0) 100.0 (0.0)
Table A.61.: Patient 5 (caption: see section A.1.3)
patient 5 V95 significance test [% CTV volume]
re-scans Trandom, max = 1 s(1) Trandom, max = 0.1 s(2)
1
3 2 1
5 2 1
9
13
Table A.62.: Patient 5 (caption: see section A.1.3)
patient 5 V107 mean (standard deviation) [% CTV volume]
re-scans Trandom, max = 1 s Trandom, max = 0.1 s
1 2.8 (0.9) 4.4 (0.3)
3 0.4 (0.0) 0.2 (0.1)
5 0.3 (0.2) 0.1 (0.1)
9 0.0 (0.0) 0.0 (0.0)
13 0.0 (0.0) 0.0 (0.0)
Table A.63.: Patient 5 (caption: see section A.1.3)
patient 5 V107 significance test [% CTV volume]
re-scans Trandom, max = 1 s(1) Trandom, max = 0.1 s(2)
1 2 1
3
5
9
13
Table A.64.: Patient 5 (caption: see section A.1.3)
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patient 5 D5 D95 mean (standard deviation) [% prescribed dose]
re-scans Trandom, max = 1 s Trandom, max = 0.1 s
1 12.0 (0.7) 12.9 (0.3)
3 8.9 (0.3) 7.8 (0.2)
5 7.6 (0.4) 6.9 (0.4)
9 5.4 (0.2) 5.4 (0.2)
13 3.6 (0.0) 5.7 (0.1)
Table A.65.: Patient 5 (caption: see section A.1.3)
patient 5 D5 D95 significance test [% prescribed dose]
re-scans Trandom, max = 1 s(1) Trandom, max = 0.1 s(2)
1
3 2 1
5
9
13 2 1
Table A.66.: Patient 5 (caption: see section A.1.3)
183

B Appendix of chapter 4
Results and additional information of the dosimetry chapter which have not been not presented
in the text are shown here.
B.1 Material & methods
B.1.1 Dosimetry at HIT
Figure B.1.: This figure shows in a) - c) the DeVarPho from di erent angles together with its
dimension and materials. d) is a picture taken from the set up. The mp3 water
phantom with the pin points can be seen behind the DeVarPho.
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Figure B.2.: The ITV dose distribution of the reference phase of the DeVarPho optimized with
the algorithm implemented by Grae  et. al. (Grae  et al., 2012). The overshoot in
the lower left and lower right corner is due to the finite FWHM width of the beam
an the density variations of the DeVarPho. This e ect is explained in figure B.3. The
white circles represent the pin point chambers.
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Figure B.3.: Schematic illustration of dose overshooting. The beams are colored di erently and
symbolized by rectangles. Like shown in a), if the width of the beam is broader
than the slit of air or the rastergrid position causes a beam to cross materials of
di erent density (in the upper half of the phantom) it will result in overshoot of
the dose. In order to fill the ITV with the prescribed dose, beam 1 in a) must have
enough energy to cross the PMMA, parts of this beam also travel trough air instead
of PMMA. Consequently, those particles will move further into the medium (e.g.
water) like shown in a’). b) shows the ideal case without overshooting.
Figure B.4.: Pin point doses of slice-by-slice re-scanning (11 re-scans) relative to the standard
mode of the DeVarPho. The pin points inside the area of 6mm  x  36mm
and 10mm  y  70mm lie well inside the ITV region without sharp dose gradi-
ents. Therefore these pin point are used when quantitative results are reported. The
phantom was not moving.
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B.2 Motion e ects mitigation
B.2.1 Motion e ects mitigation by re-scanning at HIT
Figure B.5.: Pin point doses of slice-by-slice re-scanning (r = 1) in the presence of motion of the
DeVarPho relative to the standard mode irradiation without motion. The motion
causes distinct interplay patterns. The scan-path was vertical.
Figure B.6.: Pin point doses of slice-by-slice re-scanning (r = 5) in the presence of motion of the
DeVarPho relative to the standard mode irradiation without motion. The motion
causes distinct interplay patterns. The scan-path was vertical.
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Figure B.7.: Pin point doses of slice-by-slice re-scanning (r = 1) in the presence of motion of the
DeVarPho relative to the standard mode irradiation without motion. The motion
causes distinct interplay patterns. The scan-path was horizontal
Figure B.8.: The ITV dose distribution of the BreThoPho of the reference phase optimized with
the algorithm implemented by Grae  et. al. (Grae  et al., 2012). The white circles
represent the pin point chambers.
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Figure B.9.: Pin point doses of slice-by-slice re-scanning (r = 1) in the presence of motion of the
BreThoPho relative to the standard mode irradiation without motion. The pin points
inside the area of 10mm x  30mm and 12mm y  24mm lie well inside the
ITV region without sharp dose gradients. Therefore these pin point are used when
quantitative results are reported. The scan-path was horizontal.
Figure B.10.: Pin point doses of slice-by-slice re-scanning (r = 5) in the presence of motion of
the BreThoPho relative to the standard mode irradiation without motion. The pin
points inside the area of 10mm  x  30mm and 12mm  y  24mm lie well
inside the ITV region without sharp dose gradients. Therefore these pin point are
used when quantitative results are reported. The scan-path was horizontal.
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Figure B.11.: Pin point doses of slice-by-slice re-scanning (r = 5) in the presence of motion of
the BreThoPho relative to the standard mode irradiation without motion. The pin
points inside the area of 10mm  x  30mm and 12mm  y  24mm lie well
inside the ITV region without sharp dose gradients. Therefore these pin point are
used when quantitative results are reported. The scan-path was vertical.
Figure B.12.: Pin point doses of breath-sampled re-scanning (r = 5) in the presence of motion of
the BreThoPho relative to the standard mode irradiation without motion. The pin
points inside the area of 10mm  x  30mm and 12mm  y  24mm lie well
inside the ITV region without sharp dose gradients. Therefore these pin point are
used when quantitative results are reported. The scan-path was vertical.
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versuche ich Dir lieber meine Dankbarkeit so oft wie möglich zu zeigen!
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Hiermit versichere ich, die vorliegende Dissertation ohne Hilfe Dritter nur mit den
angegebenen Quellen und Hilfsmitteln angefertigt zu haben. Alle Stellen, die aus
Quellen entnommen wurden, sind als solche kenntlich gemacht. Diese Arbeit hat
in gleicher oder ähnlicher Form noch keiner Prüfungsbehörde vorgelegen.
Darmstadt, den 16. Dezember 2013
(Dirk Müssig)
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